data_1clf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1clf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 CA--C 1.508 -0.673 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -128.32 161.84 28.46 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.78 100.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 153.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.28 174.0 10.71 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.2 -0.938 . . . . 0.0 111.474 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.31 -16.47 2.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.835 2.054 . . . . 0.0 114.787 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -51.25 -33.01 26.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.433 -0.792 . . . . 0.0 111.761 166.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.3 t -55.71 130.26 42.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.251 1.82 . . . . 0.0 112.086 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.2 150.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -67.56 70.53 0.12 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.334 0.97 . . . . 0.0 111.993 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.22 -22.74 20.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.713 1.205 . . . . 0.0 111.42 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.95 -30.68 5.7 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 113.698 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.1 56.48 2.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.359 1.079 . . . . 0.0 113.309 -164.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -155.59 -31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.306 1.042 . . . . 0.0 112.282 171.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -36.02 -60.4 0.55 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -75.92 -15.2 60.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.296 1.039 . . . . 0.0 112.494 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -81.42 -34.17 31.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.967 1.307 . . . . 0.0 109.339 -169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.23 122.35 58.43 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.587 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -33.47 73.84 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.711 2.274 . . . . 0.0 112.493 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.06 7.42 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 122.818 0.447 . . . . 0.0 110.8 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 49.09 35.22 6.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.117 1.367 . . . . 0.0 111.866 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 36.41 0.42 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.052 1.341 . . . . 0.0 111.075 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mt -142.27 147.64 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.311 1.044 . . . . 0.0 109.489 -170.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -169.79 174.24 5.8 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 127.331 2.252 . . . . 0.0 108.522 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -85.42 128.66 34.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.481 1.037 . . . . 0.0 108.368 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.98 -67.86 0.14 Allowed Glycine 0 C--N 1.339 0.721 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.434 -161.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -98.96 -52.52 3.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -166.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.8 m -141.78 -50.51 0.4 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 109.181 156.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -161.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.225 1.01 . . . . 0.0 109.62 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.289 17.1 m-85 -68.69 161.94 27.15 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 117.714 -1.594 . . . . 0.0 110.906 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.87 162.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 126.783 2.033 . . . . 0.0 107.437 -170.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -128.92 138.6 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.651 1.18 . . . . 0.0 108.695 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -73.58 76.12 1.49 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 165.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -32.99 64.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -168.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.9 -48.08 8.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.443 1.897 . . . . 0.0 112.171 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.82 -29.95 12.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.655 2.382 . . . . 0.0 111.247 -165.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.8 t -52.85 134.65 37.0 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.288 0.949 . . . . 0.0 110.141 165.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 pt -107.89 137.92 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 159.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.96 74.11 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.56 -20.03 18.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.853 0.861 . . . . 0.0 113.041 -169.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.28 4.1 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.525 -0.734 . . . . 0.0 112.511 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -54.63 165.45 0.59 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 163.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.372 6.9 p 60.61 -57.56 0.08 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.373 1.469 . . . . 0.0 112.386 -152.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.44 96.61 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.234 1.379 . . . . 0.0 109.571 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -37.29 78.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.082 0.953 . . . . 0.0 111.914 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.94 -40.59 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.894 0.77 . . . . 0.0 111.007 -169.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.8 t -54.67 118.84 18.16 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.269 -170.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.1 -36.18 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.975 3.116 . . . . 0.0 114.216 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.42 14.27 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.68 50.67 36.07 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.746 0.703 . . . . 0.0 112.791 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 52' ' ' PRO . . . -80.02 -23.75 0.39 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 114.916 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 51' ' ' ALA . 55.5 Cg_exo -60.14 82.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.747 2.298 . . . . 0.0 110.764 168.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 m -159.85 153.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 128.901 2.88 . . . . 0.0 104.068 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -90.0 149.74 22.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.674 1.859 . . . . 0.0 114.299 -138.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 116.689 -1.625 . . . . 0.0 107.434 146.662 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -142.43 -168.93 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 156.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mm -79.45 105.55 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 156.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.86 165.19 25.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.961 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.48 -15.87 3.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -53.18 -25.66 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.327 -0.858 . . . . 0.0 113.27 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -59.31 162.15 4.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.267 1.427 . . . . 0.0 111.669 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.65 173.2 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 m -70.6 64.03 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.299 -0.875 . . . . 0.0 111.011 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -179.78 4.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.04 2.136 . . . . 0.0 106.695 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.39 37.6 0.84 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 120.446 1.476 . . . . 0.0 111.315 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 -31.0 43.74 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.861 0.464 . . . . 0.0 111.537 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.286 29.9 p -80.43 -97.4 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.595 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.57 -99.01 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 121.157 1.799 . . . . 0.0 113.611 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 m -48.4 -31.73 6.61 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.926 1.691 . . . . 0.0 112.461 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -53.25 -28.23 26.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.407 1.083 . . . . 0.0 112.898 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.55 120.65 81.11 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 119.11 0.868 . . . . 0.0 110.739 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.45 -34.79 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.64 6.98 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 117.937 0.335 . . . . 0.0 111.022 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 22.69 4.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.289 1.835 . . . . 0.0 111.816 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.3 50.18 1.89 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.2 -0.938 . . . . 0.0 110.538 -164.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mt -136.72 147.71 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.608 1.563 . . . . 0.0 107.985 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -169.08 168.36 10.06 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.31 2.244 . . . . 0.0 109.327 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -71.74 117.12 12.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.06 -66.67 1.12 Allowed Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -114.8 -72.14 0.71 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -108.65 -61.09 1.65 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.611 1.165 . . . . 0.0 108.326 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.9 -166.55 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.182 0.593 . . . . 0.0 110.35 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.88 155.7 40.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 110.66 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.77 156.42 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 126.976 2.11 . . . . 0.0 106.381 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -126.12 146.34 32.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.42 84.19 0.58 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 164.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.74 -29.66 62.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.439 -0.788 . . . . 0.0 112.689 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -41.66 -47.6 3.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.54 1.936 . . . . 0.0 112.071 164.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -102.84 -34.13 9.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.095 2.158 . . . . 0.0 111.981 -164.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.6 t -52.45 129.2 28.06 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.677 1.126 . . . . 0.0 111.966 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 pt -107.64 34.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.256 1.423 . . . . 0.0 111.78 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.27 35.9 14.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.96 1.704 . . . . 0.0 112.758 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.47 -16.35 57.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.31 -27.97 7.95 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.454 1.026 . . . . 0.0 114.816 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -54.64 -50.81 67.25 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.947 1.874 . . . . 0.0 113.205 -165.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.5 p -55.01 -44.93 75.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.915 -0.49 . . . . 0.0 110.675 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.97 82.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.752 -0.592 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -39.59 75.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.7 -0.667 . . . . 0.0 111.559 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.56 -40.41 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.128 0.876 . . . . 0.0 111.869 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -53.94 121.65 30.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -164.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.93 -26.97 83.23 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.746 2.298 . . . . 0.0 112.736 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.95 19.05 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.553 0.741 . . . . 0.0 112.099 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.55 54.19 9.12 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.476 0.56 . . . . 0.0 113.122 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.65 -27.48 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.581 . . . . 0.0 114.58 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.67 82.48 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.274 1.983 . . . . 0.0 108.67 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -162.23 155.76 2.74 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -168.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -90.16 148.12 23.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 127.205 2.816 . . . . 0.0 112.671 -148.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 163.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -122.41 -179.22 4.12 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 146.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.33 104.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 155.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.7 176.41 8.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.088 0.946 . . . . 0.0 112.895 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.75 -31.59 2.09 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.66 1.984 . . . . 0.0 114.985 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -54.75 -16.37 2.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.9 t -55.55 -33.75 64.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.923 2.089 . . . . 0.0 115.607 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.288 1.8 m 71.35 -53.32 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 119.473 -2.017 . . . . 0.0 113.988 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p 129.08 29.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 131.399 3.88 . . . . 0.0 111.307 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -19.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -162.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.41 -53.0 4.08 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.109 -0.994 . . . . 0.0 114.24 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -33.11 -63.32 0.23 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.34 1.456 . . . . 0.0 114.633 -160.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -56.36 -21.46 24.8 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -170.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.39 -47.04 3.5 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.754 0.821 . . . . 0.0 112.657 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.5 m -82.72 -24.26 33.68 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -74.0 -34.65 64.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.756 1.223 . . . . 0.0 111.075 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.88 123.28 51.93 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.428 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.56 -37.4 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.294 3.329 . . . . 0.0 113.694 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.31 20.48 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.1 0.56 . . . . 0.0 112.163 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 44.72 49.37 8.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 0.0 112.432 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.18 31.61 1.66 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.389 1.076 . . . . 0.0 111.157 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.48 146.25 30.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.763 0.825 . . . . 0.0 109.107 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.47 169.24 10.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.135 2.174 . . . . 0.0 109.897 172.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -75.22 125.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.72 -73.88 1.06 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.99 -70.04 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -115.08 -62.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.71 2.004 . . . . 0.0 107.232 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -167.24 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.529 1.132 . . . . 0.0 111.075 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -73.32 151.8 41.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.427 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 159.75 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 127.677 2.391 . . . . 0.0 106.008 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.64 131.45 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.41 79.55 0.76 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.27 66.58 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -163.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.89 -34.34 77.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.795 1.238 . . . . 0.0 110.694 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -84.81 -40.83 16.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 110.433 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 t -61.27 149.67 37.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.128 0.876 . . . . 0.0 108.743 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 pt -90.84 -112.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 167.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.89 129.1 11.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 155.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -161.03 161.8 31.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.052 0.842 . . . . 0.0 109.848 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.25 -26.93 56.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.489 -0.757 . . . . 0.0 112.392 -173.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -47.8 -60.68 2.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.272 1.029 . . . . 0.0 113.207 -159.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.5 p -60.71 -41.55 95.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.651 0.659 . . . . 0.0 110.465 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.38 81.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.505 -0.747 . . . . 0.0 110.307 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -46.02 72.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.403 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.86 -37.35 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.405 1.002 . . . . 0.0 111.408 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -53.77 118.57 15.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.649 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.44 -38.17 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.65 3.567 . . . . 0.0 114.813 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.06 24.34 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 112.15 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.59 62.09 5.09 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.385 0.539 . . . . 0.0 112.962 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.17 -23.74 0.21 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 126.722 2.009 . . . . 0.0 114.699 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -60.95 90.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.82 2.347 . . . . 0.0 108.038 162.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 m -159.19 144.54 6.69 Favored 'Isoleucine or valine' 0 C--O 1.252 1.209 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -91.1 131.5 36.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 128.359 3.537 . . . . 0.0 114.23 -144.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 157.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -142.32 -163.36 1.59 Allowed 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 115.845 -2.342 . . . . 0.0 105.465 135.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.09 108.97 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 156.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.25 163.25 27.22 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.274 -0.891 . . . . 0.0 110.848 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.07 -12.31 4.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -52.43 -29.18 23.15 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.336 -0.852 . . . . 0.0 112.228 166.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.8 t -58.87 156.27 11.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.997 1.319 . . . . 0.0 111.653 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.59 167.67 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 164.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -65.39 64.48 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.012 1.325 . . . . 0.0 111.997 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -34.05 7.2 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.585 1.154 . . . . 0.0 112.716 -165.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.92 21.68 56.14 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.879 1.228 . . . . 0.0 114.742 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.79 -28.43 58.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.162 0.981 . . . . 0.0 111.46 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 p -79.31 -108.62 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 53.76 -101.65 0.12 Allowed 'General case' 0 C--N 1.34 0.174 0 CA-C-N 121.49 1.95 . . . . 0.0 111.799 170.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m -41.32 -36.29 0.78 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.409 1.884 . . . . 0.0 112.832 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -41.79 62.33 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 111.569 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.54 125.0 81.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.262 -166.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.53 -35.03 11.87 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.59 2.86 . . . . 0.0 114.096 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.4 m -107.08 5.19 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 48.69 37.43 9.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.032 1.333 . . . . 0.0 111.64 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.83 32.46 0.42 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.697 1.199 . . . . 0.0 111.958 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -132.1 151.14 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.885 1.274 . . . . 0.0 108.786 -172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 p -164.67 174.15 11.11 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.395 1.478 . . . . 0.0 109.195 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -77.38 125.24 29.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.77 -83.44 1.7 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -167.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -99.87 -50.33 4.05 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.25 1.02 . . . . 0.0 108.446 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 p -140.73 -57.7 0.52 Allowed 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.031 2.133 . . . . 0.0 106.609 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.45 -162.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.21 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -79.8 156.29 27.49 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.267 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -147.99 158.36 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.767 2.027 . . . . 0.0 108.28 -171.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.84 149.75 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 125.699 1.6 . . . . 0.0 108.957 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -82.77 114.17 20.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 157.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.621 1.1 . . . . 0.0 112.004 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 -38.92 85.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.7 1.2 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 m -79.85 -40.06 29.27 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.742 1.217 . . . . 0.0 109.745 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.9 112.04 1.9 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.582 0.628 . . . . 0.0 110.941 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.5 pt -79.76 47.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 121.244 -0.91 . . . . 0.0 111.316 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 14.73 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.609 2.763 . . . . 0.0 114.402 -173.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -5.27 40.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.99 -37.38 1.49 Allowed Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.035 -1.041 . . . . 0.0 114.23 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -46.17 -52.46 12.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -154.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -47.35 -37.7 11.62 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.147 1.779 . . . . 0.0 111.596 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -34.73 61.3 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.52 -0.738 . . . . 0.0 112.29 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -67.69 -44.89 76.69 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.87 0.304 . . . . 0.0 111.004 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.66 -30.37 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.868 -171.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -56.74 118.73 24.74 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.278 -170.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.88 -37.3 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.421 3.414 . . . . 0.0 114.253 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.73 22.65 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.995 0.918 . . . . 0.0 112.246 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.91 64.42 3.27 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.601 0.637 . . . . 0.0 113.039 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.39 -23.4 0.19 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -64.29 83.15 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.374 2.05 . . . . 0.0 108.28 163.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -162.27 151.72 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 -165.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.83 151.05 21.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 127.307 2.879 . . . . 0.0 113.614 -143.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 152.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 . . . . . 0 CA--C 1.517 -0.311 0 N-CA-C 105.429 -2.064 . . . . 0.0 105.429 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -118.17 -179.33 3.74 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 143.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.1 109.44 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 147.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.93 173.37 11.29 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 122.143 0.973 . . . . 0.0 111.286 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -47.96 -31.09 4.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.035 1.334 . . . . 0.0 113.299 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -65.11 13.19 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.7 t -74.17 -73.12 0.24 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.627 2.371 . . . . 0.0 112.793 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.274 1.3 m 75.77 137.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 127.197 2.199 . . . . 0.0 110.373 -159.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.25 57.03 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.941 2.096 . . . . 0.0 114.48 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -17.94 25.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.214 0.915 . . . . 0.0 112.903 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.92 -57.96 4.02 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 120.92 -1.112 . . . . 0.0 114.005 167.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -30.38 -57.76 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.283 1.833 . . . . 0.0 114.756 -164.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -63.28 -20.92 65.9 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -169.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.91 -58.3 2.1 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.413 1.006 . . . . 0.0 112.444 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -29.17 67.22 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.287 1.035 . . . . 0.0 112.537 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 111.632 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.31 123.66 83.25 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.519 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -42.4 -37.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.024 3.149 . . . . 0.0 113.938 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.14 14.45 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.24 44.11 6.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.525 1.13 . . . . 0.0 111.759 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.08 36.34 0.62 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.038 0.935 . . . . 0.0 110.598 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mt -137.54 149.31 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 125.212 1.405 . . . . 0.0 107.698 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.9 t -164.23 176.73 8.92 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 124.77 1.228 . . . . 0.0 109.93 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.65 102.74 2.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.3 -65.64 1.77 Allowed Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -119.14 -77.2 0.57 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -108.61 -48.72 3.27 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.412 1.485 . . . . 0.0 110.193 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.82 -169.16 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 122.711 0.405 . . . . 0.0 109.98 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -82.66 148.79 27.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.526 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.61 160.46 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 126.932 2.093 . . . . 0.0 107.734 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 71.2 mt -108.73 140.19 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.837 1.255 . . . . 0.0 107.801 174.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -72.71 76.45 1.11 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.65 67.03 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -44.93 -47.69 11.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.297 1.839 . . . . 0.0 112.343 166.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -96.99 -31.99 12.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.606 2.362 . . . . 0.0 110.847 -165.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.8 t -57.01 136.78 56.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.403 1.001 . . . . 0.0 108.606 160.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.13 -102.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -158.63 135.79 9.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 155.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.06 177.94 8.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 109.663 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.86 -42.26 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.95 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.53 -60.13 3.76 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 117.633 0.716 . . . . 0.0 112.602 -147.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -53.07 -45.15 67.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.024 0.374 . . . . 0.0 111.124 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.08 90.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.886 -0.509 . . . . 0.0 110.343 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.26 -43.84 69.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.485 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.45 -40.27 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 119.351 0.978 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -53.43 118.24 14.01 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.784 -0.627 . . . . 0.0 112.328 -163.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.83 -37.84 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.317 3.344 . . . . 0.0 114.456 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.4 m -118.73 16.17 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.94 50.22 39.22 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.713 0.688 . . . . 0.0 113.036 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.6 -19.73 0.26 Allowed Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.841 1.656 . . . . 0.0 115.061 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -58.36 86.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.036 2.491 . . . . 0.0 110.022 164.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 m -161.53 152.48 4.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -84.12 151.35 24.97 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 127.41 2.944 . . . . 0.0 114.008 -139.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 135.306 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.1 174.96 5.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 144.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 mm -79.02 107.63 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 146.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.34 165.05 25.4 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 122.09 0.948 . . . . 0.0 111.445 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.57 -15.23 10.47 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.918 1.687 . . . . 0.0 113.596 -173.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 m -56.32 -23.49 37.38 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.399 -0.813 . . . . 0.0 112.515 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -54.25 154.16 4.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.096 1.358 . . . . 0.0 110.303 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.98 164.73 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 170.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.4 m -71.74 60.66 0.36 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.949 0.795 . . . . 0.0 111.649 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 -31.22 14.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.999 1.32 . . . . 0.0 111.818 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.25 -28.86 1.68 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.979 172.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -43.43 -48.78 7.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.72 1.208 . . . . 0.0 113.518 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -64.43 -12.57 44.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.78 -65.38 0.51 Allowed 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.106 -0.997 . . . . 0.0 112.89 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 m -69.27 -29.84 67.82 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -59.06 -39.89 83.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.215 1.006 . . . . 0.0 111.737 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.28 120.09 64.73 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.895 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.89 -37.0 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.562 2.841 . . . . 0.0 113.946 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.36 0.86 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.166 0.439 . . . . 0.0 112.011 -174.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.38 57.42 5.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.776 0.83 . . . . 0.0 111.037 -174.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.65 61.75 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.671 -0.643 . . . . 0.0 111.454 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.19 149.86 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.439 1.896 . . . . 0.0 112.132 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 m -161.32 164.13 30.33 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.243 2.617 . . . . 0.0 108.488 154.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -75.15 119.23 19.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.87 -66.91 1.35 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -166.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -116.56 -71.96 0.71 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -113.5 -55.97 2.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.146 1.378 . . . . 0.0 108.745 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -100.94 -167.52 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.086 0.555 . . . . 0.0 110.649 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -84.68 146.96 27.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.412 0.625 . . . . 0.0 111.433 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.1 159.03 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 127.171 2.188 . . . . 0.0 106.153 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.42 149.65 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 C-N-CA 125.296 1.438 . . . . 0.0 109.431 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -65.76 91.96 0.14 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 155.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.79 -29.04 67.95 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.676 -1.265 . . . . 0.0 112.404 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.09 -36.63 84.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.311 0.644 . . . . 0.0 111.368 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -79.77 -43.52 22.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.502 1.121 . . . . 0.0 109.379 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.7 t -54.63 132.31 45.07 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -78.33 -102.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.87 120.38 2.66 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 159.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.39 171.81 19.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.182 0.901 . . . . 0.0 110.796 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.09 -40.51 8.59 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.544 -0.587 . . . . 0.0 113.122 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.61 -56.92 14.77 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.851 0.826 . . . . 0.0 112.995 -147.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 p -55.86 -44.64 78.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.02 -0.425 . . . . 0.0 110.926 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.07 94.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.793 -0.567 . . . . 0.0 110.108 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -62.76 -49.31 75.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.145 0.578 . . . . 0.0 111.413 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -68.25 -40.68 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 118.832 0.742 . . . . 0.0 111.833 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.36 117.95 19.26 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -162.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.92 -26.42 82.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.729 2.286 . . . . 0.0 112.38 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -116.09 21.74 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.967 0.907 . . . . 0.0 111.408 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.05 50.89 7.47 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.521 1.058 . . . . 0.0 113.346 171.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.8 -26.92 0.36 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.265 1.426 . . . . 0.0 114.828 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -63.65 84.56 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.579 2.186 . . . . 0.0 109.443 168.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.1 m -165.77 157.81 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.78 155.33 18.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 127.624 3.077 . . . . 0.0 114.04 -124.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 . . . . . 0 C--O 1.257 1.465 0 C-N-CA 127.82 2.448 . . . . 0.0 106.44 157.486 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 . . . . . 0 C--O 1.232 0.156 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -128.01 179.43 5.58 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 140.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.0 mt -79.7 107.69 12.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 156.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.83 15.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.145 0.974 . . . . 0.0 111.673 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -49.15 -23.4 1.26 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.604 2.362 . . . . 0.0 114.82 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -54.08 -24.38 17.24 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.556 -0.715 . . . . 0.0 112.521 171.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.7 t -57.72 121.63 10.88 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.291 1.437 . . . . 0.0 110.864 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.94 21.97 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.491 -0.756 . . . . 0.0 111.581 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 m 56.69 36.23 27.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.139 0.976 . . . . 0.0 110.552 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.33 152.59 38.14 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 111.21 -169.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.9 57.96 4.93 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.892 -1.13 . . . . 0.0 110.858 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.72 -161.33 1.25 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.206 1.003 . . . . 0.0 108.889 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.57 3.7 p 39.25 -120.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.065 -160.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 49.69 -105.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 122.627 2.467 . . . . 0.0 110.904 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 m -58.06 -17.59 18.85 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -61.12 -29.3 69.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.383 0.992 . . . . 0.0 111.005 170.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.39 129.25 90.84 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.343 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.97 -34.34 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.135 3.224 . . . . 0.0 114.456 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 p -126.72 26.63 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.797 0.726 . . . . 0.0 112.686 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.31 38.44 21.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.88 0.872 . . . . 0.0 111.9 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.95 32.07 0.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.78 1.232 . . . . 0.0 111.811 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.21 152.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.278 1.431 . . . . 0.0 107.434 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -165.25 173.96 10.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.997 2.119 . . . . 0.0 108.925 164.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 123.68 19.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.75 -105.74 2.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -98.78 -49.05 4.71 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.581 1.152 . . . . 0.0 109.141 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -128.21 -53.05 1.29 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.334 1.854 . . . . 0.0 107.691 -172.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -165.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.05 148.15 31.19 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.417 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 154.24 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 C-N-CA 126.072 1.749 . . . . 0.0 107.817 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.2 mt -104.53 136.65 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 107.674 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -74.6 77.16 2.0 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.58 62.25 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -41.24 -48.36 3.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 165.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -99.63 -37.51 9.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.834 2.454 . . . . 0.0 111.236 -165.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.1 t -53.98 126.9 24.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.805 0.729 . . . . 0.0 111.114 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 pt -91.94 8.88 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.817 0.847 . . . . 0.0 112.754 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 54.64 75.32 0.3 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.903 2.481 . . . . 0.0 111.936 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.51 -13.9 13.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 114.04 -174.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.71 -17.76 10.36 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.335 0.969 . . . . 0.0 115.456 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -55.69 -47.85 76.08 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.719 1.759 . . . . 0.0 112.98 -171.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -58.08 -41.3 83.16 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.533 -0.729 . . . . 0.0 109.481 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.04 -43.38 81.91 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.555 -0.715 . . . . 0.0 110.186 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -62.9 -48.11 80.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.823 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 m -68.88 -39.6 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.88 0.763 . . . . 0.0 111.941 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.1 t -55.51 122.09 42.46 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.946 -167.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.18 -39.0 2.36 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.759 3.64 . . . . 0.0 115.137 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.97 28.22 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.248 0.619 . . . . 0.0 112.055 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.21 40.85 45.67 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 118.132 0.424 . . . . 0.0 113.653 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.26 1.44 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -58.93 78.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.324 2.683 . . . . 0.0 111.773 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 m -160.63 173.34 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 130.262 3.425 . . . . 0.0 105.173 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.72 158.24 20.82 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 124.045 0.84 . . . . 0.0 112.904 -96.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 128.133 2.573 . . . . 0.0 110.182 -179.809 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.232 0.146 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -120.44 -179.42 3.96 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 141.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.5 mt -83.52 111.13 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 152.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.25 25.06 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 122.191 0.996 . . . . 0.0 112.068 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.97 -28.25 2.65 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.733 2.013 . . . . 0.0 114.11 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.42 -24.94 2.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -45.08 -73.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.268 2.227 . . . . 0.0 114.791 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 66.5 143.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.473 1.109 . . . . 0.0 110.267 -156.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.73 56.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.125 1.77 . . . . 0.0 113.142 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 158.64 25.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.135 1.374 . . . . 0.0 108.713 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.16 28.9 13.27 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.057 -1.027 . . . . 0.0 112.969 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.65 -57.2 2.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.397 1.098 . . . . 0.0 112.998 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.334 28.5 p -73.1 -90.81 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.329 0.968 . . . . 0.0 112.711 -171.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 31.94 -98.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.815 1.643 . . . . 0.0 113.994 -169.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -46.79 -31.92 3.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.938 2.095 . . . . 0.0 113.497 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -50.32 -32.41 17.07 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.683 1.193 . . . . 0.0 112.895 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.41 122.36 77.8 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.443 -0.786 . . . . 0.0 110.499 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -50.94 -35.07 48.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.011 2.474 . . . . 0.0 113.502 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.67 5.53 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 118.304 0.502 . . . . 0.0 111.033 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.06 40.94 26.8 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.007 1.723 . . . . 0.0 110.845 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.31 45.23 1.21 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.755 0.822 . . . . 0.0 110.011 -168.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.86 150.42 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.498 1.919 . . . . 0.0 106.434 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -171.48 174.56 4.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.139 2.176 . . . . 0.0 108.477 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.06 123.82 17.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 167.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.29 -98.47 2.41 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -99.27 -46.06 5.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.44 1.496 . . . . 0.0 108.822 -166.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 p -134.61 -56.51 0.84 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.183 1.793 . . . . 0.0 107.28 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 -162.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.339 1.056 . . . . 0.0 110.53 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -78.22 139.8 38.92 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.8 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.46 156.62 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 126.278 1.831 . . . . 0.0 107.616 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.11 142.94 24.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -73.81 78.42 1.59 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.62 56.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 113.022 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -42.1 -49.71 4.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.986 2.114 . . . . 0.0 112.219 165.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.56 -31.26 12.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.578 2.351 . . . . 0.0 111.36 -165.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.0 t -49.95 116.86 2.0 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.211 0.914 . . . . 0.0 110.271 169.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.84 -17.84 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 122.735 0.414 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t0 76.62 118.81 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 127.916 2.486 . . . . 0.0 108.499 -168.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.85 -47.96 0.09 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -168.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.98 -29.59 4.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.526 -1.152 . . . . 0.0 113.274 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -53.33 -51.13 63.39 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.539 1.67 . . . . 0.0 112.593 -164.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.29 -46.91 72.86 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.44 -0.162 . . . . 0.0 110.761 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.92 91.46 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.669 -0.644 . . . . 0.0 110.156 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -51.31 69.53 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.619 0.767 . . . . 0.0 111.806 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -70.13 -39.18 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 119.366 0.985 . . . . 0.0 111.797 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.0 t -55.02 116.65 11.87 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -162.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.09 -38.95 19.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.938 3.092 . . . . 0.0 113.835 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.47 9.26 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.716 1.206 . . . . 0.0 112.147 -173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.79 50.85 25.25 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.792 0.723 . . . . 0.0 112.94 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.78 -25.35 0.29 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 126.281 1.832 . . . . 0.0 114.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.26 81.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.061 2.507 . . . . 0.0 109.21 167.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -161.08 156.69 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 129.221 3.008 . . . . 0.0 104.006 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.5 174.4 7.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 127.445 2.966 . . . . 0.0 114.069 -121.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.82 158.083 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -108.51 170.18 8.18 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 152.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.8 mt -79.91 106.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 150.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.09 174.94 10.1 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 122.689 1.233 . . . . 0.0 111.667 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.36 -13.69 9.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 128.563 2.745 . . . . 0.0 113.541 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.29 64.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 111.468 170.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.5 t -57.51 153.17 13.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.3 1.44 . . . . 0.0 112.272 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.19 156.68 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 162.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m -61.25 66.59 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.815 1.646 . . . . 0.0 113.348 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 -30.33 9.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.342 1.057 . . . . 0.0 112.833 -168.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.68 60.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.191 1.377 . . . . 0.0 115.772 170.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.88 -61.84 1.83 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.552 1.676 . . . . 0.0 110.789 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.38 -34.09 32.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.275 1.03 . . . . 0.0 111.881 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.97 -45.67 7.89 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -88.02 -6.75 57.81 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -41.27 13.76 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.119 1.768 . . . . 0.0 108.021 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.4 t -49.64 116.99 6.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.333 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.94 -33.28 14.19 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.767 2.978 . . . . 0.0 113.876 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.7 m -111.56 11.53 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.264 0.484 . . . . 0.0 112.065 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 47.89 34.11 3.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.2 40.29 0.62 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.881 1.272 . . . . 0.0 111.199 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mt -133.2 146.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.109 1.364 . . . . 0.0 108.823 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -166.54 167.02 15.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.327 1.851 . . . . 0.0 109.649 167.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.34 119.18 18.18 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.24 -78.44 1.28 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -169.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -99.87 -54.91 2.78 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.941 0.896 . . . . 0.0 108.91 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -140.88 -56.24 0.5 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.867 2.067 . . . . 0.0 107.377 -167.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.64 -174.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.059 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -74.25 148.38 41.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.152 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.97 152.55 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 126.346 1.858 . . . . 0.0 106.988 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.27 138.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.516 1.527 . . . . 0.0 107.788 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -74.07 76.2 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.55 60.05 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -167.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -43.97 -47.51 8.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.141 1.776 . . . . 0.0 112.243 167.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -100.27 -30.53 11.84 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.923 2.489 . . . . 0.0 111.393 -165.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -52.29 128.54 25.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.308 0.958 . . . . 0.0 109.793 167.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.0 pt -90.1 130.18 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 161.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 74.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.103 1.361 . . . . 0.0 112.236 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -15.17 16.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.507 1.523 . . . . 0.0 111.341 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.76 -23.63 0.82 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.233 1.873 . . . . 0.0 115.188 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.15 -39.16 71.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.4 p -47.44 -32.68 5.31 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.498 1.119 . . . . 0.0 112.578 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -44.47 32.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.379 0.536 . . . . 0.0 112.403 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -51.76 -39.47 58.61 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -167.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.71 -26.05 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 117.879 0.309 . . . . 0.0 111.749 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.86 119.11 69.27 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.949 -153.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.34 -37.98 7.81 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.175 3.25 . . . . 0.0 114.377 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.67 33.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.729 0.812 . . . . 0.0 111.633 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.48 49.29 11.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.31 0.957 . . . . 0.0 114.078 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.24 -28.34 0.39 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.814 1.645 . . . . 0.0 114.429 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.96 87.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.648 2.232 . . . . 0.0 109.712 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -165.95 158.82 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.909 0 C-N-CA 128.661 2.784 . . . . 0.0 104.296 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -90.67 166.03 13.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 127.266 2.854 . . . . 0.0 112.95 -118.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 C--O 1.249 1.055 0 C-N-CA 124.896 1.279 . . . . 0.0 110.994 -162.039 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -131.18 -174.49 3.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 145.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.1 mm -79.14 110.07 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 153.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.48 162.45 27.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 122.166 0.984 . . . . 0.0 111.188 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -53.0 -21.36 4.35 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.7 2.0 . . . . 0.0 114.257 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -51.36 -25.65 6.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.737 -0.602 . . . . 0.0 112.565 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.08 109.81 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.508 1.123 . . . . 0.0 111.97 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -80.71 13.78 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.334 -0.854 . . . . 0.0 112.03 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.8 m 59.29 43.93 16.15 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.247 1.019 . . . . 0.0 110.772 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.51 -158.01 0.24 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.498 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.43 39.18 1.25 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 120.088 1.313 . . . . 0.0 111.109 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.46 -40.17 13.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 123.384 0.673 . . . . 0.0 110.987 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 p -85.43 -137.35 0.07 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.153 0.581 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.49 -77.72 0.03 OUTLIER 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.04 1.736 . . . . 0.0 113.356 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -56.63 -35.13 67.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.165 0.586 . . . . 0.0 109.952 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -53.38 -31.03 42.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 113.789 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -70.25 127.29 92.33 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.82 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.22 -36.35 5.99 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.689 2.926 . . . . 0.0 113.622 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.79 20.36 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.649 0.38 . . . . 0.0 111.41 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 44.27 39.74 3.2 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.025 1.73 . . . . 0.0 112.912 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.64 40.75 1.2 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.342 1.057 . . . . 0.0 111.296 -165.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.32 149.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.51 1.924 . . . . 0.0 106.085 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -173.07 172.9 3.8 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.658 1.983 . . . . 0.0 109.492 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 129.42 40.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.03 -111.06 3.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 124.728 1.156 . . . . 0.0 111.698 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -99.77 -48.72 4.61 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.965 0.906 . . . . 0.0 109.494 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 p -115.65 -60.83 1.82 Allowed 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.509 2.324 . . . . 0.0 106.783 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.27 -156.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.725 1.61 . . . . 0.0 110.65 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -74.62 157.19 35.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.826 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 169.97 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 127.789 2.436 . . . . 0.0 108.89 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -130.35 143.08 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.539 1.536 . . . . 0.0 107.388 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.55 79.13 2.56 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 164.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.11 63.23 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.224 -0.923 . . . . 0.0 113.262 -171.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.86 -35.91 75.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 110.57 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -84.26 -44.2 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.624 1.57 . . . . 0.0 111.091 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -57.57 139.06 54.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.572 1.078 . . . . 0.0 110.22 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.1 -116.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -140.18 30.46 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.691 1.997 . . . . 0.0 109.853 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.277 0.0 OUTLIER -72.81 177.54 4.77 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.945 -0.472 . . . . 0.0 111.555 -174.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.57 -32.87 4.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.623 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.22 -53.38 54.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.498 1.149 . . . . 0.0 113.516 -150.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.62 -45.2 85.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.566 0.222 . . . . 0.0 110.808 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.53 94.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.884 -0.51 . . . . 0.0 109.847 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -50.57 69.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 111.969 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.09 -38.34 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 119.487 1.04 . . . . 0.0 111.669 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.2 118.12 16.98 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -163.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -60.84 -23.78 77.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.718 2.278 . . . . 0.0 112.55 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.87 31.3 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.381 0.673 . . . . 0.0 111.073 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.62 63.13 1.74 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.646 1.117 . . . . 0.0 113.239 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 -30.9 0.24 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.994 1.718 . . . . 0.0 113.541 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.88 78.58 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.758 2.305 . . . . 0.0 108.684 165.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -160.79 153.36 4.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 128.67 2.788 . . . . 0.0 104.638 -167.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -91.67 149.65 21.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.493 2.995 . . . . 0.0 115.71 -132.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 102.275 -3.231 . . . . 0.0 102.275 131.808 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.04 178.35 5.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 151.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.17 108.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.79 171.11 15.26 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 122.091 0.948 . . . . 0.0 111.469 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -53.98 -20.6 6.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.196 1.798 . . . . 0.0 113.976 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -57.77 -20.68 36.87 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.53 -0.731 . . . . 0.0 112.963 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -56.1 153.58 8.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.084 1.354 . . . . 0.0 111.32 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.7 156.26 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 161.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 m -67.41 63.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.122 0.874 . . . . 0.0 112.738 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.0 -16.79 21.45 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.184 1.393 . . . . 0.0 111.894 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 -58.97 4.88 Favored Glycine 0 C--N 1.338 0.655 0 O-C-N 121.284 -0.885 . . . . 0.0 112.158 169.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -22.27 -65.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.91 2.084 . . . . 0.0 115.004 -167.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 p -56.7 -25.56 54.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.37 -50.35 1.49 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.028 0.931 . . . . 0.0 113.351 167.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 m -81.84 -23.74 36.23 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.12 -33.78 75.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.513 1.125 . . . . 0.0 110.959 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.54 115.73 20.56 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.416 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.01 -18.42 62.03 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.661 1.574 . . . . 0.0 111.478 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.4 14.16 8.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 CA-C-N 119.052 0.842 . . . . 0.0 111.582 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 43.68 48.02 6.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.851 1.26 . . . . 0.0 111.906 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.16 -5.98 51.18 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.897 0.879 . . . . 0.0 112.026 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.51 146.93 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.202 1.001 . . . . 0.0 110.308 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.6 m -164.23 167.88 19.49 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.235 2.214 . . . . 0.0 109.012 163.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -69.97 122.29 19.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.48 -65.02 1.15 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -170.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -115.08 -70.35 0.8 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -118.82 -58.35 1.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.692 1.997 . . . . 0.0 107.759 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -94.67 -174.21 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.866 -176.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -78.16 151.1 33.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.066 0.46 . . . . 0.0 111.189 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.13 142.84 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 126.256 1.823 . . . . 0.0 107.568 -170.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -103.27 139.01 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 127.11 2.164 . . . . 0.0 109.662 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.268 64.3 m-20 -69.82 102.49 1.96 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 159.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.27 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.041 -1.037 . . . . 0.0 112.332 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.55 -37.51 81.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.273 0.558 . . . . 0.0 110.929 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.0 m -80.19 -42.85 22.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.047 0.939 . . . . 0.0 110.6 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.93 127.58 32.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.919 0.781 . . . . 0.0 111.631 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.8 pt -100.64 28.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.863 1.265 . . . . 0.0 112.162 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 51.09 47.45 24.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.918 1.287 . . . . 0.0 111.707 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.256 0.5 OUTLIER -86.11 -164.7 1.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.23 -28.71 3.72 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.704 1.138 . . . . 0.0 114.069 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -54.85 -56.11 22.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.251 1.025 . . . . 0.0 112.885 -153.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.7 p -53.47 -45.6 69.62 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.239 -0.288 . . . . 0.0 110.916 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.62 97.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 110.278 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -61.34 -47.64 84.95 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.661 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.68 -42.13 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.042 0.837 . . . . 0.0 112.266 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.52 121.11 36.34 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.262 -159.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.3 -38.83 3.73 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.597 3.531 . . . . 0.0 115.029 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.97 17.55 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.359 0.663 . . . . 0.0 112.382 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.63 44.06 79.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 118.593 0.633 . . . . 0.0 112.907 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.65 -25.5 0.66 Allowed Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.46 87.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.936 2.424 . . . . 0.0 110.644 170.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 m -162.11 160.14 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.816 0 C-N-CA 128.937 2.895 . . . . 0.0 104.101 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.12 170.18 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 127.375 2.922 . . . . 0.0 115.149 -128.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 . . . . . 0 C--O 1.251 1.181 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.219 169.302 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 -177.18 4.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 149.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.27 110.1 20.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.08 162.04 28.89 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 122.083 0.945 . . . . 0.0 111.337 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -51.38 -26.23 7.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.721 1.609 . . . . 0.0 113.555 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -48.94 -25.45 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.6 t -48.63 -60.25 2.87 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 114.215 -174.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 162.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.725 -1.234 . . . . 0.0 110.856 -163.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 m -75.41 49.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 119.552 -1.968 . . . . 0.0 111.498 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.65 166.17 23.76 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 154.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.71 38.55 0.71 Allowed Glycine 0 CA--C 1.523 0.587 0 CA-C-N 120.557 1.526 . . . . 0.0 112.391 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.79 -63.02 1.51 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.471 0.635 . . . . 0.0 110.988 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.2 p -50.53 -24.58 3.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -33.85 -53.08 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.707 1.203 . . . . 0.0 114.197 166.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 p -76.09 -26.16 56.19 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.472 -0.768 . . . . 0.0 112.124 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -75.9 -29.65 58.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.817 2.047 . . . . 0.0 110.243 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.8 t -58.6 119.48 36.89 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.082 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.38 -31.83 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.166 2.577 . . . . 0.0 113.345 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.26 8.17 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.413 0.551 . . . . 0.0 111.653 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 m120 44.98 44.13 7.8 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.831 1.652 . . . . 0.0 111.748 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.14 47.77 1.25 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.976 0.91 . . . . 0.0 110.055 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.43 150.91 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.754 2.022 . . . . 0.0 107.143 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -170.86 174.54 4.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.423 2.289 . . . . 0.0 109.049 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -73.33 132.08 42.65 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.52 -81.79 1.58 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -99.37 -56.13 2.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.921 1.288 . . . . 0.0 109.199 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -138.83 -51.09 0.55 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.968 2.107 . . . . 0.0 107.859 -177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.65 -161.33 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 122.953 0.501 . . . . 0.0 109.844 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.313 5.5 m-85 -79.35 163.63 24.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.418 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.4 163.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 127.774 2.429 . . . . 0.0 108.007 -170.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.35 143.37 38.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 125.248 1.419 . . . . 0.0 108.877 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -75.37 83.71 2.48 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.36 -32.71 62.79 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.79 -48.42 8.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.921 1.688 . . . . 0.0 112.031 166.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -98.86 -30.86 12.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.842 2.057 . . . . 0.0 111.486 -165.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.8 t -55.68 127.64 30.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.586 1.084 . . . . 0.0 111.22 172.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.9 pt -104.63 33.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.594 1.558 . . . . 0.0 111.377 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 49.27 32.28 4.27 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.547 1.939 . . . . 0.0 113.491 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -76.43 -9.66 58.81 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -165.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 -23.52 6.3 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.788 -1.007 . . . . 0.0 114.23 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -53.69 -54.77 33.11 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.585 1.692 . . . . 0.0 111.338 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.43 -42.09 73.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.59 87.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.72 -0.613 . . . . 0.0 110.298 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -33.87 64.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 m -73.71 -38.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.813 1.188 . . . . 0.0 110.872 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.6 t -56.11 120.01 31.25 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.605 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -59.79 -29.83 90.55 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.692 2.261 . . . . 0.0 112.031 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.19 17.61 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.323 1.049 . . . . 0.0 111.675 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.03 49.93 5.27 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.818 1.199 . . . . 0.0 113.636 173.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.38 -30.28 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 125.523 1.529 . . . . 0.0 114.76 -174.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.7 90.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.73 2.286 . . . . 0.0 109.942 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.1 t -165.99 151.05 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 128.788 2.835 . . . . 0.0 103.688 -165.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -92.66 157.52 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 128.961 3.913 . . . . 0.0 115.609 -130.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 . . . . . 0 C--O 1.249 1.047 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 150.666 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 CA--C 1.517 -0.3 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -129.94 -176.73 4.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 148.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.6 mt -84.06 107.74 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 152.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.55 170.34 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 122.05 0.928 . . . . 0.0 111.289 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.34 -25.61 1.05 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.015 2.126 . . . . 0.0 114.527 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -55.94 -19.12 10.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.93 156.85 6.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.241 1.416 . . . . 0.0 111.253 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.53 156.91 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 164.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -67.65 65.03 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.909 0.884 . . . . 0.0 111.832 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.261 0.1 OUTLIER -93.54 -162.2 0.92 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.609 1.563 . . . . 0.0 108.816 -177.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.62 42.45 0.71 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 120.932 1.696 . . . . 0.0 110.708 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.96 -37.46 12.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.436 0.695 . . . . 0.0 111.431 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.332 21.5 p -85.53 -100.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.55 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.68 -119.4 0.62 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 121.406 1.912 . . . . 0.0 112.058 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m -68.69 11.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -40.15 96.91 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.2 t -58.42 120.22 42.59 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.705 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -44.72 -36.98 11.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.774 2.983 . . . . 0.0 113.901 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -107.43 5.53 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 117.97 0.35 . . . . 0.0 111.54 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.11 48.36 12.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.436 1.095 . . . . 0.0 111.573 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.02 -11.96 61.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.085 0.954 . . . . 0.0 111.813 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -99.98 144.3 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.469 1.507 . . . . 0.0 110.484 -170.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -166.67 170.9 12.11 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.824 2.45 . . . . 0.0 108.765 162.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -66.74 130.73 44.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.37 -84.7 1.82 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -173.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.32 -52.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.59 1.156 . . . . 0.0 108.272 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -140.84 -57.58 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.267 2.227 . . . . 0.0 106.37 -171.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -158.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.453 0.701 . . . . 0.0 109.828 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.18 149.68 21.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 111.814 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.57 137.28 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 126.678 1.991 . . . . 0.0 108.662 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -96.72 136.15 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 127.094 2.157 . . . . 0.0 109.733 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.252 29.1 m-20 -66.89 102.4 0.96 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 156.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.0 -33.53 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.743 -1.223 . . . . 0.0 112.352 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.79 -38.65 82.47 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.499 0.666 . . . . 0.0 110.609 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -79.23 -43.05 24.57 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.498 1.119 . . . . 0.0 110.1 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.2 t -55.88 115.97 2.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.526 0.603 . . . . 0.0 111.527 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.03 -0.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 t0 68.92 79.3 0.21 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 110.332 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.22 -31.43 4.39 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -164.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.78 -35.82 4.77 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.636 1.107 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -53.54 163.89 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.352 5.2 p 60.3 -55.29 0.08 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.535 1.534 . . . . 0.0 112.963 -153.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.5 94.4 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 120.022 1.283 . . . . 0.0 109.806 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.83 -28.34 69.49 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.739 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -88.26 -38.87 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.808 1.185 . . . . 0.0 111.176 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -53.6 118.48 14.96 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -166.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.1 -38.22 10.42 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 124.273 3.315 . . . . 0.0 114.159 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.36 18.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.272 1.029 . . . . 0.0 112.377 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.84 42.49 37.84 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.588 0.631 . . . . 0.0 113.792 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 -22.96 0.38 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.696 1.599 . . . . 0.0 115.183 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.78 84.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.55 2.167 . . . . 0.0 109.621 166.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -159.68 157.2 3.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 128.808 2.843 . . . . 0.0 104.765 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -91.62 155.85 18.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 127.681 3.113 . . . . 0.0 115.12 -133.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 144.749 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -118.97 168.69 10.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 102.999 -2.963 . . . . 0.0 102.999 145.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -80.43 105.34 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 148.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.54 163.83 26.53 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 119.366 -0.933 . . . . 0.0 111.01 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.27 -23.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.624 2.77 . . . . 0.0 114.85 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -25.77 4.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 168.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.8 t -57.62 158.64 5.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 111.764 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.54 160.84 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 164.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -66.12 63.64 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.99 1.316 . . . . 0.0 112.948 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.73 -32.65 8.32 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.531 1.133 . . . . 0.0 112.44 -165.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.49 15.34 57.05 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.014 1.292 . . . . 0.0 114.585 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.59 -33.14 68.77 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.383 1.092 . . . . 0.0 111.376 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.255 29.0 p -74.17 -90.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 44.05 -110.54 0.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 121.149 1.795 . . . . 0.0 112.236 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m -65.7 -5.96 10.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -38.21 64.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.977 0.808 . . . . 0.0 109.063 164.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 t -58.07 123.11 63.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.903 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -45.02 -38.45 13.66 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.752 2.968 . . . . 0.0 113.799 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -101.4 1.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.592 0.357 . . . . 0.0 111.344 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 54.22 33.47 18.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.791 1.236 . . . . 0.0 110.925 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.27 38.67 0.49 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.158 1.383 . . . . 0.0 112.053 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.16 150.48 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 124.292 1.037 . . . . 0.0 109.584 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.4 m -166.5 172.58 10.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.576 2.351 . . . . 0.0 108.136 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.32 127.76 33.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.82 -81.73 1.44 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.84 -53.68 3.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.415 1.086 . . . . 0.0 108.436 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 p -141.39 -54.58 0.47 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.192 2.197 . . . . 0.0 107.319 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.25 -173.91 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 122.919 0.488 . . . . 0.0 110.792 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.24 142.9 32.71 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.022 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.09 155.25 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 126.413 1.885 . . . . 0.0 108.662 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.48 140.78 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.57 1.548 . . . . 0.0 108.604 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.0 91.25 4.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.82 -36.77 72.72 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.921 -1.112 . . . . 0.0 113.864 -168.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.94 -35.86 67.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.122 0.969 . . . . 0.0 110.391 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.0 m -84.41 -47.63 10.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.864 1.666 . . . . 0.0 110.489 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.1 t -57.31 123.16 14.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.989 -0.444 . . . . 0.0 112.119 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.44 23.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.029 0.932 . . . . 0.0 112.498 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.32 39.52 28.39 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.013 1.725 . . . . 0.0 111.539 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.42 -10.07 59.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.03 -33.23 1.28 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.916 1.246 . . . . 0.0 115.056 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -48.93 -46.73 43.58 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -157.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.1 p -46.9 -31.67 3.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.991 1.317 . . . . 0.0 112.679 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -43.23 31.19 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.504 0.593 . . . . 0.0 112.368 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -49.92 -38.96 38.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.71 -24.94 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.44 119.24 71.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.531 -153.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -43.92 -40.16 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.043 3.162 . . . . 0.0 114.41 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.49 16.29 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 112.521 -173.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.52 53.62 19.92 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 118.711 0.687 . . . . 0.0 112.959 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.86 -23.01 0.24 Allowed Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.576 1.951 . . . . 0.0 115.065 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.33 90.15 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.128 1.885 . . . . 0.0 107.603 164.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 m -162.79 152.71 3.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -171.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -90.44 175.11 7.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.986 3.304 . . . . 0.0 112.076 -128.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 115.585 -2.15 . . . . 0.0 110.337 -157.843 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 103.803 -2.665 . . . . 0.0 103.803 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -112.19 168.59 9.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 144.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.0 mt -80.58 109.46 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 152.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.38 165.73 24.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.468 1.128 . . . . 0.0 111.259 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.57 -20.98 15.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.571 1.548 . . . . 0.0 113.903 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -55.9 -21.41 20.16 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.584 -0.697 . . . . 0.0 112.829 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.0 t -46.58 -72.78 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.538 1.935 . . . . 0.0 115.107 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 68.05 155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.813 1.245 . . . . 0.0 111.864 -163.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m -66.7 57.39 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.889 1.276 . . . . 0.0 113.431 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -84.41 -38.38 20.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.472 1.033 . . . . 0.0 113.033 -168.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.71 -155.85 18.3 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.74 1.162 . . . . 0.0 113.207 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.79 -70.58 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.414 1.886 . . . . 0.0 113.725 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.22 -29.03 63.41 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -161.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.32 -49.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.081 0.953 . . . . 0.0 113.128 166.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.9 m -85.68 -15.74 41.33 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.117 0.567 . . . . 0.0 112.398 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -76.71 -37.11 56.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.471 1.109 . . . . 0.0 110.302 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.09 119.89 38.48 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.498 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.28 -34.44 31.63 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.155 2.57 . . . . 0.0 113.601 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.85 5.72 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.717 0.407 . . . . 0.0 111.238 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.92 31.15 10.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.019 1.327 . . . . 0.0 111.579 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 38.44 0.42 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mt -142.2 146.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.417 1.487 . . . . 0.0 107.342 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.08 163.83 13.49 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.454 1.902 . . . . 0.0 110.032 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -68.57 117.19 9.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.69 -76.8 1.21 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -164.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -110.57 -71.2 0.77 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -104.56 -61.01 1.51 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.362 1.065 . . . . 0.0 108.945 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.76 -160.52 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.064 0.946 . . . . 0.0 110.024 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.88 144.26 41.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.736 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.76 151.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.414 1.885 . . . . 0.0 106.094 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 mt -105.27 140.3 23.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.74 74.44 1.11 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 162.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -33.19 64.59 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -170.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -42.83 -46.48 5.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.805 2.042 . . . . 0.0 112.216 166.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -104.1 -27.29 12.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.116 2.566 . . . . 0.0 112.034 -163.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.6 t -45.2 119.08 1.91 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.622 1.101 . . . . 0.0 110.54 167.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 pt -80.28 34.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.368 -0.833 . . . . 0.0 112.01 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t0 29.38 63.35 0.14 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.152 2.581 . . . . 0.0 113.251 -174.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.28 0.5 OUTLIER -98.36 -141.76 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.291 1.036 . . . . 0.0 108.596 173.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 10.94 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 CA-C-N 121.843 2.11 . . . . 0.0 114.685 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.64 -47.61 76.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.048 1.924 . . . . 0.0 110.876 -172.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.1 p -57.33 -43.93 83.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.028 0.531 . . . . 0.0 110.692 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.35 94.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.465 -0.772 . . . . 0.0 109.505 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -51.71 68.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.71 0.804 . . . . 0.0 112.083 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.66 -39.22 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.527 1.058 . . . . 0.0 112.446 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.2 t -55.7 121.62 40.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -161.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.24 -31.93 82.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.735 2.29 . . . . 0.0 111.961 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.68 11.05 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.893 0.877 . . . . 0.0 111.851 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.69 63.95 3.19 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.18 0.895 . . . . 0.0 112.714 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.56 -28.07 0.19 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 126.382 1.873 . . . . 0.0 114.005 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 78.98 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.962 2.441 . . . . 0.0 108.437 164.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.8 m -158.65 153.65 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 128.562 2.745 . . . . 0.0 104.361 -168.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.16 174.18 7.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 128.555 3.66 . . . . 0.0 112.551 -113.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.254 1.308 0 CA-C-O 115.686 -2.102 . . . . 0.0 109.256 -164.307 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -122.0 178.31 4.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 146.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.76 107.55 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 151.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.64 168.0 20.85 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.371 1.081 . . . . 0.0 111.268 171.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.57 -9.28 5.62 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.305 1.842 . . . . 0.0 113.888 -173.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -23.58 61.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.863 -1.148 . . . . 0.0 111.861 166.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.3 t -63.17 158.83 18.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.006 0.923 . . . . 0.0 110.822 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -136.87 -175.44 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.9 p -73.28 64.08 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.75 175.2 5.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.853 1.661 . . . . 0.0 108.093 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.81 38.36 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 CA-C-N 120.143 1.338 . . . . 0.0 110.868 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -15.18 30.68 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.52 0.728 . . . . 0.0 112.29 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.305 29.9 p -101.41 -95.22 0.28 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 118.589 -0.72 . . . . 0.0 111.219 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 39.7 -99.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 113.689 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -49.49 -29.62 6.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.507 1.523 . . . . 0.0 112.864 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -52.02 -33.39 38.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.316 1.046 . . . . 0.0 112.877 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -64.26 119.89 60.01 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.483 -0.76 . . . . 0.0 109.781 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.04 -32.29 23.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.236 2.624 . . . . 0.0 113.147 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.7 19.85 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 122.706 0.403 . . . . 0.0 110.947 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.45 22.8 0.77 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.339 1.855 . . . . 0.0 114.231 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.5 44.19 1.02 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.878 1.271 . . . . 0.0 111.322 -166.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.05 147.34 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.818 1.247 . . . . 0.0 107.934 -174.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -170.7 169.31 7.12 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.171 2.188 . . . . 0.0 109.49 167.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -67.5 125.66 26.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.69 -84.22 1.68 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -168.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -102.3 -48.04 4.31 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.942 1.297 . . . . 0.0 108.463 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 p -140.21 -59.71 0.53 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.615 1.966 . . . . 0.0 106.854 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -155.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.12 0.968 . . . . 0.0 109.642 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -82.38 157.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.98 0.419 . . . . 0.0 110.672 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.23 160.91 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.099 1.759 . . . . 0.0 106.887 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -119.48 146.74 23.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 125.259 1.424 . . . . 0.0 108.486 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.14 76.29 1.26 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 165.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.68 -35.34 60.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -167.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.4 -37.79 73.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.175 1.39 . . . . 0.0 110.384 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 m -79.9 -49.49 11.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.513 1.525 . . . . 0.0 110.815 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.3 t -61.33 111.8 1.91 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.697 1.237 . . . . 0.0 113.434 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.0 pt -83.45 142.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 156.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 60.68 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.54 2.336 . . . . 0.0 112.412 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -27.79 48.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.789 0.836 . . . . 0.0 112.806 -166.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.8 -34.03 5.32 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.38 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -54.61 -55.77 25.97 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.674 1.737 . . . . 0.0 112.051 -162.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 p -52.56 -43.04 64.97 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.719 0.295 . . . . 0.0 111.226 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.43 77.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.522 -0.736 . . . . 0.0 110.719 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -70.49 -47.32 61.1 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.407 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -68.82 -38.41 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.62 0.646 . . . . 0.0 112.167 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -55.94 120.06 30.83 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.318 -0.373 . . . . 0.0 111.958 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -59.59 -26.6 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.905 2.404 . . . . 0.0 112.37 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.04 24.49 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.705 0.802 . . . . 0.0 111.682 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.79 62.72 2.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.113 0.864 . . . . 0.0 113.07 172.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.69 -28.03 0.24 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 126.027 1.731 . . . . 0.0 113.998 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.6 80.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.634 2.223 . . . . 0.0 108.009 164.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -157.67 149.01 9.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -92.7 153.88 18.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 128.974 3.921 . . . . 0.0 115.714 -133.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 144.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -129.62 -159.59 0.97 Allowed 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 126.505 1.922 . . . . 0.0 106.532 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -128.32 161.84 28.46 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.78 100.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 153.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.28 174.0 10.71 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.2 -0.938 . . . . 0.0 111.474 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.31 -16.47 2.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.835 2.054 . . . . 0.0 114.787 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -51.25 -33.01 26.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.433 -0.792 . . . . 0.0 111.761 166.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.3 t -55.71 130.26 42.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.251 1.82 . . . . 0.0 112.086 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.2 150.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -67.56 70.53 0.12 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.334 0.97 . . . . 0.0 111.993 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.22 -22.74 20.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.713 1.205 . . . . 0.0 111.42 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.95 -30.68 5.7 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 113.698 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.1 56.48 2.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.359 1.079 . . . . 0.0 113.309 -164.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -155.59 -31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.306 1.042 . . . . 0.0 112.282 171.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -36.02 -60.4 0.55 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -75.92 -15.2 60.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.296 1.039 . . . . 0.0 112.494 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -81.42 -34.17 31.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.967 1.307 . . . . 0.0 109.339 -169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.23 122.35 58.43 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.587 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -33.47 73.84 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.711 2.274 . . . . 0.0 112.493 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.06 7.42 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 122.818 0.447 . . . . 0.0 110.8 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 49.09 35.22 6.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.117 1.367 . . . . 0.0 111.866 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 36.41 0.42 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.052 1.341 . . . . 0.0 111.075 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mt -142.27 147.64 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.311 1.044 . . . . 0.0 109.489 -170.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -169.79 174.24 5.8 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 127.331 2.252 . . . . 0.0 108.522 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -85.42 128.66 34.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.481 1.037 . . . . 0.0 108.368 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.98 -67.86 0.14 Allowed Glycine 0 C--N 1.339 0.721 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.434 -161.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -98.96 -52.52 3.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -166.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.8 m -141.78 -50.51 0.4 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 109.181 156.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -161.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.225 1.01 . . . . 0.0 109.62 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.289 17.1 m-85 -68.69 161.94 27.15 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 117.714 -1.594 . . . . 0.0 110.906 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.87 162.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 126.783 2.033 . . . . 0.0 107.437 -170.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -128.92 138.6 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.651 1.18 . . . . 0.0 108.695 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -73.58 76.12 1.49 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 165.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -32.99 64.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -168.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.9 -48.08 8.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.443 1.897 . . . . 0.0 112.171 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.82 -29.95 12.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.655 2.382 . . . . 0.0 111.247 -165.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.8 t -52.85 134.65 37.0 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.288 0.949 . . . . 0.0 110.141 165.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 pt -107.89 137.92 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 159.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.96 74.11 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.56 -20.03 18.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.853 0.861 . . . . 0.0 113.041 -169.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.28 4.1 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.525 -0.734 . . . . 0.0 112.511 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -54.63 165.45 0.59 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 163.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.372 6.9 p 60.61 -57.56 0.08 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.373 1.469 . . . . 0.0 112.386 -152.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.44 96.61 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.234 1.379 . . . . 0.0 109.571 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -37.29 78.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.082 0.953 . . . . 0.0 111.914 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.94 -40.59 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.894 0.77 . . . . 0.0 111.007 -169.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.8 t -54.67 118.84 18.16 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.269 -170.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.1 -36.18 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.975 3.116 . . . . 0.0 114.216 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.42 14.27 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.68 50.67 36.07 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.746 0.703 . . . . 0.0 112.791 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 52' ' ' PRO . . . -80.02 -23.75 0.39 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 114.916 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 51' ' ' ALA . 55.5 Cg_exo -60.14 82.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.747 2.298 . . . . 0.0 110.764 168.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 m -159.85 153.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 128.901 2.88 . . . . 0.0 104.068 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -90.0 149.74 22.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.674 1.859 . . . . 0.0 114.299 -138.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 116.689 -1.625 . . . . 0.0 107.434 146.662 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -76.25 -158.35 0.09 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 160.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -142.43 -168.93 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 156.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mm -79.45 105.55 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 156.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.86 165.19 25.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.961 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.48 -15.87 3.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -53.18 -25.66 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.327 -0.858 . . . . 0.0 113.27 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -59.31 162.15 4.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.267 1.427 . . . . 0.0 111.669 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.65 173.2 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 m -70.6 64.03 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.299 -0.875 . . . . 0.0 111.011 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -179.78 4.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.04 2.136 . . . . 0.0 106.695 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.39 37.6 0.84 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 120.446 1.476 . . . . 0.0 111.315 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 -31.0 43.74 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.861 0.464 . . . . 0.0 111.537 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.286 29.9 p -80.43 -97.4 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.595 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.57 -99.01 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 121.157 1.799 . . . . 0.0 113.611 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 m -48.4 -31.73 6.61 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.926 1.691 . . . . 0.0 112.461 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -53.25 -28.23 26.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.407 1.083 . . . . 0.0 112.898 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.55 120.65 81.11 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 119.11 0.868 . . . . 0.0 110.739 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.45 -34.79 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.64 6.98 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 117.937 0.335 . . . . 0.0 111.022 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 22.69 4.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.289 1.835 . . . . 0.0 111.816 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.3 50.18 1.89 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.2 -0.938 . . . . 0.0 110.538 -164.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mt -136.72 147.71 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.608 1.563 . . . . 0.0 107.985 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -169.08 168.36 10.06 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.31 2.244 . . . . 0.0 109.327 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -71.74 117.12 12.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.06 -66.67 1.12 Allowed Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -114.8 -72.14 0.71 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -108.65 -61.09 1.65 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.611 1.165 . . . . 0.0 108.326 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.9 -166.55 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.182 0.593 . . . . 0.0 110.35 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.88 155.7 40.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 110.66 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.77 156.42 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 126.976 2.11 . . . . 0.0 106.381 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -126.12 146.34 32.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.42 84.19 0.58 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 164.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.74 -29.66 62.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.439 -0.788 . . . . 0.0 112.689 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -41.66 -47.6 3.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.54 1.936 . . . . 0.0 112.071 164.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -102.84 -34.13 9.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.095 2.158 . . . . 0.0 111.981 -164.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.6 t -52.45 129.2 28.06 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.677 1.126 . . . . 0.0 111.966 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 pt -107.64 34.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.256 1.423 . . . . 0.0 111.78 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 5.4 m-20 51.27 35.9 14.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.96 1.704 . . . . 0.0 112.758 170.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.47 -16.35 57.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.31 -27.97 7.95 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.454 1.026 . . . . 0.0 114.816 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -54.64 -50.81 67.25 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.947 1.874 . . . . 0.0 113.205 -165.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.5 p -55.01 -44.93 75.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.915 -0.49 . . . . 0.0 110.675 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.97 82.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.752 -0.592 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -39.59 75.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.7 -0.667 . . . . 0.0 111.559 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.56 -40.41 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.128 0.876 . . . . 0.0 111.869 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -53.94 121.65 30.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -164.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.93 -26.97 83.23 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.746 2.298 . . . . 0.0 112.736 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.95 19.05 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.553 0.741 . . . . 0.0 112.099 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.55 54.19 9.12 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.476 0.56 . . . . 0.0 113.122 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.65 -27.48 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.581 . . . . 0.0 114.58 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.67 82.48 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.274 1.983 . . . . 0.0 108.67 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -162.23 155.76 2.74 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -168.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -90.16 148.12 23.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 127.205 2.816 . . . . 0.0 112.671 -148.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 163.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.531 0.205 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -74.25 -154.17 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 126.479 1.912 . . . . 0.0 106.767 156.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -122.41 -179.22 4.12 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 146.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.33 104.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 155.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.7 176.41 8.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.088 0.946 . . . . 0.0 112.895 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.75 -31.59 2.09 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.66 1.984 . . . . 0.0 114.985 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -54.75 -16.37 2.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.9 t -55.55 -33.75 64.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.923 2.089 . . . . 0.0 115.607 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.288 1.8 m 71.35 -53.32 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 119.473 -2.017 . . . . 0.0 113.988 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p 129.08 29.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 131.399 3.88 . . . . 0.0 111.307 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -19.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -162.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.41 -53.0 4.08 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.109 -0.994 . . . . 0.0 114.24 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -33.11 -63.32 0.23 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.34 1.456 . . . . 0.0 114.633 -160.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -56.36 -21.46 24.8 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -170.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.39 -47.04 3.5 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.754 0.821 . . . . 0.0 112.657 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.5 m -82.72 -24.26 33.68 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -74.0 -34.65 64.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.756 1.223 . . . . 0.0 111.075 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.88 123.28 51.93 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.428 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.56 -37.4 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.294 3.329 . . . . 0.0 113.694 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.31 20.48 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.1 0.56 . . . . 0.0 112.163 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 44.72 49.37 8.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 0.0 112.432 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.18 31.61 1.66 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.389 1.076 . . . . 0.0 111.157 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.48 146.25 30.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.763 0.825 . . . . 0.0 109.107 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.47 169.24 10.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.135 2.174 . . . . 0.0 109.897 172.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -75.22 125.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.72 -73.88 1.06 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.99 -70.04 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -115.08 -62.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.71 2.004 . . . . 0.0 107.232 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -167.24 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.529 1.132 . . . . 0.0 111.075 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -73.32 151.8 41.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.427 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 159.75 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 127.677 2.391 . . . . 0.0 106.008 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.64 131.45 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.41 79.55 0.76 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.27 66.58 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -163.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.89 -34.34 77.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.795 1.238 . . . . 0.0 110.694 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -84.81 -40.83 16.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 110.433 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 t -61.27 149.67 37.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.128 0.876 . . . . 0.0 108.743 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 pt -90.84 -112.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 167.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.89 129.1 11.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 155.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -161.03 161.8 31.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.052 0.842 . . . . 0.0 109.848 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.25 -26.93 56.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.489 -0.757 . . . . 0.0 112.392 -173.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -47.8 -60.68 2.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.272 1.029 . . . . 0.0 113.207 -159.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.5 p -60.71 -41.55 95.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.651 0.659 . . . . 0.0 110.465 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.38 81.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.505 -0.747 . . . . 0.0 110.307 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -46.02 72.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.403 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.86 -37.35 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.405 1.002 . . . . 0.0 111.408 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -53.77 118.57 15.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.649 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.44 -38.17 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.65 3.567 . . . . 0.0 114.813 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.06 24.34 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 112.15 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.59 62.09 5.09 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.385 0.539 . . . . 0.0 112.962 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.17 -23.74 0.21 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 126.722 2.009 . . . . 0.0 114.699 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -60.95 90.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.82 2.347 . . . . 0.0 108.038 162.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 m -159.19 144.54 6.69 Favored 'Isoleucine or valine' 0 C--O 1.252 1.209 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -91.1 131.5 36.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 128.359 3.537 . . . . 0.0 114.23 -144.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 157.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.306 0 CA-C-O 117.354 -1.308 . . . . 0.0 108.801 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 61.45 -137.06 0.54 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -142.32 -163.36 1.59 Allowed 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 115.845 -2.342 . . . . 0.0 105.465 135.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.09 108.97 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 156.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.25 163.25 27.22 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.274 -0.891 . . . . 0.0 110.848 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.07 -12.31 4.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -52.43 -29.18 23.15 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.336 -0.852 . . . . 0.0 112.228 166.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.8 t -58.87 156.27 11.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.997 1.319 . . . . 0.0 111.653 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.59 167.67 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 164.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -65.39 64.48 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.012 1.325 . . . . 0.0 111.997 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -34.05 7.2 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.585 1.154 . . . . 0.0 112.716 -165.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.92 21.68 56.14 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.879 1.228 . . . . 0.0 114.742 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.79 -28.43 58.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.162 0.981 . . . . 0.0 111.46 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 p -79.31 -108.62 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 53.76 -101.65 0.12 Allowed 'General case' 0 C--N 1.34 0.174 0 CA-C-N 121.49 1.95 . . . . 0.0 111.799 170.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m -41.32 -36.29 0.78 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.409 1.884 . . . . 0.0 112.832 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -41.79 62.33 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 111.569 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.54 125.0 81.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.262 -166.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.53 -35.03 11.87 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.59 2.86 . . . . 0.0 114.096 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.4 m -107.08 5.19 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 48.69 37.43 9.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.032 1.333 . . . . 0.0 111.64 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.83 32.46 0.42 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.697 1.199 . . . . 0.0 111.958 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -132.1 151.14 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.885 1.274 . . . . 0.0 108.786 -172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 p -164.67 174.15 11.11 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.395 1.478 . . . . 0.0 109.195 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -77.38 125.24 29.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.77 -83.44 1.7 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -167.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -99.87 -50.33 4.05 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.25 1.02 . . . . 0.0 108.446 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 p -140.73 -57.7 0.52 Allowed 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.031 2.133 . . . . 0.0 106.609 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.45 -162.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.21 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -79.8 156.29 27.49 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.267 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -147.99 158.36 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.767 2.027 . . . . 0.0 108.28 -171.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.84 149.75 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 125.699 1.6 . . . . 0.0 108.957 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -82.77 114.17 20.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 157.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.621 1.1 . . . . 0.0 112.004 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 -38.92 85.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.7 1.2 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 m -79.85 -40.06 29.27 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.742 1.217 . . . . 0.0 109.745 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.9 112.04 1.9 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.582 0.628 . . . . 0.0 110.941 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.5 pt -79.76 47.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 121.244 -0.91 . . . . 0.0 111.316 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 14.73 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.609 2.763 . . . . 0.0 114.402 -173.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -5.27 40.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.99 -37.38 1.49 Allowed Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.035 -1.041 . . . . 0.0 114.23 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -46.17 -52.46 12.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -154.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -47.35 -37.7 11.62 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.147 1.779 . . . . 0.0 111.596 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -34.73 61.3 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.52 -0.738 . . . . 0.0 112.29 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -67.69 -44.89 76.69 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.87 0.304 . . . . 0.0 111.004 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.66 -30.37 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.868 -171.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -56.74 118.73 24.74 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.278 -170.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.88 -37.3 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.421 3.414 . . . . 0.0 114.253 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.73 22.65 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.995 0.918 . . . . 0.0 112.246 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.91 64.42 3.27 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.601 0.637 . . . . 0.0 113.039 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.39 -23.4 0.19 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -64.29 83.15 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.374 2.05 . . . . 0.0 108.28 163.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -162.27 151.72 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 -165.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.83 151.05 21.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 127.307 2.879 . . . . 0.0 113.614 -143.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 152.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -123.78 -157.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.604 2.362 . . . . 0.0 105.429 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -118.17 -179.33 3.74 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 143.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.1 109.44 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 147.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.93 173.37 11.29 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 122.143 0.973 . . . . 0.0 111.286 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -47.96 -31.09 4.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.035 1.334 . . . . 0.0 113.299 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -65.11 13.19 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.7 t -74.17 -73.12 0.24 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.627 2.371 . . . . 0.0 112.793 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.274 1.3 m 75.77 137.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 127.197 2.199 . . . . 0.0 110.373 -159.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.25 57.03 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.941 2.096 . . . . 0.0 114.48 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -17.94 25.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.214 0.915 . . . . 0.0 112.903 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.92 -57.96 4.02 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 120.92 -1.112 . . . . 0.0 114.005 167.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -30.38 -57.76 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.283 1.833 . . . . 0.0 114.756 -164.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -63.28 -20.92 65.9 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -169.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.91 -58.3 2.1 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.413 1.006 . . . . 0.0 112.444 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -29.17 67.22 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.287 1.035 . . . . 0.0 112.537 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 111.632 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.31 123.66 83.25 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.519 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -42.4 -37.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.024 3.149 . . . . 0.0 113.938 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.14 14.45 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.24 44.11 6.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.525 1.13 . . . . 0.0 111.759 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.08 36.34 0.62 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.038 0.935 . . . . 0.0 110.598 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mt -137.54 149.31 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 125.212 1.405 . . . . 0.0 107.698 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.9 t -164.23 176.73 8.92 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 124.77 1.228 . . . . 0.0 109.93 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.65 102.74 2.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.3 -65.64 1.77 Allowed Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -119.14 -77.2 0.57 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -108.61 -48.72 3.27 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.412 1.485 . . . . 0.0 110.193 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.82 -169.16 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 122.711 0.405 . . . . 0.0 109.98 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -82.66 148.79 27.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.526 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.61 160.46 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 126.932 2.093 . . . . 0.0 107.734 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 71.2 mt -108.73 140.19 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.837 1.255 . . . . 0.0 107.801 174.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -72.71 76.45 1.11 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.65 67.03 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -44.93 -47.69 11.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.297 1.839 . . . . 0.0 112.343 166.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -96.99 -31.99 12.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.606 2.362 . . . . 0.0 110.847 -165.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.8 t -57.01 136.78 56.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.403 1.001 . . . . 0.0 108.606 160.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.13 -102.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -158.63 135.79 9.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 155.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.06 177.94 8.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 109.663 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.86 -42.26 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.95 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.53 -60.13 3.76 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 117.633 0.716 . . . . 0.0 112.602 -147.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -53.07 -45.15 67.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.024 0.374 . . . . 0.0 111.124 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.08 90.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.886 -0.509 . . . . 0.0 110.343 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.26 -43.84 69.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.485 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.45 -40.27 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 119.351 0.978 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -53.43 118.24 14.01 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.784 -0.627 . . . . 0.0 112.328 -163.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.83 -37.84 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.317 3.344 . . . . 0.0 114.456 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.4 m -118.73 16.17 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.94 50.22 39.22 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.713 0.688 . . . . 0.0 113.036 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.6 -19.73 0.26 Allowed Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.841 1.656 . . . . 0.0 115.061 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -58.36 86.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.036 2.491 . . . . 0.0 110.022 164.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 m -161.53 152.48 4.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -84.12 151.35 24.97 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 127.41 2.944 . . . . 0.0 114.008 -139.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 135.306 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -85.76 -157.46 0.33 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.1 174.96 5.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 144.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 mm -79.02 107.63 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 146.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.34 165.05 25.4 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 122.09 0.948 . . . . 0.0 111.445 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.57 -15.23 10.47 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.918 1.687 . . . . 0.0 113.596 -173.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 m -56.32 -23.49 37.38 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.399 -0.813 . . . . 0.0 112.515 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -54.25 154.16 4.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.096 1.358 . . . . 0.0 110.303 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.98 164.73 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 170.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.4 m -71.74 60.66 0.36 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.949 0.795 . . . . 0.0 111.649 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 -31.22 14.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.999 1.32 . . . . 0.0 111.818 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.25 -28.86 1.68 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.979 172.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -43.43 -48.78 7.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.72 1.208 . . . . 0.0 113.518 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -64.43 -12.57 44.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.78 -65.38 0.51 Allowed 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.106 -0.997 . . . . 0.0 112.89 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 m -69.27 -29.84 67.82 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -59.06 -39.89 83.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.215 1.006 . . . . 0.0 111.737 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.28 120.09 64.73 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.895 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.89 -37.0 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.562 2.841 . . . . 0.0 113.946 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.36 0.86 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.166 0.439 . . . . 0.0 112.011 -174.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.38 57.42 5.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.776 0.83 . . . . 0.0 111.037 -174.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.65 61.75 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.671 -0.643 . . . . 0.0 111.454 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.19 149.86 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.439 1.896 . . . . 0.0 112.132 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 m -161.32 164.13 30.33 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.243 2.617 . . . . 0.0 108.488 154.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -75.15 119.23 19.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.87 -66.91 1.35 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -166.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -116.56 -71.96 0.71 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -113.5 -55.97 2.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.146 1.378 . . . . 0.0 108.745 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -100.94 -167.52 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.086 0.555 . . . . 0.0 110.649 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -84.68 146.96 27.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.412 0.625 . . . . 0.0 111.433 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.1 159.03 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 127.171 2.188 . . . . 0.0 106.153 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.42 149.65 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 C-N-CA 125.296 1.438 . . . . 0.0 109.431 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -65.76 91.96 0.14 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 155.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.79 -29.04 67.95 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.676 -1.265 . . . . 0.0 112.404 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.09 -36.63 84.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.311 0.644 . . . . 0.0 111.368 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -79.77 -43.52 22.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.502 1.121 . . . . 0.0 109.379 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.7 t -54.63 132.31 45.07 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -78.33 -102.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.87 120.38 2.66 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 159.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.39 171.81 19.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.182 0.901 . . . . 0.0 110.796 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.09 -40.51 8.59 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.544 -0.587 . . . . 0.0 113.122 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.61 -56.92 14.77 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.851 0.826 . . . . 0.0 112.995 -147.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 p -55.86 -44.64 78.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.02 -0.425 . . . . 0.0 110.926 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.07 94.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.793 -0.567 . . . . 0.0 110.108 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -62.76 -49.31 75.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.145 0.578 . . . . 0.0 111.413 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -68.25 -40.68 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 118.832 0.742 . . . . 0.0 111.833 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.36 117.95 19.26 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -162.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.92 -26.42 82.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.729 2.286 . . . . 0.0 112.38 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -116.09 21.74 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.967 0.907 . . . . 0.0 111.408 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.05 50.89 7.47 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.521 1.058 . . . . 0.0 113.346 171.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.8 -26.92 0.36 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.265 1.426 . . . . 0.0 114.828 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -63.65 84.56 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.579 2.186 . . . . 0.0 109.443 168.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.1 m -165.77 157.81 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.78 155.33 18.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 127.624 3.077 . . . . 0.0 114.04 -124.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 . . . . . 0 C--O 1.257 1.465 0 C-N-CA 127.82 2.448 . . . . 0.0 106.44 157.486 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 66.6 -175.39 0.19 Allowed 'General case' 0 C--N 1.341 0.239 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -156.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -128.01 179.43 5.58 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 140.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.0 mt -79.7 107.69 12.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 156.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.83 15.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.145 0.974 . . . . 0.0 111.673 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -49.15 -23.4 1.26 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.604 2.362 . . . . 0.0 114.82 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -54.08 -24.38 17.24 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.556 -0.715 . . . . 0.0 112.521 171.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.7 t -57.72 121.63 10.88 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.291 1.437 . . . . 0.0 110.864 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.94 21.97 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.491 -0.756 . . . . 0.0 111.581 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 m 56.69 36.23 27.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.139 0.976 . . . . 0.0 110.552 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.33 152.59 38.14 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 111.21 -169.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.9 57.96 4.93 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.892 -1.13 . . . . 0.0 110.858 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.72 -161.33 1.25 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.206 1.003 . . . . 0.0 108.889 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.57 3.7 p 39.25 -120.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.065 -160.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 49.69 -105.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 122.627 2.467 . . . . 0.0 110.904 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 m -58.06 -17.59 18.85 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -61.12 -29.3 69.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.383 0.992 . . . . 0.0 111.005 170.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.39 129.25 90.84 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.343 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.97 -34.34 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.135 3.224 . . . . 0.0 114.456 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 p -126.72 26.63 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.797 0.726 . . . . 0.0 112.686 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.31 38.44 21.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.88 0.872 . . . . 0.0 111.9 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.95 32.07 0.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.78 1.232 . . . . 0.0 111.811 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.21 152.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.278 1.431 . . . . 0.0 107.434 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -165.25 173.96 10.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.997 2.119 . . . . 0.0 108.925 164.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 123.68 19.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.75 -105.74 2.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -98.78 -49.05 4.71 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.581 1.152 . . . . 0.0 109.141 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -128.21 -53.05 1.29 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.334 1.854 . . . . 0.0 107.691 -172.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -165.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.05 148.15 31.19 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.417 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 154.24 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 C-N-CA 126.072 1.749 . . . . 0.0 107.817 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.2 mt -104.53 136.65 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 107.674 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -74.6 77.16 2.0 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.58 62.25 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -41.24 -48.36 3.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 165.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -99.63 -37.51 9.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.834 2.454 . . . . 0.0 111.236 -165.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.1 t -53.98 126.9 24.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.805 0.729 . . . . 0.0 111.114 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 pt -91.94 8.88 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.817 0.847 . . . . 0.0 112.754 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 54.64 75.32 0.3 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.903 2.481 . . . . 0.0 111.936 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.51 -13.9 13.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 114.04 -174.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.71 -17.76 10.36 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.335 0.969 . . . . 0.0 115.456 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -55.69 -47.85 76.08 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.719 1.759 . . . . 0.0 112.98 -171.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -58.08 -41.3 83.16 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.533 -0.729 . . . . 0.0 109.481 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.04 -43.38 81.91 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.555 -0.715 . . . . 0.0 110.186 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -62.9 -48.11 80.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.823 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 m -68.88 -39.6 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.88 0.763 . . . . 0.0 111.941 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.1 t -55.51 122.09 42.46 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.946 -167.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.18 -39.0 2.36 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.759 3.64 . . . . 0.0 115.137 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.97 28.22 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.248 0.619 . . . . 0.0 112.055 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.21 40.85 45.67 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 118.132 0.424 . . . . 0.0 113.653 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.26 1.44 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -58.93 78.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.324 2.683 . . . . 0.0 111.773 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 m -160.63 173.34 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 130.262 3.425 . . . . 0.0 105.173 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.72 158.24 20.82 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 124.045 0.84 . . . . 0.0 112.904 -96.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 128.133 2.573 . . . . 0.0 110.182 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.39 -161.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 166.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -120.44 -179.42 3.96 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 141.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.5 mt -83.52 111.13 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 152.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.25 25.06 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 122.191 0.996 . . . . 0.0 112.068 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.97 -28.25 2.65 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.733 2.013 . . . . 0.0 114.11 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.42 -24.94 2.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -45.08 -73.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.268 2.227 . . . . 0.0 114.791 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 66.5 143.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.473 1.109 . . . . 0.0 110.267 -156.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.73 56.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.125 1.77 . . . . 0.0 113.142 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 158.64 25.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.135 1.374 . . . . 0.0 108.713 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.16 28.9 13.27 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.057 -1.027 . . . . 0.0 112.969 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.65 -57.2 2.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.397 1.098 . . . . 0.0 112.998 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.334 28.5 p -73.1 -90.81 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.329 0.968 . . . . 0.0 112.711 -171.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 31.94 -98.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.815 1.643 . . . . 0.0 113.994 -169.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -46.79 -31.92 3.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.938 2.095 . . . . 0.0 113.497 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -50.32 -32.41 17.07 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.683 1.193 . . . . 0.0 112.895 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.41 122.36 77.8 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.443 -0.786 . . . . 0.0 110.499 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -50.94 -35.07 48.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.011 2.474 . . . . 0.0 113.502 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.67 5.53 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 118.304 0.502 . . . . 0.0 111.033 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.06 40.94 26.8 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.007 1.723 . . . . 0.0 110.845 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.31 45.23 1.21 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.755 0.822 . . . . 0.0 110.011 -168.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.86 150.42 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.498 1.919 . . . . 0.0 106.434 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -171.48 174.56 4.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.139 2.176 . . . . 0.0 108.477 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.06 123.82 17.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 167.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.29 -98.47 2.41 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -99.27 -46.06 5.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.44 1.496 . . . . 0.0 108.822 -166.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 p -134.61 -56.51 0.84 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.183 1.793 . . . . 0.0 107.28 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 -162.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.339 1.056 . . . . 0.0 110.53 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -78.22 139.8 38.92 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.8 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.46 156.62 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 126.278 1.831 . . . . 0.0 107.616 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.11 142.94 24.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -73.81 78.42 1.59 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.62 56.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 113.022 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -42.1 -49.71 4.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.986 2.114 . . . . 0.0 112.219 165.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.56 -31.26 12.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.578 2.351 . . . . 0.0 111.36 -165.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.0 t -49.95 116.86 2.0 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.211 0.914 . . . . 0.0 110.271 169.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.84 -17.84 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 122.735 0.414 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t0 76.62 118.81 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 127.916 2.486 . . . . 0.0 108.499 -168.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.85 -47.96 0.09 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -168.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.98 -29.59 4.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.526 -1.152 . . . . 0.0 113.274 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -53.33 -51.13 63.39 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.539 1.67 . . . . 0.0 112.593 -164.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.29 -46.91 72.86 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.44 -0.162 . . . . 0.0 110.761 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.92 91.46 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.669 -0.644 . . . . 0.0 110.156 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -51.31 69.53 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.619 0.767 . . . . 0.0 111.806 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -70.13 -39.18 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 119.366 0.985 . . . . 0.0 111.797 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.0 t -55.02 116.65 11.87 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -162.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.09 -38.95 19.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.938 3.092 . . . . 0.0 113.835 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.47 9.26 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.716 1.206 . . . . 0.0 112.147 -173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.79 50.85 25.25 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.792 0.723 . . . . 0.0 112.94 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.78 -25.35 0.29 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 126.281 1.832 . . . . 0.0 114.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.26 81.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.061 2.507 . . . . 0.0 109.21 167.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -161.08 156.69 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 129.221 3.008 . . . . 0.0 104.006 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.5 174.4 7.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 127.445 2.966 . . . . 0.0 114.069 -121.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.82 158.083 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.291 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -100.22 178.29 4.82 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 142.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -108.51 170.18 8.18 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 152.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.8 mt -79.91 106.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 150.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.09 174.94 10.1 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 122.689 1.233 . . . . 0.0 111.667 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.36 -13.69 9.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 128.563 2.745 . . . . 0.0 113.541 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.29 64.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 111.468 170.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.5 t -57.51 153.17 13.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.3 1.44 . . . . 0.0 112.272 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.19 156.68 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 162.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m -61.25 66.59 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.815 1.646 . . . . 0.0 113.348 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 -30.33 9.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.342 1.057 . . . . 0.0 112.833 -168.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.68 60.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.191 1.377 . . . . 0.0 115.772 170.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.88 -61.84 1.83 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.552 1.676 . . . . 0.0 110.789 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.38 -34.09 32.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.275 1.03 . . . . 0.0 111.881 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.97 -45.67 7.89 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -88.02 -6.75 57.81 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -41.27 13.76 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.119 1.768 . . . . 0.0 108.021 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.4 t -49.64 116.99 6.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.333 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.94 -33.28 14.19 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.767 2.978 . . . . 0.0 113.876 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.7 m -111.56 11.53 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.264 0.484 . . . . 0.0 112.065 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 47.89 34.11 3.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.2 40.29 0.62 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.881 1.272 . . . . 0.0 111.199 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mt -133.2 146.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.109 1.364 . . . . 0.0 108.823 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -166.54 167.02 15.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.327 1.851 . . . . 0.0 109.649 167.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.34 119.18 18.18 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.24 -78.44 1.28 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -169.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -99.87 -54.91 2.78 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.941 0.896 . . . . 0.0 108.91 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -140.88 -56.24 0.5 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.867 2.067 . . . . 0.0 107.377 -167.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.64 -174.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.059 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -74.25 148.38 41.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.152 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.97 152.55 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 126.346 1.858 . . . . 0.0 106.988 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.27 138.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.516 1.527 . . . . 0.0 107.788 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -74.07 76.2 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.55 60.05 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -167.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -43.97 -47.51 8.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.141 1.776 . . . . 0.0 112.243 167.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -100.27 -30.53 11.84 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.923 2.489 . . . . 0.0 111.393 -165.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -52.29 128.54 25.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.308 0.958 . . . . 0.0 109.793 167.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.0 pt -90.1 130.18 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 161.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 74.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.103 1.361 . . . . 0.0 112.236 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -15.17 16.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.507 1.523 . . . . 0.0 111.341 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.76 -23.63 0.82 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.233 1.873 . . . . 0.0 115.188 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.15 -39.16 71.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.4 p -47.44 -32.68 5.31 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.498 1.119 . . . . 0.0 112.578 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -44.47 32.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.379 0.536 . . . . 0.0 112.403 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -51.76 -39.47 58.61 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -167.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.71 -26.05 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 117.879 0.309 . . . . 0.0 111.749 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.86 119.11 69.27 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.949 -153.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.34 -37.98 7.81 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.175 3.25 . . . . 0.0 114.377 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.67 33.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.729 0.812 . . . . 0.0 111.633 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.48 49.29 11.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.31 0.957 . . . . 0.0 114.078 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.24 -28.34 0.39 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.814 1.645 . . . . 0.0 114.429 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.96 87.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.648 2.232 . . . . 0.0 109.712 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -165.95 158.82 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.909 0 C-N-CA 128.661 2.784 . . . . 0.0 104.296 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -90.67 166.03 13.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 127.266 2.854 . . . . 0.0 112.95 -118.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 C--O 1.249 1.055 0 C-N-CA 124.896 1.279 . . . . 0.0 110.994 -162.039 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 62.32 -152.13 0.36 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -168.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -131.18 -174.49 3.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 145.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.1 mm -79.14 110.07 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 153.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.48 162.45 27.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 122.166 0.984 . . . . 0.0 111.188 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -53.0 -21.36 4.35 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.7 2.0 . . . . 0.0 114.257 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -51.36 -25.65 6.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.737 -0.602 . . . . 0.0 112.565 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.08 109.81 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.508 1.123 . . . . 0.0 111.97 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -80.71 13.78 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.334 -0.854 . . . . 0.0 112.03 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.8 m 59.29 43.93 16.15 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.247 1.019 . . . . 0.0 110.772 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.51 -158.01 0.24 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.498 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.43 39.18 1.25 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 120.088 1.313 . . . . 0.0 111.109 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.46 -40.17 13.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 123.384 0.673 . . . . 0.0 110.987 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 p -85.43 -137.35 0.07 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.153 0.581 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.49 -77.72 0.03 OUTLIER 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.04 1.736 . . . . 0.0 113.356 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -56.63 -35.13 67.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.165 0.586 . . . . 0.0 109.952 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -53.38 -31.03 42.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 113.789 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -70.25 127.29 92.33 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.82 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.22 -36.35 5.99 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.689 2.926 . . . . 0.0 113.622 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.79 20.36 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.649 0.38 . . . . 0.0 111.41 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 44.27 39.74 3.2 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.025 1.73 . . . . 0.0 112.912 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.64 40.75 1.2 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.342 1.057 . . . . 0.0 111.296 -165.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.32 149.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.51 1.924 . . . . 0.0 106.085 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -173.07 172.9 3.8 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.658 1.983 . . . . 0.0 109.492 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 129.42 40.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.03 -111.06 3.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 124.728 1.156 . . . . 0.0 111.698 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -99.77 -48.72 4.61 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.965 0.906 . . . . 0.0 109.494 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 p -115.65 -60.83 1.82 Allowed 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.509 2.324 . . . . 0.0 106.783 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.27 -156.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.725 1.61 . . . . 0.0 110.65 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -74.62 157.19 35.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.826 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 169.97 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 127.789 2.436 . . . . 0.0 108.89 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -130.35 143.08 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.539 1.536 . . . . 0.0 107.388 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.55 79.13 2.56 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 164.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.11 63.23 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.224 -0.923 . . . . 0.0 113.262 -171.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.86 -35.91 75.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 110.57 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -84.26 -44.2 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.624 1.57 . . . . 0.0 111.091 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' A' ' 1' ' ' ALA . 50.5 t -57.57 139.06 54.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.572 1.078 . . . . 0.0 110.22 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.1 -116.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -140.18 30.46 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.691 1.997 . . . . 0.0 109.853 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.277 0.0 OUTLIER -72.81 177.54 4.77 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.945 -0.472 . . . . 0.0 111.555 -174.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.57 -32.87 4.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.623 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.22 -53.38 54.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.498 1.149 . . . . 0.0 113.516 -150.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.62 -45.2 85.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.566 0.222 . . . . 0.0 110.808 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.53 94.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.884 -0.51 . . . . 0.0 109.847 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -50.57 69.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 111.969 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.09 -38.34 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 119.487 1.04 . . . . 0.0 111.669 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.2 118.12 16.98 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -163.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -60.84 -23.78 77.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.718 2.278 . . . . 0.0 112.55 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.87 31.3 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.381 0.673 . . . . 0.0 111.073 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.62 63.13 1.74 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.646 1.117 . . . . 0.0 113.239 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 -30.9 0.24 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.994 1.718 . . . . 0.0 113.541 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.88 78.58 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.758 2.305 . . . . 0.0 108.684 165.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -160.79 153.36 4.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 128.67 2.788 . . . . 0.0 104.638 -167.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -91.67 149.65 21.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.493 2.995 . . . . 0.0 115.71 -132.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 102.275 -3.231 . . . . 0.0 102.275 131.808 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -92.61 -165.12 1.28 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.04 178.35 5.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 151.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.17 108.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.79 171.11 15.26 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 122.091 0.948 . . . . 0.0 111.469 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -53.98 -20.6 6.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.196 1.798 . . . . 0.0 113.976 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -57.77 -20.68 36.87 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.53 -0.731 . . . . 0.0 112.963 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -56.1 153.58 8.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.084 1.354 . . . . 0.0 111.32 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.7 156.26 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 161.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 m -67.41 63.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.122 0.874 . . . . 0.0 112.738 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.0 -16.79 21.45 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.184 1.393 . . . . 0.0 111.894 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 -58.97 4.88 Favored Glycine 0 C--N 1.338 0.655 0 O-C-N 121.284 -0.885 . . . . 0.0 112.158 169.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -22.27 -65.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.91 2.084 . . . . 0.0 115.004 -167.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 p -56.7 -25.56 54.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.37 -50.35 1.49 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.028 0.931 . . . . 0.0 113.351 167.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 m -81.84 -23.74 36.23 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.12 -33.78 75.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.513 1.125 . . . . 0.0 110.959 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.54 115.73 20.56 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.416 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.01 -18.42 62.03 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.661 1.574 . . . . 0.0 111.478 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.4 14.16 8.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 CA-C-N 119.052 0.842 . . . . 0.0 111.582 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 43.68 48.02 6.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.851 1.26 . . . . 0.0 111.906 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.16 -5.98 51.18 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.897 0.879 . . . . 0.0 112.026 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.51 146.93 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.202 1.001 . . . . 0.0 110.308 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.6 m -164.23 167.88 19.49 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.235 2.214 . . . . 0.0 109.012 163.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -69.97 122.29 19.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.48 -65.02 1.15 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -170.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -115.08 -70.35 0.8 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -118.82 -58.35 1.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.692 1.997 . . . . 0.0 107.759 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -94.67 -174.21 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.866 -176.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -78.16 151.1 33.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.066 0.46 . . . . 0.0 111.189 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.13 142.84 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 126.256 1.823 . . . . 0.0 107.568 -170.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -103.27 139.01 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 127.11 2.164 . . . . 0.0 109.662 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.268 64.3 m-20 -69.82 102.49 1.96 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 159.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.27 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.041 -1.037 . . . . 0.0 112.332 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.55 -37.51 81.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.273 0.558 . . . . 0.0 110.929 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.0 m -80.19 -42.85 22.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.047 0.939 . . . . 0.0 110.6 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.93 127.58 32.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.919 0.781 . . . . 0.0 111.631 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.8 pt -100.64 28.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.863 1.265 . . . . 0.0 112.162 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 10.3 m-20 51.09 47.45 24.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.918 1.287 . . . . 0.0 111.707 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.256 0.5 OUTLIER -86.11 -164.7 1.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.23 -28.71 3.72 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.704 1.138 . . . . 0.0 114.069 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -54.85 -56.11 22.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.251 1.025 . . . . 0.0 112.885 -153.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.7 p -53.47 -45.6 69.62 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.239 -0.288 . . . . 0.0 110.916 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.62 97.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 110.278 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -61.34 -47.64 84.95 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.661 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.68 -42.13 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.042 0.837 . . . . 0.0 112.266 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.52 121.11 36.34 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.262 -159.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.3 -38.83 3.73 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.597 3.531 . . . . 0.0 115.029 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.97 17.55 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.359 0.663 . . . . 0.0 112.382 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.63 44.06 79.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 118.593 0.633 . . . . 0.0 112.907 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.65 -25.5 0.66 Allowed Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.46 87.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.936 2.424 . . . . 0.0 110.644 170.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 m -162.11 160.14 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.816 0 C-N-CA 128.937 2.895 . . . . 0.0 104.101 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.12 170.18 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 127.375 2.922 . . . . 0.0 115.149 -128.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 . . . . . 0 C--O 1.251 1.181 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.219 169.302 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -89.31 -162.31 0.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 166.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 -177.18 4.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 149.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.27 110.1 20.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.08 162.04 28.89 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 122.083 0.945 . . . . 0.0 111.337 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -51.38 -26.23 7.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.721 1.609 . . . . 0.0 113.555 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -48.94 -25.45 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.6 t -48.63 -60.25 2.87 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 114.215 -174.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 162.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.725 -1.234 . . . . 0.0 110.856 -163.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 m -75.41 49.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 119.552 -1.968 . . . . 0.0 111.498 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.65 166.17 23.76 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 154.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.71 38.55 0.71 Allowed Glycine 0 CA--C 1.523 0.587 0 CA-C-N 120.557 1.526 . . . . 0.0 112.391 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.79 -63.02 1.51 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.471 0.635 . . . . 0.0 110.988 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.2 p -50.53 -24.58 3.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -33.85 -53.08 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.707 1.203 . . . . 0.0 114.197 166.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 p -76.09 -26.16 56.19 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.472 -0.768 . . . . 0.0 112.124 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -75.9 -29.65 58.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.817 2.047 . . . . 0.0 110.243 -169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.8 t -58.6 119.48 36.89 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.082 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.38 -31.83 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.166 2.577 . . . . 0.0 113.345 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.26 8.17 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.413 0.551 . . . . 0.0 111.653 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 m120 44.98 44.13 7.8 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.831 1.652 . . . . 0.0 111.748 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.14 47.77 1.25 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.976 0.91 . . . . 0.0 110.055 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.43 150.91 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.754 2.022 . . . . 0.0 107.143 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -170.86 174.54 4.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.423 2.289 . . . . 0.0 109.049 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -73.33 132.08 42.65 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.52 -81.79 1.58 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -99.37 -56.13 2.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.921 1.288 . . . . 0.0 109.199 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -138.83 -51.09 0.55 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.968 2.107 . . . . 0.0 107.859 -177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.65 -161.33 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 122.953 0.501 . . . . 0.0 109.844 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.313 5.5 m-85 -79.35 163.63 24.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.418 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.4 163.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 127.774 2.429 . . . . 0.0 108.007 -170.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.35 143.37 38.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 125.248 1.419 . . . . 0.0 108.877 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -75.37 83.71 2.48 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.36 -32.71 62.79 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.79 -48.42 8.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.921 1.688 . . . . 0.0 112.031 166.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -98.86 -30.86 12.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.842 2.057 . . . . 0.0 111.486 -165.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.8 t -55.68 127.64 30.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.586 1.084 . . . . 0.0 111.22 172.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.9 pt -104.63 33.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.594 1.558 . . . . 0.0 111.377 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 5.1 m-20 49.27 32.28 4.27 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.547 1.939 . . . . 0.0 113.491 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -76.43 -9.66 58.81 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -165.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 -23.52 6.3 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.788 -1.007 . . . . 0.0 114.23 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -53.69 -54.77 33.11 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.585 1.692 . . . . 0.0 111.338 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.43 -42.09 73.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.59 87.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.72 -0.613 . . . . 0.0 110.298 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -33.87 64.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 m -73.71 -38.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.813 1.188 . . . . 0.0 110.872 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.6 t -56.11 120.01 31.25 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.605 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -59.79 -29.83 90.55 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.692 2.261 . . . . 0.0 112.031 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.19 17.61 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.323 1.049 . . . . 0.0 111.675 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.03 49.93 5.27 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.818 1.199 . . . . 0.0 113.636 173.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.38 -30.28 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 125.523 1.529 . . . . 0.0 114.76 -174.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.7 90.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.73 2.286 . . . . 0.0 109.942 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.1 t -165.99 151.05 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 128.788 2.835 . . . . 0.0 103.688 -165.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -92.66 157.52 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 128.961 3.913 . . . . 0.0 115.609 -130.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 . . . . . 0 C--O 1.249 1.047 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 150.666 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -93.31 -160.97 0.8 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 164.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -129.94 -176.73 4.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 148.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.6 mt -84.06 107.74 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 152.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.55 170.34 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 122.05 0.928 . . . . 0.0 111.289 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.34 -25.61 1.05 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.015 2.126 . . . . 0.0 114.527 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -55.94 -19.12 10.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.93 156.85 6.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.241 1.416 . . . . 0.0 111.253 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.53 156.91 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 164.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -67.65 65.03 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.909 0.884 . . . . 0.0 111.832 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.261 0.1 OUTLIER -93.54 -162.2 0.92 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.609 1.563 . . . . 0.0 108.816 -177.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.62 42.45 0.71 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 120.932 1.696 . . . . 0.0 110.708 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.96 -37.46 12.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.436 0.695 . . . . 0.0 111.431 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.332 21.5 p -85.53 -100.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.55 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.68 -119.4 0.62 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 121.406 1.912 . . . . 0.0 112.058 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m -68.69 11.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -40.15 96.91 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.2 t -58.42 120.22 42.59 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.705 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -44.72 -36.98 11.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.774 2.983 . . . . 0.0 113.901 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -107.43 5.53 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 117.97 0.35 . . . . 0.0 111.54 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.11 48.36 12.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.436 1.095 . . . . 0.0 111.573 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.02 -11.96 61.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.085 0.954 . . . . 0.0 111.813 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -99.98 144.3 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.469 1.507 . . . . 0.0 110.484 -170.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -166.67 170.9 12.11 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.824 2.45 . . . . 0.0 108.765 162.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -66.74 130.73 44.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.37 -84.7 1.82 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -173.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.32 -52.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.59 1.156 . . . . 0.0 108.272 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -140.84 -57.58 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.267 2.227 . . . . 0.0 106.37 -171.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -158.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.453 0.701 . . . . 0.0 109.828 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.18 149.68 21.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 111.814 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.57 137.28 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 126.678 1.991 . . . . 0.0 108.662 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -96.72 136.15 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 127.094 2.157 . . . . 0.0 109.733 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.252 29.1 m-20 -66.89 102.4 0.96 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 156.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.0 -33.53 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.743 -1.223 . . . . 0.0 112.352 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.79 -38.65 82.47 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.499 0.666 . . . . 0.0 110.609 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -79.23 -43.05 24.57 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.498 1.119 . . . . 0.0 110.1 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.2 t -55.88 115.97 2.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.526 0.603 . . . . 0.0 111.527 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.03 -0.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 t0 68.92 79.3 0.21 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 110.332 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.22 -31.43 4.39 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -164.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.78 -35.82 4.77 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.636 1.107 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -53.54 163.89 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.352 5.2 p 60.3 -55.29 0.08 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.535 1.534 . . . . 0.0 112.963 -153.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.5 94.4 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 120.022 1.283 . . . . 0.0 109.806 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.83 -28.34 69.49 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.739 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -88.26 -38.87 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.808 1.185 . . . . 0.0 111.176 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -53.6 118.48 14.96 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -166.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.1 -38.22 10.42 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 124.273 3.315 . . . . 0.0 114.159 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.36 18.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.272 1.029 . . . . 0.0 112.377 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.84 42.49 37.84 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.588 0.631 . . . . 0.0 113.792 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 -22.96 0.38 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.696 1.599 . . . . 0.0 115.183 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.78 84.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.55 2.167 . . . . 0.0 109.621 166.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -159.68 157.2 3.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 128.808 2.843 . . . . 0.0 104.765 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -91.62 155.85 18.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 127.681 3.113 . . . . 0.0 115.12 -133.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 144.749 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -76.84 -177.86 4.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 153.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -118.97 168.69 10.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 102.999 -2.963 . . . . 0.0 102.999 145.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -80.43 105.34 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 148.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.54 163.83 26.53 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 119.366 -0.933 . . . . 0.0 111.01 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.27 -23.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.624 2.77 . . . . 0.0 114.85 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -25.77 4.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 168.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.8 t -57.62 158.64 5.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 111.764 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.54 160.84 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 164.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -66.12 63.64 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.99 1.316 . . . . 0.0 112.948 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.73 -32.65 8.32 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.531 1.133 . . . . 0.0 112.44 -165.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.49 15.34 57.05 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.014 1.292 . . . . 0.0 114.585 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.59 -33.14 68.77 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.383 1.092 . . . . 0.0 111.376 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.255 29.0 p -74.17 -90.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 44.05 -110.54 0.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 121.149 1.795 . . . . 0.0 112.236 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m -65.7 -5.96 10.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -38.21 64.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.977 0.808 . . . . 0.0 109.063 164.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 t -58.07 123.11 63.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.903 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -45.02 -38.45 13.66 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.752 2.968 . . . . 0.0 113.799 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -101.4 1.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.592 0.357 . . . . 0.0 111.344 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 54.22 33.47 18.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.791 1.236 . . . . 0.0 110.925 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.27 38.67 0.49 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.158 1.383 . . . . 0.0 112.053 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.16 150.48 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 124.292 1.037 . . . . 0.0 109.584 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.4 m -166.5 172.58 10.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.576 2.351 . . . . 0.0 108.136 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.32 127.76 33.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.82 -81.73 1.44 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.84 -53.68 3.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.415 1.086 . . . . 0.0 108.436 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 p -141.39 -54.58 0.47 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.192 2.197 . . . . 0.0 107.319 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.25 -173.91 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 122.919 0.488 . . . . 0.0 110.792 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.24 142.9 32.71 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.022 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.09 155.25 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 126.413 1.885 . . . . 0.0 108.662 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.48 140.78 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.57 1.548 . . . . 0.0 108.604 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.0 91.25 4.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.82 -36.77 72.72 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.921 -1.112 . . . . 0.0 113.864 -168.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.94 -35.86 67.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.122 0.969 . . . . 0.0 110.391 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.0 m -84.41 -47.63 10.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.864 1.666 . . . . 0.0 110.489 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.1 t -57.31 123.16 14.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.989 -0.444 . . . . 0.0 112.119 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.44 23.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.029 0.932 . . . . 0.0 112.498 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.32 39.52 28.39 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.013 1.725 . . . . 0.0 111.539 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.42 -10.07 59.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.03 -33.23 1.28 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.916 1.246 . . . . 0.0 115.056 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -48.93 -46.73 43.58 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -157.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.1 p -46.9 -31.67 3.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.991 1.317 . . . . 0.0 112.679 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -43.23 31.19 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.504 0.593 . . . . 0.0 112.368 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -49.92 -38.96 38.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.71 -24.94 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.44 119.24 71.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.531 -153.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -43.92 -40.16 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.043 3.162 . . . . 0.0 114.41 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.49 16.29 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 112.521 -173.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.52 53.62 19.92 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 118.711 0.687 . . . . 0.0 112.959 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.86 -23.01 0.24 Allowed Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.576 1.951 . . . . 0.0 115.065 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.33 90.15 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.128 1.885 . . . . 0.0 107.603 164.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 m -162.79 152.71 3.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -171.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -90.44 175.11 7.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.986 3.304 . . . . 0.0 112.076 -128.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 115.585 -2.15 . . . . 0.0 110.337 -157.843 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -113.61 -178.27 3.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 103.803 -2.665 . . . . 0.0 103.803 152.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -112.19 168.59 9.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 144.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.0 mt -80.58 109.46 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 152.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.38 165.73 24.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.468 1.128 . . . . 0.0 111.259 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.57 -20.98 15.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.571 1.548 . . . . 0.0 113.903 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -55.9 -21.41 20.16 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.584 -0.697 . . . . 0.0 112.829 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.0 t -46.58 -72.78 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.538 1.935 . . . . 0.0 115.107 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 68.05 155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.813 1.245 . . . . 0.0 111.864 -163.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m -66.7 57.39 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.889 1.276 . . . . 0.0 113.431 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -84.41 -38.38 20.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.472 1.033 . . . . 0.0 113.033 -168.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.71 -155.85 18.3 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.74 1.162 . . . . 0.0 113.207 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.79 -70.58 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.414 1.886 . . . . 0.0 113.725 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.22 -29.03 63.41 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -161.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.32 -49.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.081 0.953 . . . . 0.0 113.128 166.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.9 m -85.68 -15.74 41.33 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.117 0.567 . . . . 0.0 112.398 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -76.71 -37.11 56.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.471 1.109 . . . . 0.0 110.302 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.09 119.89 38.48 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.498 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.28 -34.44 31.63 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.155 2.57 . . . . 0.0 113.601 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.85 5.72 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.717 0.407 . . . . 0.0 111.238 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.92 31.15 10.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.019 1.327 . . . . 0.0 111.579 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 38.44 0.42 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mt -142.2 146.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.417 1.487 . . . . 0.0 107.342 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.08 163.83 13.49 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.454 1.902 . . . . 0.0 110.032 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -68.57 117.19 9.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.69 -76.8 1.21 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -164.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -110.57 -71.2 0.77 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -104.56 -61.01 1.51 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.362 1.065 . . . . 0.0 108.945 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.76 -160.52 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.064 0.946 . . . . 0.0 110.024 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.88 144.26 41.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.736 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.76 151.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.414 1.885 . . . . 0.0 106.094 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 mt -105.27 140.3 23.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.74 74.44 1.11 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 162.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -33.19 64.59 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -170.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -42.83 -46.48 5.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.805 2.042 . . . . 0.0 112.216 166.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -104.1 -27.29 12.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.116 2.566 . . . . 0.0 112.034 -163.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.6 t -45.2 119.08 1.91 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.622 1.101 . . . . 0.0 110.54 167.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 pt -80.28 34.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.368 -0.833 . . . . 0.0 112.01 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t0 29.38 63.35 0.14 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.152 2.581 . . . . 0.0 113.251 -174.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.28 0.5 OUTLIER -98.36 -141.76 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.291 1.036 . . . . 0.0 108.596 173.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 10.94 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 CA-C-N 121.843 2.11 . . . . 0.0 114.685 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.64 -47.61 76.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.048 1.924 . . . . 0.0 110.876 -172.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.1 p -57.33 -43.93 83.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.028 0.531 . . . . 0.0 110.692 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.35 94.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.465 -0.772 . . . . 0.0 109.505 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -51.71 68.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.71 0.804 . . . . 0.0 112.083 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.66 -39.22 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.527 1.058 . . . . 0.0 112.446 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.2 t -55.7 121.62 40.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -161.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.24 -31.93 82.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.735 2.29 . . . . 0.0 111.961 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.68 11.05 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.893 0.877 . . . . 0.0 111.851 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.69 63.95 3.19 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.18 0.895 . . . . 0.0 112.714 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.56 -28.07 0.19 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 126.382 1.873 . . . . 0.0 114.005 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 78.98 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.962 2.441 . . . . 0.0 108.437 164.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.8 m -158.65 153.65 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 128.562 2.745 . . . . 0.0 104.361 -168.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.16 174.18 7.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 128.555 3.66 . . . . 0.0 112.551 -113.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.254 1.308 0 CA-C-O 115.686 -2.102 . . . . 0.0 109.256 -164.307 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.291 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -68.08 -160.13 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.475 1.11 . . . . 0.0 108.299 150.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -122.0 178.31 4.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 146.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.76 107.55 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 151.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.64 168.0 20.85 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.371 1.081 . . . . 0.0 111.268 171.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.57 -9.28 5.62 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.305 1.842 . . . . 0.0 113.888 -173.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -23.58 61.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.863 -1.148 . . . . 0.0 111.861 166.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.3 t -63.17 158.83 18.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.006 0.923 . . . . 0.0 110.822 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -136.87 -175.44 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.9 p -73.28 64.08 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.75 175.2 5.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.853 1.661 . . . . 0.0 108.093 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.81 38.36 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 CA-C-N 120.143 1.338 . . . . 0.0 110.868 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -15.18 30.68 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.52 0.728 . . . . 0.0 112.29 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.305 29.9 p -101.41 -95.22 0.28 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 118.589 -0.72 . . . . 0.0 111.219 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 39.7 -99.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 113.689 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -49.49 -29.62 6.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.507 1.523 . . . . 0.0 112.864 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -52.02 -33.39 38.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.316 1.046 . . . . 0.0 112.877 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -64.26 119.89 60.01 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.483 -0.76 . . . . 0.0 109.781 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.04 -32.29 23.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.236 2.624 . . . . 0.0 113.147 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.7 19.85 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 122.706 0.403 . . . . 0.0 110.947 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.45 22.8 0.77 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.339 1.855 . . . . 0.0 114.231 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.5 44.19 1.02 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.878 1.271 . . . . 0.0 111.322 -166.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.05 147.34 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.818 1.247 . . . . 0.0 107.934 -174.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -170.7 169.31 7.12 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.171 2.188 . . . . 0.0 109.49 167.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -67.5 125.66 26.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.69 -84.22 1.68 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -168.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -102.3 -48.04 4.31 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.942 1.297 . . . . 0.0 108.463 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 p -140.21 -59.71 0.53 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.615 1.966 . . . . 0.0 106.854 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -155.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.12 0.968 . . . . 0.0 109.642 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -82.38 157.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.98 0.419 . . . . 0.0 110.672 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.23 160.91 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.099 1.759 . . . . 0.0 106.887 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -119.48 146.74 23.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 125.259 1.424 . . . . 0.0 108.486 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.14 76.29 1.26 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 165.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.68 -35.34 60.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -167.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.4 -37.79 73.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.175 1.39 . . . . 0.0 110.384 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 m -79.9 -49.49 11.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.513 1.525 . . . . 0.0 110.815 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.3 t -61.33 111.8 1.91 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.697 1.237 . . . . 0.0 113.434 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.0 pt -83.45 142.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 156.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 60.68 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.54 2.336 . . . . 0.0 112.412 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -27.79 48.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.789 0.836 . . . . 0.0 112.806 -166.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.8 -34.03 5.32 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.38 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -54.61 -55.77 25.97 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.674 1.737 . . . . 0.0 112.051 -162.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 p -52.56 -43.04 64.97 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.719 0.295 . . . . 0.0 111.226 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.43 77.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.522 -0.736 . . . . 0.0 110.719 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -70.49 -47.32 61.1 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.407 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -68.82 -38.41 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.62 0.646 . . . . 0.0 112.167 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -55.94 120.06 30.83 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.318 -0.373 . . . . 0.0 111.958 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -59.59 -26.6 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.905 2.404 . . . . 0.0 112.37 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.04 24.49 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.705 0.802 . . . . 0.0 111.682 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.79 62.72 2.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.113 0.864 . . . . 0.0 113.07 172.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.69 -28.03 0.24 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 126.027 1.731 . . . . 0.0 113.998 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.6 80.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.634 2.223 . . . . 0.0 108.009 164.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -157.67 149.01 9.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -92.7 153.88 18.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 128.974 3.921 . . . . 0.0 115.714 -133.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 144.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 CA--C 1.508 -0.673 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -128.32 161.84 28.46 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 27.6 mm -79.78 100.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 153.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.28 174.0 10.71 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.2 -0.938 . . . . 0.0 111.474 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.31 -16.47 2.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.835 2.054 . . . . 0.0 114.787 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -51.25 -33.01 26.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.433 -0.792 . . . . 0.0 111.761 166.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 47.3 t -55.71 130.26 42.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.251 1.82 . . . . 0.0 112.086 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.2 150.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -67.56 70.53 0.12 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.334 0.97 . . . . 0.0 111.993 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.22 -22.74 20.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.713 1.205 . . . . 0.0 111.42 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.95 -30.68 5.7 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 113.698 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.1 56.48 2.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.359 1.079 . . . . 0.0 113.309 -164.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 23.0 p -155.59 -31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.306 1.042 . . . . 0.0 112.282 171.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -36.02 -60.4 0.55 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -75.92 -15.2 60.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.296 1.039 . . . . 0.0 112.494 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 23.7 mm-40 -81.42 -34.17 31.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.967 1.307 . . . . 0.0 109.339 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.23 122.35 58.43 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.587 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -33.47 73.84 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.711 2.274 . . . . 0.0 112.493 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.06 7.42 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 122.818 0.447 . . . . 0.0 110.8 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 49.09 35.22 6.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.117 1.367 . . . . 0.0 111.866 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 36.41 0.42 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.052 1.341 . . . . 0.0 111.075 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mt -142.27 147.64 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.311 1.044 . . . . 0.0 109.489 -170.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -169.79 174.24 5.8 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 127.331 2.252 . . . . 0.0 108.522 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -85.42 128.66 34.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.481 1.037 . . . . 0.0 108.368 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.98 -67.86 0.14 Allowed Glycine 0 C--N 1.339 0.721 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.434 -161.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -98.96 -52.52 3.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -166.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.8 m -141.78 -50.51 0.4 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 109.181 156.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -161.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.225 1.01 . . . . 0.0 109.62 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.289 17.1 m-85 -68.69 161.94 27.15 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 117.714 -1.594 . . . . 0.0 110.906 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.87 162.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 126.783 2.033 . . . . 0.0 107.437 -170.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -128.92 138.6 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.651 1.18 . . . . 0.0 108.695 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -73.58 76.12 1.49 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 165.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -32.99 64.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -168.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.9 -48.08 8.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.443 1.897 . . . . 0.0 112.171 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.82 -29.95 12.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.655 2.382 . . . . 0.0 111.247 -165.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.8 t -52.85 134.65 37.0 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.288 0.949 . . . . 0.0 110.141 165.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 pt -107.89 137.92 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 159.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.96 74.11 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.56 -20.03 18.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.853 0.861 . . . . 0.0 113.041 -169.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.28 4.1 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.525 -0.734 . . . . 0.0 112.511 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -54.63 165.45 0.59 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 163.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.372 6.9 p 60.61 -57.56 0.08 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.373 1.469 . . . . 0.0 112.386 -152.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.44 96.61 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.234 1.379 . . . . 0.0 109.571 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -37.29 78.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.082 0.953 . . . . 0.0 111.914 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.94 -40.59 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.894 0.77 . . . . 0.0 111.007 -169.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.8 t -54.67 118.84 18.16 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.269 -170.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.1 -36.18 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.975 3.116 . . . . 0.0 114.216 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.42 14.27 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.68 50.67 36.07 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.746 0.703 . . . . 0.0 112.791 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 52' ' ' PRO . . . -80.02 -23.75 0.39 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 114.916 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 51' ' ' ALA . 55.5 Cg_exo -60.14 82.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.747 2.298 . . . . 0.0 110.764 168.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 m -159.85 153.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 128.901 2.88 . . . . 0.0 104.068 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -90.0 149.74 22.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.674 1.859 . . . . 0.0 114.299 -138.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 116.689 -1.625 . . . . 0.0 107.434 146.662 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -142.43 -168.93 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 156.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.478 HG12 ' CG1' ' A' ' 32' ' ' ILE . 4.2 mm -79.45 105.55 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 156.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.86 165.19 25.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.961 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.48 -15.87 3.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -53.18 -25.66 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.327 -0.858 . . . . 0.0 113.27 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -59.31 162.15 4.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.267 1.427 . . . . 0.0 111.669 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.65 173.2 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 m -70.6 64.03 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.299 -0.875 . . . . 0.0 111.011 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -179.78 4.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.04 2.136 . . . . 0.0 106.695 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.39 37.6 0.84 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 120.446 1.476 . . . . 0.0 111.315 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 -31.0 43.74 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.861 0.464 . . . . 0.0 111.537 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.286 29.9 p -80.43 -97.4 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.595 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.57 -99.01 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 121.157 1.799 . . . . 0.0 113.611 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 m -48.4 -31.73 6.61 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.926 1.691 . . . . 0.0 112.461 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -53.25 -28.23 26.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.407 1.083 . . . . 0.0 112.898 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.55 120.65 81.11 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 119.11 0.868 . . . . 0.0 110.739 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.45 -34.79 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.64 6.98 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 117.937 0.335 . . . . 0.0 111.022 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 22.69 4.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.289 1.835 . . . . 0.0 111.816 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.3 50.18 1.89 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.2 -0.938 . . . . 0.0 110.538 -164.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mt -136.72 147.71 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.608 1.563 . . . . 0.0 107.985 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -169.08 168.36 10.06 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.31 2.244 . . . . 0.0 109.327 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -71.74 117.12 12.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.06 -66.67 1.12 Allowed Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -114.8 -72.14 0.71 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -108.65 -61.09 1.65 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.611 1.165 . . . . 0.0 108.326 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.9 -166.55 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.182 0.593 . . . . 0.0 110.35 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.88 155.7 40.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 110.66 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.77 156.42 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 126.976 2.11 . . . . 0.0 106.381 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.478 ' CG1' HG12 ' A' ' 4' ' ' ILE . 3.2 mt -126.12 146.34 32.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.42 84.19 0.58 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 164.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.74 -29.66 62.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.439 -0.788 . . . . 0.0 112.689 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -41.66 -47.6 3.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.54 1.936 . . . . 0.0 112.071 164.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -102.84 -34.13 9.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.095 2.158 . . . . 0.0 111.981 -164.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.6 t -52.45 129.2 28.06 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.677 1.126 . . . . 0.0 111.966 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 pt -107.64 34.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.256 1.423 . . . . 0.0 111.78 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.27 35.9 14.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.96 1.704 . . . . 0.0 112.758 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.47 -16.35 57.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.31 -27.97 7.95 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.454 1.026 . . . . 0.0 114.816 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -54.64 -50.81 67.25 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.947 1.874 . . . . 0.0 113.205 -165.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.5 p -55.01 -44.93 75.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.915 -0.49 . . . . 0.0 110.675 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.97 82.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.752 -0.592 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -39.59 75.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.7 -0.667 . . . . 0.0 111.559 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.56 -40.41 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.128 0.876 . . . . 0.0 111.869 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -53.94 121.65 30.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -164.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.93 -26.97 83.23 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.746 2.298 . . . . 0.0 112.736 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.95 19.05 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.553 0.741 . . . . 0.0 112.099 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.55 54.19 9.12 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.476 0.56 . . . . 0.0 113.122 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.65 -27.48 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.581 . . . . 0.0 114.58 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.67 82.48 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.274 1.983 . . . . 0.0 108.67 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -162.23 155.76 2.74 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -168.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -90.16 148.12 23.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 127.205 2.816 . . . . 0.0 112.671 -148.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 163.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.457 ' H ' ' HA ' ' A' ' 54' ' ' GLN . 2.5 ptpp? -122.41 -179.22 4.12 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 146.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 71.2 mt -85.33 104.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 155.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.7 176.41 8.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.088 0.946 . . . . 0.0 112.895 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.75 -31.59 2.09 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.66 1.984 . . . . 0.0 114.985 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -54.75 -16.37 2.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' VAL . 53.9 t -55.55 -33.75 64.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.923 2.089 . . . . 0.0 115.607 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 8' ' ' CYS 0.288 1.8 m 71.35 -53.32 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 119.473 -2.017 . . . . 0.0 113.988 -173.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p 129.08 29.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 131.399 3.88 . . . . 0.0 111.307 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -19.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -162.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' CZ ' ' A' ' 30' ' ' PHE . . . 88.41 -53.0 4.08 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.109 -0.994 . . . . 0.0 114.24 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -33.11 -63.32 0.23 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.34 1.456 . . . . 0.0 114.633 -160.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 23.0 p -56.36 -21.46 24.8 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.39 -47.04 3.5 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.754 0.821 . . . . 0.0 112.657 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.5 m -82.72 -24.26 33.68 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 75.8 mm-40 -74.0 -34.65 64.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.756 1.223 . . . . 0.0 111.075 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.88 123.28 51.93 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.428 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.56 -37.4 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.294 3.329 . . . . 0.0 113.694 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.31 20.48 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.1 0.56 . . . . 0.0 112.163 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 44.72 49.37 8.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 0.0 112.432 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.18 31.61 1.66 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.389 1.076 . . . . 0.0 111.157 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.48 146.25 30.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.763 0.825 . . . . 0.0 109.107 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.47 169.24 10.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.135 2.174 . . . . 0.0 109.897 172.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -75.22 125.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.72 -73.88 1.06 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.99 -70.04 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -115.08 -62.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.71 2.004 . . . . 0.0 107.232 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -167.24 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.529 1.132 . . . . 0.0 111.075 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 20.9 m-85 -73.32 151.8 41.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.427 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 159.75 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 127.677 2.391 . . . . 0.0 106.008 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.64 131.45 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.41 79.55 0.76 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.27 66.58 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -163.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.89 -34.34 77.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.795 1.238 . . . . 0.0 110.694 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -84.81 -40.83 16.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 110.433 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 t -61.27 149.67 37.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.128 0.876 . . . . 0.0 108.743 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 pt -90.84 -112.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 167.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.89 129.1 11.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 155.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -161.03 161.8 31.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.052 0.842 . . . . 0.0 109.848 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.25 -26.93 56.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.489 -0.757 . . . . 0.0 112.392 -173.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -47.8 -60.68 2.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.272 1.029 . . . . 0.0 113.207 -159.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.5 p -60.71 -41.55 95.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.651 0.659 . . . . 0.0 110.465 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.38 81.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.505 -0.747 . . . . 0.0 110.307 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -46.02 72.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.403 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.86 -37.35 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.405 1.002 . . . . 0.0 111.408 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -53.77 118.57 15.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.649 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.44 -38.17 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.65 3.567 . . . . 0.0 114.813 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.06 24.34 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 112.15 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.59 62.09 5.09 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.385 0.539 . . . . 0.0 112.962 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.17 -23.74 0.21 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 126.722 2.009 . . . . 0.0 114.699 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -60.95 90.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.82 2.347 . . . . 0.0 108.038 162.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 m -159.19 144.54 6.69 Favored 'Isoleucine or valine' 0 C--O 1.252 1.209 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HA ' ' H ' ' A' ' 3' ' ' LYS . 35.3 tt0 -91.1 131.5 36.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 128.359 3.537 . . . . 0.0 114.23 -144.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 157.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -142.32 -163.36 1.59 Allowed 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 115.845 -2.342 . . . . 0.0 105.465 135.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.09 108.97 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 156.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.25 163.25 27.22 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.274 -0.891 . . . . 0.0 110.848 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.07 -12.31 4.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -52.43 -29.18 23.15 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.336 -0.852 . . . . 0.0 112.228 166.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 49.8 t -58.87 156.27 11.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.997 1.319 . . . . 0.0 111.653 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.59 167.67 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 164.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -65.39 64.48 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.012 1.325 . . . . 0.0 111.997 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -34.05 7.2 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.585 1.154 . . . . 0.0 112.716 -165.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.92 21.68 56.14 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.879 1.228 . . . . 0.0 114.742 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.79 -28.43 58.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.162 0.981 . . . . 0.0 111.46 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 p -79.31 -108.62 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 53.76 -101.65 0.12 Allowed 'General case' 0 C--N 1.34 0.174 0 CA-C-N 121.49 1.95 . . . . 0.0 111.799 170.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m -41.32 -36.29 0.78 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.409 1.884 . . . . 0.0 112.832 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -41.79 62.33 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 111.569 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.54 125.0 81.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.262 -166.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.53 -35.03 11.87 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.59 2.86 . . . . 0.0 114.096 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.4 m -107.08 5.19 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 48.69 37.43 9.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.032 1.333 . . . . 0.0 111.64 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.83 32.46 0.42 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.697 1.199 . . . . 0.0 111.958 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -132.1 151.14 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.885 1.274 . . . . 0.0 108.786 -172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 p -164.67 174.15 11.11 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.395 1.478 . . . . 0.0 109.195 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -77.38 125.24 29.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.77 -83.44 1.7 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -167.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -99.87 -50.33 4.05 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.25 1.02 . . . . 0.0 108.446 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 p -140.73 -57.7 0.52 Allowed 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.031 2.133 . . . . 0.0 106.609 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -104.45 -162.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.21 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -79.8 156.29 27.49 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.267 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -147.99 158.36 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.767 2.027 . . . . 0.0 108.28 -171.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.84 149.75 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 125.699 1.6 . . . . 0.0 108.957 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -82.77 114.17 20.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 157.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.621 1.1 . . . . 0.0 112.004 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 -38.92 85.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.7 1.2 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 m -79.85 -40.06 29.27 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.742 1.217 . . . . 0.0 109.745 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.9 112.04 1.9 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.582 0.628 . . . . 0.0 110.941 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.5 pt -79.76 47.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 121.244 -0.91 . . . . 0.0 111.316 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 14.73 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.609 2.763 . . . . 0.0 114.402 -173.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -5.27 40.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.99 -37.38 1.49 Allowed Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.035 -1.041 . . . . 0.0 114.23 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -46.17 -52.46 12.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -154.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -47.35 -37.7 11.62 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.147 1.779 . . . . 0.0 111.596 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -34.73 61.3 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.52 -0.738 . . . . 0.0 112.29 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -67.69 -44.89 76.69 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.87 0.304 . . . . 0.0 111.004 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.66 -30.37 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.868 -171.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -56.74 118.73 24.74 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.278 -170.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.88 -37.3 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.421 3.414 . . . . 0.0 114.253 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.73 22.65 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.995 0.918 . . . . 0.0 112.246 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.91 64.42 3.27 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.601 0.637 . . . . 0.0 113.039 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.39 -23.4 0.19 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -64.29 83.15 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.374 2.05 . . . . 0.0 108.28 163.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -162.27 151.72 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 -165.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.83 151.05 21.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 127.307 2.879 . . . . 0.0 113.614 -143.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 152.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 . . . . . 0 CA--C 1.517 -0.311 0 N-CA-C 105.429 -2.064 . . . . 0.0 105.429 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' C ' HD12 ' A' ' 32' ' ' ILE . 13.1 ptpt -118.17 -179.33 3.74 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 143.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.449 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 48.8 mt -79.1 109.44 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 147.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.93 173.37 11.29 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 122.143 0.973 . . . . 0.0 111.286 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -47.96 -31.09 4.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.035 1.334 . . . . 0.0 113.299 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -65.11 13.19 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.613 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.7 t -74.17 -73.12 0.24 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.627 2.371 . . . . 0.0 112.793 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 8' ' ' CYS 0.274 1.3 m 75.77 137.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 127.197 2.199 . . . . 0.0 110.373 -159.119 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.25 57.03 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.941 2.096 . . . . 0.0 114.48 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -17.94 25.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.214 0.915 . . . . 0.0 112.903 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 30' ' ' PHE . . . 88.92 -57.96 4.02 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 120.92 -1.112 . . . . 0.0 114.005 167.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -30.38 -57.76 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.283 1.833 . . . . 0.0 114.756 -164.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -63.28 -20.92 65.9 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -169.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.91 -58.3 2.1 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.413 1.006 . . . . 0.0 112.444 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -29.17 67.22 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.287 1.035 . . . . 0.0 112.537 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 111.632 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.31 123.66 83.25 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.519 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -42.4 -37.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.024 3.149 . . . . 0.0 113.938 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.14 14.45 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.24 44.11 6.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.525 1.13 . . . . 0.0 111.759 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.08 36.34 0.62 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.038 0.935 . . . . 0.0 110.598 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mt -137.54 149.31 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 125.212 1.405 . . . . 0.0 107.698 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.9 t -164.23 176.73 8.92 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 124.77 1.228 . . . . 0.0 109.93 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.65 102.74 2.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.3 -65.64 1.77 Allowed Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -119.14 -77.2 0.57 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -108.61 -48.72 3.27 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.412 1.485 . . . . 0.0 110.193 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.82 -169.16 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 122.711 0.405 . . . . 0.0 109.98 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 20.1 m-85 -82.66 148.79 27.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.526 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.61 160.46 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 126.932 2.093 . . . . 0.0 107.734 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 3' ' ' LYS . 71.2 mt -108.73 140.19 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.837 1.255 . . . . 0.0 107.801 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -72.71 76.45 1.11 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.65 67.03 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -44.93 -47.69 11.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.297 1.839 . . . . 0.0 112.343 166.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -96.99 -31.99 12.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.606 2.362 . . . . 0.0 110.847 -165.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.8 t -57.01 136.78 56.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.403 1.001 . . . . 0.0 108.606 160.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.13 -102.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -158.63 135.79 9.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 155.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.06 177.94 8.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 109.663 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.86 -42.26 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.95 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.53 -60.13 3.76 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 117.633 0.716 . . . . 0.0 112.602 -147.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -53.07 -45.15 67.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.024 0.374 . . . . 0.0 111.124 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.08 90.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.886 -0.509 . . . . 0.0 110.343 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.26 -43.84 69.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.485 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.45 -40.27 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 119.351 0.978 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -53.43 118.24 14.01 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.784 -0.627 . . . . 0.0 112.328 -163.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.83 -37.84 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.317 3.344 . . . . 0.0 114.456 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.4 m -118.73 16.17 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.94 50.22 39.22 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.713 0.688 . . . . 0.0 113.036 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.6 -19.73 0.26 Allowed Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.841 1.656 . . . . 0.0 115.061 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -58.36 86.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.036 2.491 . . . . 0.0 110.022 164.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 m -161.53 152.48 4.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -84.12 151.35 24.97 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 127.41 2.944 . . . . 0.0 114.008 -139.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 135.306 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.1 174.96 5.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 144.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 mm -79.02 107.63 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 146.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.34 165.05 25.4 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 122.09 0.948 . . . . 0.0 111.445 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.57 -15.23 10.47 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.918 1.687 . . . . 0.0 113.596 -173.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 m -56.32 -23.49 37.38 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.399 -0.813 . . . . 0.0 112.515 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -54.25 154.16 4.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.096 1.358 . . . . 0.0 110.303 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.98 164.73 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 170.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.4 m -71.74 60.66 0.36 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.949 0.795 . . . . 0.0 111.649 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 -31.22 14.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.999 1.32 . . . . 0.0 111.818 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.25 -28.86 1.68 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.979 172.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -43.43 -48.78 7.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.72 1.208 . . . . 0.0 113.518 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -64.43 -12.57 44.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.78 -65.38 0.51 Allowed 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.106 -0.997 . . . . 0.0 112.89 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 m -69.27 -29.84 67.82 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -59.06 -39.89 83.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.215 1.006 . . . . 0.0 111.737 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.28 120.09 64.73 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.895 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.89 -37.0 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.562 2.841 . . . . 0.0 113.946 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.36 0.86 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.166 0.439 . . . . 0.0 112.011 -174.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.38 57.42 5.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.776 0.83 . . . . 0.0 111.037 -174.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.65 61.75 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.671 -0.643 . . . . 0.0 111.454 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.19 149.86 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.439 1.896 . . . . 0.0 112.132 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 m -161.32 164.13 30.33 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.243 2.617 . . . . 0.0 108.488 154.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -75.15 119.23 19.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.87 -66.91 1.35 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -166.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -116.56 -71.96 0.71 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -113.5 -55.97 2.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.146 1.378 . . . . 0.0 108.745 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -100.94 -167.52 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.086 0.555 . . . . 0.0 110.649 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -84.68 146.96 27.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.412 0.625 . . . . 0.0 111.433 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.1 159.03 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 127.171 2.188 . . . . 0.0 106.153 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.42 149.65 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 C-N-CA 125.296 1.438 . . . . 0.0 109.431 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -65.76 91.96 0.14 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 155.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.79 -29.04 67.95 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.676 -1.265 . . . . 0.0 112.404 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.09 -36.63 84.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.311 0.644 . . . . 0.0 111.368 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -79.77 -43.52 22.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.502 1.121 . . . . 0.0 109.379 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.7 t -54.63 132.31 45.07 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -78.33 -102.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.87 120.38 2.66 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 159.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.39 171.81 19.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.182 0.901 . . . . 0.0 110.796 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.09 -40.51 8.59 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.544 -0.587 . . . . 0.0 113.122 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.61 -56.92 14.77 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.851 0.826 . . . . 0.0 112.995 -147.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 p -55.86 -44.64 78.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.02 -0.425 . . . . 0.0 110.926 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.07 94.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.793 -0.567 . . . . 0.0 110.108 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -62.76 -49.31 75.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.145 0.578 . . . . 0.0 111.413 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -68.25 -40.68 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 118.832 0.742 . . . . 0.0 111.833 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.36 117.95 19.26 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -162.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.92 -26.42 82.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.729 2.286 . . . . 0.0 112.38 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -116.09 21.74 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.967 0.907 . . . . 0.0 111.408 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.05 50.89 7.47 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.521 1.058 . . . . 0.0 113.346 171.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.8 -26.92 0.36 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.265 1.426 . . . . 0.0 114.828 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -63.65 84.56 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.579 2.186 . . . . 0.0 109.443 168.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.1 m -165.77 157.81 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.78 155.33 18.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 127.624 3.077 . . . . 0.0 114.04 -124.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 . . . . . 0 C--O 1.257 1.465 0 C-N-CA 127.82 2.448 . . . . 0.0 106.44 157.486 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 . . . . . 0 C--O 1.232 0.156 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -128.01 179.43 5.58 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 140.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 50.0 mt -79.7 107.69 12.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 156.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.83 15.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.145 0.974 . . . . 0.0 111.673 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -49.15 -23.4 1.26 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.604 2.362 . . . . 0.0 114.82 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -54.08 -24.38 17.24 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.556 -0.715 . . . . 0.0 112.521 171.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 47.7 t -57.72 121.63 10.88 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.291 1.437 . . . . 0.0 110.864 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.94 21.97 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.491 -0.756 . . . . 0.0 111.581 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 m 56.69 36.23 27.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.139 0.976 . . . . 0.0 110.552 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -75.33 152.59 38.14 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 111.21 -169.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.9 57.96 4.93 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.892 -1.13 . . . . 0.0 110.858 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . . . -143.72 -161.33 1.25 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.206 1.003 . . . . 0.0 108.889 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 17' ' ' GLU 0.57 3.7 p 39.25 -120.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.065 -160.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 49.69 -105.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 122.627 2.467 . . . . 0.0 110.904 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 m -58.06 -17.59 18.85 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 23.5 mt-10 -61.12 -29.3 69.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.383 0.992 . . . . 0.0 111.005 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.39 129.25 90.84 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.343 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.97 -34.34 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.135 3.224 . . . . 0.0 114.456 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 p -126.72 26.63 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.797 0.726 . . . . 0.0 112.686 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.31 38.44 21.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.88 0.872 . . . . 0.0 111.9 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.95 32.07 0.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.78 1.232 . . . . 0.0 111.811 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.21 152.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.278 1.431 . . . . 0.0 107.434 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -165.25 173.96 10.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.997 2.119 . . . . 0.0 108.925 164.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 123.68 19.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.75 -105.74 2.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -98.78 -49.05 4.71 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.581 1.152 . . . . 0.0 109.141 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -128.21 -53.05 1.29 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.334 1.854 . . . . 0.0 107.691 -172.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -165.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.05 148.15 31.19 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.417 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 154.24 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 C-N-CA 126.072 1.749 . . . . 0.0 107.817 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.2 mt -104.53 136.65 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 107.674 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -74.6 77.16 2.0 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.58 62.25 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -41.24 -48.36 3.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 165.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -99.63 -37.51 9.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.834 2.454 . . . . 0.0 111.236 -165.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.1 t -53.98 126.9 24.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.805 0.729 . . . . 0.0 111.114 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 pt -91.94 8.88 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.817 0.847 . . . . 0.0 112.754 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 54.64 75.32 0.3 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.903 2.481 . . . . 0.0 111.936 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.51 -13.9 13.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 114.04 -174.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.71 -17.76 10.36 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.335 0.969 . . . . 0.0 115.456 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -55.69 -47.85 76.08 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.719 1.759 . . . . 0.0 112.98 -171.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -58.08 -41.3 83.16 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.533 -0.729 . . . . 0.0 109.481 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.04 -43.38 81.91 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.555 -0.715 . . . . 0.0 110.186 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -62.9 -48.11 80.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.823 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 m -68.88 -39.6 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.88 0.763 . . . . 0.0 111.941 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.1 t -55.51 122.09 42.46 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.946 -167.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.18 -39.0 2.36 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.759 3.64 . . . . 0.0 115.137 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.97 28.22 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.248 0.619 . . . . 0.0 112.055 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.21 40.85 45.67 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 118.132 0.424 . . . . 0.0 113.653 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.26 1.44 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -58.93 78.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.324 2.683 . . . . 0.0 111.773 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 m -160.63 173.34 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 130.262 3.425 . . . . 0.0 105.173 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.72 158.24 20.82 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 124.045 0.84 . . . . 0.0 112.904 -96.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 128.133 2.573 . . . . 0.0 110.182 -179.809 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.232 0.146 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -120.44 -179.42 3.96 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 141.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 55.5 mt -83.52 111.13 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 152.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.25 25.06 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 122.191 0.996 . . . . 0.0 112.068 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.97 -28.25 2.65 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.733 2.013 . . . . 0.0 114.11 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.42 -24.94 2.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' VAL . 41.7 t -45.08 -73.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.268 2.227 . . . . 0.0 114.791 -174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER 66.5 143.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.473 1.109 . . . . 0.0 110.267 -156.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.73 56.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.125 1.77 . . . . 0.0 113.142 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 158.64 25.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.135 1.374 . . . . 0.0 108.713 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.16 28.9 13.27 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.057 -1.027 . . . . 0.0 112.969 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.65 -57.2 2.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.397 1.098 . . . . 0.0 112.998 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.334 28.5 p -73.1 -90.81 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.329 0.968 . . . . 0.0 112.711 -171.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 31.94 -98.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.815 1.643 . . . . 0.0 113.994 -169.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -46.79 -31.92 3.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.938 2.095 . . . . 0.0 113.497 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -50.32 -32.41 17.07 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.683 1.193 . . . . 0.0 112.895 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.41 122.36 77.8 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.443 -0.786 . . . . 0.0 110.499 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -50.94 -35.07 48.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.011 2.474 . . . . 0.0 113.502 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.67 5.53 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 118.304 0.502 . . . . 0.0 111.033 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.06 40.94 26.8 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.007 1.723 . . . . 0.0 110.845 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.31 45.23 1.21 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.755 0.822 . . . . 0.0 110.011 -168.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.86 150.42 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.498 1.919 . . . . 0.0 106.434 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -171.48 174.56 4.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.139 2.176 . . . . 0.0 108.477 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.06 123.82 17.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 167.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.29 -98.47 2.41 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -99.27 -46.06 5.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.44 1.496 . . . . 0.0 108.822 -166.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 p -134.61 -56.51 0.84 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.183 1.793 . . . . 0.0 107.28 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 -162.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.339 1.056 . . . . 0.0 110.53 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -78.22 139.8 38.92 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.8 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.46 156.62 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 126.278 1.831 . . . . 0.0 107.616 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.11 142.94 24.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -73.81 78.42 1.59 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.62 56.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 113.022 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -42.1 -49.71 4.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.986 2.114 . . . . 0.0 112.219 165.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.56 -31.26 12.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.578 2.351 . . . . 0.0 111.36 -165.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.0 t -49.95 116.86 2.0 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.211 0.914 . . . . 0.0 110.271 169.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.84 -17.84 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 122.735 0.414 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t0 76.62 118.81 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 127.916 2.486 . . . . 0.0 108.499 -168.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.85 -47.96 0.09 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -168.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.98 -29.59 4.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.526 -1.152 . . . . 0.0 113.274 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -53.33 -51.13 63.39 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.539 1.67 . . . . 0.0 112.593 -164.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.29 -46.91 72.86 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.44 -0.162 . . . . 0.0 110.761 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.92 91.46 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.669 -0.644 . . . . 0.0 110.156 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -51.31 69.53 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.619 0.767 . . . . 0.0 111.806 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -70.13 -39.18 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 119.366 0.985 . . . . 0.0 111.797 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.0 t -55.02 116.65 11.87 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -162.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.09 -38.95 19.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.938 3.092 . . . . 0.0 113.835 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.47 9.26 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.716 1.206 . . . . 0.0 112.147 -173.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.79 50.85 25.25 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.792 0.723 . . . . 0.0 112.94 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.78 -25.35 0.29 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 126.281 1.832 . . . . 0.0 114.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.26 81.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.061 2.507 . . . . 0.0 109.21 167.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -161.08 156.69 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 129.221 3.008 . . . . 0.0 104.006 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.5 174.4 7.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 127.445 2.966 . . . . 0.0 114.069 -121.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.82 158.083 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -108.51 170.18 8.18 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 152.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 55.8 mt -79.91 106.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 150.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.09 174.94 10.1 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 122.689 1.233 . . . . 0.0 111.667 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.36 -13.69 9.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 128.563 2.745 . . . . 0.0 113.541 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.29 64.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 111.468 170.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 48.5 t -57.51 153.17 13.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.3 1.44 . . . . 0.0 112.272 -177.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.19 156.68 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 162.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m -61.25 66.59 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.815 1.646 . . . . 0.0 113.348 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 -30.33 9.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.342 1.057 . . . . 0.0 112.833 -168.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.68 60.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.191 1.377 . . . . 0.0 115.772 170.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.88 -61.84 1.83 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.552 1.676 . . . . 0.0 110.789 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.38 -34.09 32.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.275 1.03 . . . . 0.0 111.881 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.97 -45.67 7.89 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -88.02 -6.75 57.81 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -41.27 13.76 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.119 1.768 . . . . 0.0 108.021 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.4 t -49.64 116.99 6.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.333 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.94 -33.28 14.19 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.767 2.978 . . . . 0.0 113.876 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.7 m -111.56 11.53 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.264 0.484 . . . . 0.0 112.065 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 47.89 34.11 3.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.2 40.29 0.62 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.881 1.272 . . . . 0.0 111.199 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mt -133.2 146.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.109 1.364 . . . . 0.0 108.823 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -166.54 167.02 15.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.327 1.851 . . . . 0.0 109.649 167.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.34 119.18 18.18 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.24 -78.44 1.28 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -169.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -99.87 -54.91 2.78 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.941 0.896 . . . . 0.0 108.91 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -140.88 -56.24 0.5 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.867 2.067 . . . . 0.0 107.377 -167.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -102.64 -174.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.059 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -74.25 148.38 41.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.152 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.97 152.55 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 126.346 1.858 . . . . 0.0 106.988 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.27 138.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.516 1.527 . . . . 0.0 107.788 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -74.07 76.2 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.55 60.05 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -167.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -43.97 -47.51 8.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.141 1.776 . . . . 0.0 112.243 167.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -100.27 -30.53 11.84 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.923 2.489 . . . . 0.0 111.393 -165.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -52.29 128.54 25.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.308 0.958 . . . . 0.0 109.793 167.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.0 pt -90.1 130.18 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 161.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 74.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.103 1.361 . . . . 0.0 112.236 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -15.17 16.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.507 1.523 . . . . 0.0 111.341 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.76 -23.63 0.82 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.233 1.873 . . . . 0.0 115.188 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.15 -39.16 71.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.4 p -47.44 -32.68 5.31 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.498 1.119 . . . . 0.0 112.578 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -44.47 32.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.379 0.536 . . . . 0.0 112.403 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -51.76 -39.47 58.61 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -167.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.71 -26.05 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 117.879 0.309 . . . . 0.0 111.749 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.86 119.11 69.27 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.949 -153.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.34 -37.98 7.81 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.175 3.25 . . . . 0.0 114.377 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.67 33.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.729 0.812 . . . . 0.0 111.633 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.48 49.29 11.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.31 0.957 . . . . 0.0 114.078 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.24 -28.34 0.39 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.814 1.645 . . . . 0.0 114.429 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.96 87.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.648 2.232 . . . . 0.0 109.712 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -165.95 158.82 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.909 0 C-N-CA 128.661 2.784 . . . . 0.0 104.296 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -90.67 166.03 13.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 127.266 2.854 . . . . 0.0 112.95 -118.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 C--O 1.249 1.055 0 C-N-CA 124.896 1.279 . . . . 0.0 110.994 -162.039 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -131.18 -174.49 3.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 145.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 29.1 mm -79.14 110.07 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 153.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.48 162.45 27.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 122.166 0.984 . . . . 0.0 111.188 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -53.0 -21.36 4.35 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.7 2.0 . . . . 0.0 114.257 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -51.36 -25.65 6.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.737 -0.602 . . . . 0.0 112.565 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.3 t -56.08 109.81 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.508 1.123 . . . . 0.0 111.97 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -80.71 13.78 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.334 -0.854 . . . . 0.0 112.03 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.8 m 59.29 43.93 16.15 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.247 1.019 . . . . 0.0 110.772 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.51 -158.01 0.24 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.498 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.43 39.18 1.25 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 120.088 1.313 . . . . 0.0 111.109 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.46 -40.17 13.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 123.384 0.673 . . . . 0.0 110.987 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 p -85.43 -137.35 0.07 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.153 0.581 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.49 -77.72 0.03 OUTLIER 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.04 1.736 . . . . 0.0 113.356 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -56.63 -35.13 67.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.165 0.586 . . . . 0.0 109.952 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -53.38 -31.03 42.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 113.789 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -70.25 127.29 92.33 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.82 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.22 -36.35 5.99 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.689 2.926 . . . . 0.0 113.622 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.79 20.36 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.649 0.38 . . . . 0.0 111.41 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 44.27 39.74 3.2 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.025 1.73 . . . . 0.0 112.912 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.64 40.75 1.2 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.342 1.057 . . . . 0.0 111.296 -165.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.32 149.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.51 1.924 . . . . 0.0 106.085 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -173.07 172.9 3.8 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.658 1.983 . . . . 0.0 109.492 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 129.42 40.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.03 -111.06 3.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 124.728 1.156 . . . . 0.0 111.698 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -99.77 -48.72 4.61 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.965 0.906 . . . . 0.0 109.494 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 p -115.65 -60.83 1.82 Allowed 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.509 2.324 . . . . 0.0 106.783 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.27 -156.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.725 1.61 . . . . 0.0 110.65 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -74.62 157.19 35.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.826 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 169.97 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 127.789 2.436 . . . . 0.0 108.89 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -130.35 143.08 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.539 1.536 . . . . 0.0 107.388 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.55 79.13 2.56 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 164.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.11 63.23 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.224 -0.923 . . . . 0.0 113.262 -171.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.86 -35.91 75.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 110.57 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -84.26 -44.2 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.624 1.57 . . . . 0.0 111.091 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -57.57 139.06 54.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.572 1.078 . . . . 0.0 110.22 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.1 -116.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -140.18 30.46 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.691 1.997 . . . . 0.0 109.853 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.277 0.0 OUTLIER -72.81 177.54 4.77 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.945 -0.472 . . . . 0.0 111.555 -174.266 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.57 -32.87 4.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.623 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.22 -53.38 54.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.498 1.149 . . . . 0.0 113.516 -150.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.62 -45.2 85.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.566 0.222 . . . . 0.0 110.808 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.53 94.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.884 -0.51 . . . . 0.0 109.847 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -50.57 69.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 111.969 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.09 -38.34 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 119.487 1.04 . . . . 0.0 111.669 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.2 118.12 16.98 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -163.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -60.84 -23.78 77.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.718 2.278 . . . . 0.0 112.55 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.87 31.3 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.381 0.673 . . . . 0.0 111.073 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.62 63.13 1.74 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.646 1.117 . . . . 0.0 113.239 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 -30.9 0.24 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.994 1.718 . . . . 0.0 113.541 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.88 78.58 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.758 2.305 . . . . 0.0 108.684 165.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -160.79 153.36 4.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 128.67 2.788 . . . . 0.0 104.638 -167.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -91.67 149.65 21.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.493 2.995 . . . . 0.0 115.71 -132.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 102.275 -3.231 . . . . 0.0 102.275 131.808 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.04 178.35 5.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 151.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 57.9 mt -84.17 108.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.79 171.11 15.26 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 122.091 0.948 . . . . 0.0 111.469 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -53.98 -20.6 6.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.196 1.798 . . . . 0.0 113.976 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -57.77 -20.68 36.87 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.53 -0.731 . . . . 0.0 112.963 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.5 t -56.1 153.58 8.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.084 1.354 . . . . 0.0 111.32 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.7 156.26 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 161.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 m -67.41 63.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.122 0.874 . . . . 0.0 112.738 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.0 -16.79 21.45 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.184 1.393 . . . . 0.0 111.894 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 -58.97 4.88 Favored Glycine 0 C--N 1.338 0.655 0 O-C-N 121.284 -0.885 . . . . 0.0 112.158 169.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -22.27 -65.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.91 2.084 . . . . 0.0 115.004 -167.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 p -56.7 -25.56 54.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.37 -50.35 1.49 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.028 0.931 . . . . 0.0 113.351 167.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 m -81.84 -23.74 36.23 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.12 -33.78 75.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.513 1.125 . . . . 0.0 110.959 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.54 115.73 20.56 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.416 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.01 -18.42 62.03 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.661 1.574 . . . . 0.0 111.478 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.4 14.16 8.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 CA-C-N 119.052 0.842 . . . . 0.0 111.582 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 43.68 48.02 6.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.851 1.26 . . . . 0.0 111.906 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.16 -5.98 51.18 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.897 0.879 . . . . 0.0 112.026 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.51 146.93 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.202 1.001 . . . . 0.0 110.308 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.6 m -164.23 167.88 19.49 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.235 2.214 . . . . 0.0 109.012 163.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -69.97 122.29 19.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.48 -65.02 1.15 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -170.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -115.08 -70.35 0.8 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -118.82 -58.35 1.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.692 1.997 . . . . 0.0 107.759 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -94.67 -174.21 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.866 -176.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -78.16 151.1 33.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.066 0.46 . . . . 0.0 111.189 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.13 142.84 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 126.256 1.823 . . . . 0.0 107.568 -170.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -103.27 139.01 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 127.11 2.164 . . . . 0.0 109.662 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.268 64.3 m-20 -69.82 102.49 1.96 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 159.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.27 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.041 -1.037 . . . . 0.0 112.332 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.55 -37.51 81.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.273 0.558 . . . . 0.0 110.929 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.0 m -80.19 -42.85 22.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.047 0.939 . . . . 0.0 110.6 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.93 127.58 32.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.919 0.781 . . . . 0.0 111.631 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.8 pt -100.64 28.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.863 1.265 . . . . 0.0 112.162 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 51.09 47.45 24.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.918 1.287 . . . . 0.0 111.707 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.256 0.5 OUTLIER -86.11 -164.7 1.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.23 -28.71 3.72 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.704 1.138 . . . . 0.0 114.069 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -54.85 -56.11 22.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.251 1.025 . . . . 0.0 112.885 -153.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.7 p -53.47 -45.6 69.62 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.239 -0.288 . . . . 0.0 110.916 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.62 97.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 110.278 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -61.34 -47.64 84.95 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.661 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.68 -42.13 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.042 0.837 . . . . 0.0 112.266 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.52 121.11 36.34 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.262 -159.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.3 -38.83 3.73 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.597 3.531 . . . . 0.0 115.029 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.97 17.55 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.359 0.663 . . . . 0.0 112.382 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.63 44.06 79.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 118.593 0.633 . . . . 0.0 112.907 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.65 -25.5 0.66 Allowed Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.46 87.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.936 2.424 . . . . 0.0 110.644 170.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 m -162.11 160.14 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.816 0 C-N-CA 128.937 2.895 . . . . 0.0 104.101 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.12 170.18 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 127.375 2.922 . . . . 0.0 115.149 -128.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 . . . . . 0 C--O 1.251 1.181 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.219 169.302 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 -177.18 4.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 149.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.27 110.1 20.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.08 162.04 28.89 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 122.083 0.945 . . . . 0.0 111.337 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -51.38 -26.23 7.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.721 1.609 . . . . 0.0 113.555 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -48.94 -25.45 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.6 t -48.63 -60.25 2.87 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 114.215 -174.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 162.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.725 -1.234 . . . . 0.0 110.856 -163.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 m -75.41 49.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 119.552 -1.968 . . . . 0.0 111.498 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.65 166.17 23.76 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 154.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.71 38.55 0.71 Allowed Glycine 0 CA--C 1.523 0.587 0 CA-C-N 120.557 1.526 . . . . 0.0 112.391 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.79 -63.02 1.51 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.471 0.635 . . . . 0.0 110.988 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 26.2 p -50.53 -24.58 3.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -169.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -33.85 -53.08 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.707 1.203 . . . . 0.0 114.197 166.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 p -76.09 -26.16 56.19 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.472 -0.768 . . . . 0.0 112.124 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 24.5 mm-40 -75.9 -29.65 58.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.817 2.047 . . . . 0.0 110.243 -169.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.8 t -58.6 119.48 36.89 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.082 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.38 -31.83 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.166 2.577 . . . . 0.0 113.345 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.26 8.17 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.413 0.551 . . . . 0.0 111.653 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 m120 44.98 44.13 7.8 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.831 1.652 . . . . 0.0 111.748 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 33' ' ' ASP . . . -115.14 47.77 1.25 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.976 0.91 . . . . 0.0 110.055 -169.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.43 150.91 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.754 2.022 . . . . 0.0 107.143 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -170.86 174.54 4.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.423 2.289 . . . . 0.0 109.049 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -73.33 132.08 42.65 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.52 -81.79 1.58 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -99.37 -56.13 2.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.921 1.288 . . . . 0.0 109.199 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -138.83 -51.09 0.55 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.968 2.107 . . . . 0.0 107.859 -177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.65 -161.33 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 122.953 0.501 . . . . 0.0 109.844 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.313 5.5 m-85 -79.35 163.63 24.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.418 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.4 163.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 127.774 2.429 . . . . 0.0 108.007 -170.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.35 143.37 38.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 125.248 1.419 . . . . 0.0 108.877 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 26.9 m-20 -75.37 83.71 2.48 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.36 -32.71 62.79 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.79 -48.42 8.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.921 1.688 . . . . 0.0 112.031 166.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -98.86 -30.86 12.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.842 2.057 . . . . 0.0 111.486 -165.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.8 t -55.68 127.64 30.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.586 1.084 . . . . 0.0 111.22 172.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.9 pt -104.63 33.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.594 1.558 . . . . 0.0 111.377 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 49.27 32.28 4.27 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.547 1.939 . . . . 0.0 113.491 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -76.43 -9.66 58.81 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -165.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 -23.52 6.3 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.788 -1.007 . . . . 0.0 114.23 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -53.69 -54.77 33.11 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.585 1.692 . . . . 0.0 111.338 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.43 -42.09 73.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.59 87.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.72 -0.613 . . . . 0.0 110.298 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -33.87 64.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 m -73.71 -38.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.813 1.188 . . . . 0.0 110.872 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.6 t -56.11 120.01 31.25 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.605 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -59.79 -29.83 90.55 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.692 2.261 . . . . 0.0 112.031 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.19 17.61 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.323 1.049 . . . . 0.0 111.675 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.03 49.93 5.27 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.818 1.199 . . . . 0.0 113.636 173.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.38 -30.28 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 125.523 1.529 . . . . 0.0 114.76 -174.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.7 90.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.73 2.286 . . . . 0.0 109.942 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 54' ' ' GLN . 28.1 t -165.99 151.05 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 128.788 2.835 . . . . 0.0 103.688 -165.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.558 ' H ' HG12 ' A' ' 53' ' ' VAL . 26.5 tt0 -92.66 157.52 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 128.961 3.913 . . . . 0.0 115.609 -130.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 . . . . . 0 C--O 1.249 1.047 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 150.666 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 CA--C 1.517 -0.3 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -129.94 -176.73 4.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 148.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 64.6 mt -84.06 107.74 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 152.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.55 170.34 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 122.05 0.928 . . . . 0.0 111.289 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.34 -25.61 1.05 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.015 2.126 . . . . 0.0 114.527 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -55.94 -19.12 10.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 42.3 t -56.93 156.85 6.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.241 1.416 . . . . 0.0 111.253 174.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.53 156.91 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 164.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -67.65 65.03 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.909 0.884 . . . . 0.0 111.832 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.261 0.1 OUTLIER -93.54 -162.2 0.92 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.609 1.563 . . . . 0.0 108.816 -177.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.62 42.45 0.71 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 120.932 1.696 . . . . 0.0 110.708 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.96 -37.46 12.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.436 0.695 . . . . 0.0 111.431 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.332 21.5 p -85.53 -100.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.55 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.68 -119.4 0.62 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 121.406 1.912 . . . . 0.0 112.058 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m -68.69 11.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -40.15 96.91 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.2 t -58.42 120.22 42.59 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.705 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -44.72 -36.98 11.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.774 2.983 . . . . 0.0 113.901 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -107.43 5.53 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 117.97 0.35 . . . . 0.0 111.54 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.11 48.36 12.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.436 1.095 . . . . 0.0 111.573 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.02 -11.96 61.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.085 0.954 . . . . 0.0 111.813 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -99.98 144.3 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.469 1.507 . . . . 0.0 110.484 -170.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -166.67 170.9 12.11 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.824 2.45 . . . . 0.0 108.765 162.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -66.74 130.73 44.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.37 -84.7 1.82 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -173.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.32 -52.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.59 1.156 . . . . 0.0 108.272 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -140.84 -57.58 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.267 2.227 . . . . 0.0 106.37 -171.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -99.91 -158.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.453 0.701 . . . . 0.0 109.828 178.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.18 149.68 21.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 111.814 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.57 137.28 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 126.678 1.991 . . . . 0.0 108.662 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -96.72 136.15 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 127.094 2.157 . . . . 0.0 109.733 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.252 29.1 m-20 -66.89 102.4 0.96 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 156.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.0 -33.53 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.743 -1.223 . . . . 0.0 112.352 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.79 -38.65 82.47 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.499 0.666 . . . . 0.0 110.609 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -79.23 -43.05 24.57 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.498 1.119 . . . . 0.0 110.1 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.2 t -55.88 115.97 2.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.526 0.603 . . . . 0.0 111.527 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.03 -0.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 t0 68.92 79.3 0.21 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 110.332 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.22 -31.43 4.39 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -164.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.78 -35.82 4.77 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.636 1.107 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -53.54 163.89 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.352 5.2 p 60.3 -55.29 0.08 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.535 1.534 . . . . 0.0 112.963 -153.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.5 94.4 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 120.022 1.283 . . . . 0.0 109.806 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.83 -28.34 69.49 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.739 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -88.26 -38.87 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.808 1.185 . . . . 0.0 111.176 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -53.6 118.48 14.96 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -166.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.1 -38.22 10.42 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 124.273 3.315 . . . . 0.0 114.159 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.36 18.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.272 1.029 . . . . 0.0 112.377 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.84 42.49 37.84 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.588 0.631 . . . . 0.0 113.792 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 -22.96 0.38 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.696 1.599 . . . . 0.0 115.183 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.78 84.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.55 2.167 . . . . 0.0 109.621 166.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -159.68 157.2 3.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 128.808 2.843 . . . . 0.0 104.765 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -91.62 155.85 18.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 127.681 3.113 . . . . 0.0 115.12 -133.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 144.749 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -118.97 168.69 10.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 102.999 -2.963 . . . . 0.0 102.999 145.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 53.1 mt -80.43 105.34 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 148.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.54 163.83 26.53 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 119.366 -0.933 . . . . 0.0 111.01 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.27 -23.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.624 2.77 . . . . 0.0 114.85 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -25.77 4.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 168.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.8 t -57.62 158.64 5.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 111.764 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.54 160.84 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 164.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -66.12 63.64 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.99 1.316 . . . . 0.0 112.948 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.73 -32.65 8.32 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.531 1.133 . . . . 0.0 112.44 -165.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.49 15.34 57.05 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.014 1.292 . . . . 0.0 114.585 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.59 -33.14 68.77 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.383 1.092 . . . . 0.0 111.376 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.255 29.0 p -74.17 -90.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 44.05 -110.54 0.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 121.149 1.795 . . . . 0.0 112.236 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m -65.7 -5.96 10.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -38.21 64.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.977 0.808 . . . . 0.0 109.063 164.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 t -58.07 123.11 63.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.903 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -45.02 -38.45 13.66 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.752 2.968 . . . . 0.0 113.799 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -101.4 1.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.592 0.357 . . . . 0.0 111.344 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 54.22 33.47 18.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.791 1.236 . . . . 0.0 110.925 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.27 38.67 0.49 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.158 1.383 . . . . 0.0 112.053 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.16 150.48 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 124.292 1.037 . . . . 0.0 109.584 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.4 m -166.5 172.58 10.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.576 2.351 . . . . 0.0 108.136 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.32 127.76 33.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.82 -81.73 1.44 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.84 -53.68 3.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.415 1.086 . . . . 0.0 108.436 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 p -141.39 -54.58 0.47 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.192 2.197 . . . . 0.0 107.319 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.25 -173.91 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 122.919 0.488 . . . . 0.0 110.792 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.24 142.9 32.71 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.022 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.09 155.25 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 126.413 1.885 . . . . 0.0 108.662 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.48 140.78 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.57 1.548 . . . . 0.0 108.604 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.0 91.25 4.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.82 -36.77 72.72 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.921 -1.112 . . . . 0.0 113.864 -168.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.94 -35.86 67.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.122 0.969 . . . . 0.0 110.391 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.0 m -84.41 -47.63 10.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.864 1.666 . . . . 0.0 110.489 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.1 t -57.31 123.16 14.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.989 -0.444 . . . . 0.0 112.119 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.44 23.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.029 0.932 . . . . 0.0 112.498 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.32 39.52 28.39 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.013 1.725 . . . . 0.0 111.539 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.42 -10.07 59.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.03 -33.23 1.28 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.916 1.246 . . . . 0.0 115.056 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -48.93 -46.73 43.58 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -157.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.1 p -46.9 -31.67 3.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.991 1.317 . . . . 0.0 112.679 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -43.23 31.19 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.504 0.593 . . . . 0.0 112.368 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -49.92 -38.96 38.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.71 -24.94 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.44 119.24 71.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.531 -153.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -43.92 -40.16 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.043 3.162 . . . . 0.0 114.41 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.49 16.29 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 112.521 -173.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.52 53.62 19.92 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 118.711 0.687 . . . . 0.0 112.959 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.86 -23.01 0.24 Allowed Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.576 1.951 . . . . 0.0 115.065 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.33 90.15 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.128 1.885 . . . . 0.0 107.603 164.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 m -162.79 152.71 3.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -171.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -90.44 175.11 7.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.986 3.304 . . . . 0.0 112.076 -128.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 115.585 -2.15 . . . . 0.0 110.337 -157.843 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 103.803 -2.665 . . . . 0.0 103.803 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -112.19 168.59 9.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 144.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 36.0 mt -80.58 109.46 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 152.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.38 165.73 24.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.468 1.128 . . . . 0.0 111.259 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.57 -20.98 15.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.571 1.548 . . . . 0.0 113.903 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -55.9 -21.41 20.16 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.584 -0.697 . . . . 0.0 112.829 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.0 t -46.58 -72.78 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.538 1.935 . . . . 0.0 115.107 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 68.05 155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.813 1.245 . . . . 0.0 111.864 -163.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m -66.7 57.39 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.889 1.276 . . . . 0.0 113.431 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -84.41 -38.38 20.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.472 1.033 . . . . 0.0 113.033 -168.074 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.71 -155.85 18.3 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.74 1.162 . . . . 0.0 113.207 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.79 -70.58 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.414 1.886 . . . . 0.0 113.725 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.22 -29.03 63.41 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -161.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.32 -49.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.081 0.953 . . . . 0.0 113.128 166.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.9 m -85.68 -15.74 41.33 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.117 0.567 . . . . 0.0 112.398 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -76.71 -37.11 56.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.471 1.109 . . . . 0.0 110.302 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.09 119.89 38.48 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.498 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.28 -34.44 31.63 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.155 2.57 . . . . 0.0 113.601 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.85 5.72 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.717 0.407 . . . . 0.0 111.238 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.92 31.15 10.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.019 1.327 . . . . 0.0 111.579 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 38.44 0.42 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mt -142.2 146.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.417 1.487 . . . . 0.0 107.342 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.08 163.83 13.49 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.454 1.902 . . . . 0.0 110.032 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -68.57 117.19 9.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.69 -76.8 1.21 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -164.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -110.57 -71.2 0.77 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -104.56 -61.01 1.51 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.362 1.065 . . . . 0.0 108.945 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.76 -160.52 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.064 0.946 . . . . 0.0 110.024 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.88 144.26 41.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.736 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.76 151.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.414 1.885 . . . . 0.0 106.094 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 mt -105.27 140.3 23.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.74 74.44 1.11 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 162.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -33.19 64.59 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -170.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -42.83 -46.48 5.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.805 2.042 . . . . 0.0 112.216 166.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -104.1 -27.29 12.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.116 2.566 . . . . 0.0 112.034 -163.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.6 t -45.2 119.08 1.91 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.622 1.101 . . . . 0.0 110.54 167.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 pt -80.28 34.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.368 -0.833 . . . . 0.0 112.01 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t0 29.38 63.35 0.14 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.152 2.581 . . . . 0.0 113.251 -174.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.28 0.5 OUTLIER -98.36 -141.76 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.291 1.036 . . . . 0.0 108.596 173.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 10.94 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 CA-C-N 121.843 2.11 . . . . 0.0 114.685 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.64 -47.61 76.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.048 1.924 . . . . 0.0 110.876 -172.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.1 p -57.33 -43.93 83.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.028 0.531 . . . . 0.0 110.692 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.35 94.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.465 -0.772 . . . . 0.0 109.505 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -51.71 68.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.71 0.804 . . . . 0.0 112.083 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.66 -39.22 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.527 1.058 . . . . 0.0 112.446 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.2 t -55.7 121.62 40.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -161.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.24 -31.93 82.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.735 2.29 . . . . 0.0 111.961 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.68 11.05 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.893 0.877 . . . . 0.0 111.851 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.69 63.95 3.19 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.18 0.895 . . . . 0.0 112.714 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.56 -28.07 0.19 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 126.382 1.873 . . . . 0.0 114.005 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 78.98 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.962 2.441 . . . . 0.0 108.437 164.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.8 m -158.65 153.65 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 128.562 2.745 . . . . 0.0 104.361 -168.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.16 174.18 7.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 128.555 3.66 . . . . 0.0 112.551 -113.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.254 1.308 0 CA-C-O 115.686 -2.102 . . . . 0.0 109.256 -164.307 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -122.0 178.31 4.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 146.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.76 107.55 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 151.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.64 168.0 20.85 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.371 1.081 . . . . 0.0 111.268 171.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.57 -9.28 5.62 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.305 1.842 . . . . 0.0 113.888 -173.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -23.58 61.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.863 -1.148 . . . . 0.0 111.861 166.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.3 t -63.17 158.83 18.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.006 0.923 . . . . 0.0 110.822 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -136.87 -175.44 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.9 p -73.28 64.08 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.75 175.2 5.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.853 1.661 . . . . 0.0 108.093 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.81 38.36 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 CA-C-N 120.143 1.338 . . . . 0.0 110.868 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -15.18 30.68 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.52 0.728 . . . . 0.0 112.29 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.305 29.9 p -101.41 -95.22 0.28 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 118.589 -0.72 . . . . 0.0 111.219 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 39.7 -99.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 113.689 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -49.49 -29.62 6.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.507 1.523 . . . . 0.0 112.864 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -52.02 -33.39 38.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.316 1.046 . . . . 0.0 112.877 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -64.26 119.89 60.01 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.483 -0.76 . . . . 0.0 109.781 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.04 -32.29 23.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.236 2.624 . . . . 0.0 113.147 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.7 19.85 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 122.706 0.403 . . . . 0.0 110.947 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.45 22.8 0.77 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.339 1.855 . . . . 0.0 114.231 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.5 44.19 1.02 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.878 1.271 . . . . 0.0 111.322 -166.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.05 147.34 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.818 1.247 . . . . 0.0 107.934 -174.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -170.7 169.31 7.12 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.171 2.188 . . . . 0.0 109.49 167.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -67.5 125.66 26.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.69 -84.22 1.68 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -168.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -102.3 -48.04 4.31 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.942 1.297 . . . . 0.0 108.463 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 p -140.21 -59.71 0.53 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.615 1.966 . . . . 0.0 106.854 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -155.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.12 0.968 . . . . 0.0 109.642 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -82.38 157.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.98 0.419 . . . . 0.0 110.672 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.23 160.91 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.099 1.759 . . . . 0.0 106.887 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -119.48 146.74 23.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 125.259 1.424 . . . . 0.0 108.486 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.14 76.29 1.26 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 165.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.68 -35.34 60.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -167.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.4 -37.79 73.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.175 1.39 . . . . 0.0 110.384 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 m -79.9 -49.49 11.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.513 1.525 . . . . 0.0 110.815 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.3 t -61.33 111.8 1.91 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.697 1.237 . . . . 0.0 113.434 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.0 pt -83.45 142.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 156.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 60.68 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.54 2.336 . . . . 0.0 112.412 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -27.79 48.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.789 0.836 . . . . 0.0 112.806 -166.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.8 -34.03 5.32 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.38 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -54.61 -55.77 25.97 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.674 1.737 . . . . 0.0 112.051 -162.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 p -52.56 -43.04 64.97 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.719 0.295 . . . . 0.0 111.226 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.43 77.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.522 -0.736 . . . . 0.0 110.719 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -70.49 -47.32 61.1 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.407 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -68.82 -38.41 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.62 0.646 . . . . 0.0 112.167 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -55.94 120.06 30.83 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.318 -0.373 . . . . 0.0 111.958 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -59.59 -26.6 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.905 2.404 . . . . 0.0 112.37 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.04 24.49 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.705 0.802 . . . . 0.0 111.682 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.79 62.72 2.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.113 0.864 . . . . 0.0 113.07 172.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.69 -28.03 0.24 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 126.027 1.731 . . . . 0.0 113.998 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.6 80.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.634 2.223 . . . . 0.0 108.009 164.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -157.67 149.01 9.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -92.7 153.88 18.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 128.974 3.921 . . . . 0.0 115.714 -133.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 144.946 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -129.62 -159.59 0.97 Allowed 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 126.505 1.922 . . . . 0.0 106.532 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -128.32 161.84 28.46 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 27.6 mm -79.78 100.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 153.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.28 174.0 10.71 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.2 -0.938 . . . . 0.0 111.474 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.31 -16.47 2.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.835 2.054 . . . . 0.0 114.787 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -51.25 -33.01 26.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.433 -0.792 . . . . 0.0 111.761 166.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 47.3 t -55.71 130.26 42.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.251 1.82 . . . . 0.0 112.086 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.2 150.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -67.56 70.53 0.12 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.334 0.97 . . . . 0.0 111.993 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.22 -22.74 20.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.713 1.205 . . . . 0.0 111.42 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.95 -30.68 5.7 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 113.698 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.1 56.48 2.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.359 1.079 . . . . 0.0 113.309 -164.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 23.0 p -155.59 -31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.306 1.042 . . . . 0.0 112.282 171.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -36.02 -60.4 0.55 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -75.92 -15.2 60.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.296 1.039 . . . . 0.0 112.494 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 23.7 mm-40 -81.42 -34.17 31.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.967 1.307 . . . . 0.0 109.339 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.23 122.35 58.43 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.587 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -33.47 73.84 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.711 2.274 . . . . 0.0 112.493 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.06 7.42 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 122.818 0.447 . . . . 0.0 110.8 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 49.09 35.22 6.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.117 1.367 . . . . 0.0 111.866 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 36.41 0.42 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.052 1.341 . . . . 0.0 111.075 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mt -142.27 147.64 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.311 1.044 . . . . 0.0 109.489 -170.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -169.79 174.24 5.8 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 127.331 2.252 . . . . 0.0 108.522 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -85.42 128.66 34.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.481 1.037 . . . . 0.0 108.368 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.98 -67.86 0.14 Allowed Glycine 0 C--N 1.339 0.721 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.434 -161.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -98.96 -52.52 3.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -166.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.8 m -141.78 -50.51 0.4 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 109.181 156.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -161.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.225 1.01 . . . . 0.0 109.62 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.289 17.1 m-85 -68.69 161.94 27.15 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 117.714 -1.594 . . . . 0.0 110.906 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.87 162.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 126.783 2.033 . . . . 0.0 107.437 -170.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -128.92 138.6 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.651 1.18 . . . . 0.0 108.695 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -73.58 76.12 1.49 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 165.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -32.99 64.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -168.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.9 -48.08 8.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.443 1.897 . . . . 0.0 112.171 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.82 -29.95 12.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.655 2.382 . . . . 0.0 111.247 -165.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.8 t -52.85 134.65 37.0 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.288 0.949 . . . . 0.0 110.141 165.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 pt -107.89 137.92 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 159.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.96 74.11 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.56 -20.03 18.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.853 0.861 . . . . 0.0 113.041 -169.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.28 4.1 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.525 -0.734 . . . . 0.0 112.511 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -54.63 165.45 0.59 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 163.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.372 6.9 p 60.61 -57.56 0.08 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.373 1.469 . . . . 0.0 112.386 -152.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.44 96.61 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.234 1.379 . . . . 0.0 109.571 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -37.29 78.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.082 0.953 . . . . 0.0 111.914 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.94 -40.59 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.894 0.77 . . . . 0.0 111.007 -169.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.8 t -54.67 118.84 18.16 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.269 -170.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.1 -36.18 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.975 3.116 . . . . 0.0 114.216 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.42 14.27 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.68 50.67 36.07 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.746 0.703 . . . . 0.0 112.791 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 52' ' ' PRO . . . -80.02 -23.75 0.39 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 114.916 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 51' ' ' ALA . 55.5 Cg_exo -60.14 82.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.747 2.298 . . . . 0.0 110.764 168.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 m -159.85 153.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 128.901 2.88 . . . . 0.0 104.068 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -90.0 149.74 22.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.674 1.859 . . . . 0.0 114.299 -138.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 116.689 -1.625 . . . . 0.0 107.434 146.662 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -76.25 -158.35 0.09 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 160.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -142.43 -168.93 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 156.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.478 HG12 ' CG1' ' A' ' 32' ' ' ILE . 4.2 mm -79.45 105.55 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 156.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.86 165.19 25.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.961 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.48 -15.87 3.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -53.18 -25.66 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.327 -0.858 . . . . 0.0 113.27 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -59.31 162.15 4.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.267 1.427 . . . . 0.0 111.669 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.65 173.2 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 m -70.6 64.03 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.299 -0.875 . . . . 0.0 111.011 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -179.78 4.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.04 2.136 . . . . 0.0 106.695 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.39 37.6 0.84 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 120.446 1.476 . . . . 0.0 111.315 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 -31.0 43.74 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.861 0.464 . . . . 0.0 111.537 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.286 29.9 p -80.43 -97.4 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.595 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.57 -99.01 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 121.157 1.799 . . . . 0.0 113.611 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 m -48.4 -31.73 6.61 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.926 1.691 . . . . 0.0 112.461 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -53.25 -28.23 26.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.407 1.083 . . . . 0.0 112.898 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.502 ' HA ' ' S1 ' ' A' ' 57' ' ' SF4 . 51.4 t -71.55 120.65 81.11 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 119.11 0.868 . . . . 0.0 110.739 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.45 -34.79 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.64 6.98 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 117.937 0.335 . . . . 0.0 111.022 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 22.69 4.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.289 1.835 . . . . 0.0 111.816 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.3 50.18 1.89 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.2 -0.938 . . . . 0.0 110.538 -164.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mt -136.72 147.71 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.608 1.563 . . . . 0.0 107.985 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -169.08 168.36 10.06 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.31 2.244 . . . . 0.0 109.327 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -71.74 117.12 12.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.06 -66.67 1.12 Allowed Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -114.8 -72.14 0.71 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -108.65 -61.09 1.65 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.611 1.165 . . . . 0.0 108.326 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.9 -166.55 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.182 0.593 . . . . 0.0 110.35 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.88 155.7 40.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 110.66 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.77 156.42 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 126.976 2.11 . . . . 0.0 106.381 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.478 ' CG1' HG12 ' A' ' 4' ' ' ILE . 3.2 mt -126.12 146.34 32.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.42 84.19 0.58 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 164.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.74 -29.66 62.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.439 -0.788 . . . . 0.0 112.689 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -41.66 -47.6 3.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.54 1.936 . . . . 0.0 112.071 164.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -102.84 -34.13 9.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.095 2.158 . . . . 0.0 111.981 -164.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.6 t -52.45 129.2 28.06 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.677 1.126 . . . . 0.0 111.966 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 pt -107.64 34.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.256 1.423 . . . . 0.0 111.78 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 5.4 m-20 51.27 35.9 14.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.96 1.704 . . . . 0.0 112.758 170.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.47 -16.35 57.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.31 -27.97 7.95 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.454 1.026 . . . . 0.0 114.816 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -54.64 -50.81 67.25 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.947 1.874 . . . . 0.0 113.205 -165.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.5 p -55.01 -44.93 75.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.915 -0.49 . . . . 0.0 110.675 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.97 82.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.752 -0.592 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -39.59 75.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.7 -0.667 . . . . 0.0 111.559 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.56 -40.41 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.128 0.876 . . . . 0.0 111.869 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -53.94 121.65 30.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -164.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.93 -26.97 83.23 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.746 2.298 . . . . 0.0 112.736 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.95 19.05 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.553 0.741 . . . . 0.0 112.099 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.55 54.19 9.12 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.476 0.56 . . . . 0.0 113.122 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.65 -27.48 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.581 . . . . 0.0 114.58 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.67 82.48 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.274 1.983 . . . . 0.0 108.67 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -162.23 155.76 2.74 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -168.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -90.16 148.12 23.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 127.205 2.816 . . . . 0.0 112.671 -148.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 163.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . 0.502 ' S1 ' ' HA ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.531 0.205 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -74.25 -154.17 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 126.479 1.912 . . . . 0.0 106.767 156.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.457 ' H ' ' HA ' ' A' ' 54' ' ' GLN . 2.5 ptpp? -122.41 -179.22 4.12 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 146.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 71.2 mt -85.33 104.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 155.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.7 176.41 8.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.088 0.946 . . . . 0.0 112.895 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.75 -31.59 2.09 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.66 1.984 . . . . 0.0 114.985 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -54.75 -16.37 2.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' VAL . 53.9 t -55.55 -33.75 64.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.923 2.089 . . . . 0.0 115.607 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 8' ' ' CYS 0.288 1.8 m 71.35 -53.32 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 119.473 -2.017 . . . . 0.0 113.988 -173.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p 129.08 29.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 131.399 3.88 . . . . 0.0 111.307 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -19.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -162.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' CZ ' ' A' ' 30' ' ' PHE . . . 88.41 -53.0 4.08 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.109 -0.994 . . . . 0.0 114.24 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -33.11 -63.32 0.23 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.34 1.456 . . . . 0.0 114.633 -160.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 23.0 p -56.36 -21.46 24.8 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.39 -47.04 3.5 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.754 0.821 . . . . 0.0 112.657 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.5 m -82.72 -24.26 33.68 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 75.8 mm-40 -74.0 -34.65 64.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.756 1.223 . . . . 0.0 111.075 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.88 123.28 51.93 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.428 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.56 -37.4 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.294 3.329 . . . . 0.0 113.694 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.31 20.48 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.1 0.56 . . . . 0.0 112.163 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 44.72 49.37 8.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 0.0 112.432 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.18 31.61 1.66 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.389 1.076 . . . . 0.0 111.157 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.48 146.25 30.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.763 0.825 . . . . 0.0 109.107 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.47 169.24 10.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.135 2.174 . . . . 0.0 109.897 172.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -75.22 125.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.72 -73.88 1.06 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.99 -70.04 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -115.08 -62.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.71 2.004 . . . . 0.0 107.232 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -167.24 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.529 1.132 . . . . 0.0 111.075 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 20.9 m-85 -73.32 151.8 41.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.427 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 159.75 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 127.677 2.391 . . . . 0.0 106.008 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.64 131.45 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.41 79.55 0.76 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.27 66.58 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -163.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.89 -34.34 77.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.795 1.238 . . . . 0.0 110.694 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -84.81 -40.83 16.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 110.433 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 t -61.27 149.67 37.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.128 0.876 . . . . 0.0 108.743 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 pt -90.84 -112.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 167.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.89 129.1 11.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 155.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -161.03 161.8 31.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.052 0.842 . . . . 0.0 109.848 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.25 -26.93 56.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.489 -0.757 . . . . 0.0 112.392 -173.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -47.8 -60.68 2.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.272 1.029 . . . . 0.0 113.207 -159.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.5 p -60.71 -41.55 95.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.651 0.659 . . . . 0.0 110.465 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.38 81.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.505 -0.747 . . . . 0.0 110.307 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -46.02 72.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.403 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.86 -37.35 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.405 1.002 . . . . 0.0 111.408 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -53.77 118.57 15.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.649 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.44 -38.17 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.65 3.567 . . . . 0.0 114.813 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.06 24.34 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 112.15 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.59 62.09 5.09 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.385 0.539 . . . . 0.0 112.962 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.17 -23.74 0.21 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 126.722 2.009 . . . . 0.0 114.699 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -60.95 90.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.82 2.347 . . . . 0.0 108.038 162.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 m -159.19 144.54 6.69 Favored 'Isoleucine or valine' 0 C--O 1.252 1.209 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HA ' ' H ' ' A' ' 3' ' ' LYS . 35.3 tt0 -91.1 131.5 36.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 128.359 3.537 . . . . 0.0 114.23 -144.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 157.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.306 0 CA-C-O 117.354 -1.308 . . . . 0.0 108.801 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 61.45 -137.06 0.54 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -142.32 -163.36 1.59 Allowed 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 115.845 -2.342 . . . . 0.0 105.465 135.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.09 108.97 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 156.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.25 163.25 27.22 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.274 -0.891 . . . . 0.0 110.848 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.07 -12.31 4.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -52.43 -29.18 23.15 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.336 -0.852 . . . . 0.0 112.228 166.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 49.8 t -58.87 156.27 11.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.997 1.319 . . . . 0.0 111.653 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.59 167.67 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 164.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -65.39 64.48 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.012 1.325 . . . . 0.0 111.997 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -34.05 7.2 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.585 1.154 . . . . 0.0 112.716 -165.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.92 21.68 56.14 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.879 1.228 . . . . 0.0 114.742 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.79 -28.43 58.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.162 0.981 . . . . 0.0 111.46 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 p -79.31 -108.62 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 53.76 -101.65 0.12 Allowed 'General case' 0 C--N 1.34 0.174 0 CA-C-N 121.49 1.95 . . . . 0.0 111.799 170.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m -41.32 -36.29 0.78 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.409 1.884 . . . . 0.0 112.832 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -41.79 62.33 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 111.569 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.54 125.0 81.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.262 -166.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.53 -35.03 11.87 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.59 2.86 . . . . 0.0 114.096 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.4 m -107.08 5.19 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 48.69 37.43 9.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.032 1.333 . . . . 0.0 111.64 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.83 32.46 0.42 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.697 1.199 . . . . 0.0 111.958 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -132.1 151.14 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.885 1.274 . . . . 0.0 108.786 -172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 p -164.67 174.15 11.11 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.395 1.478 . . . . 0.0 109.195 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -77.38 125.24 29.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.77 -83.44 1.7 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -167.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -99.87 -50.33 4.05 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.25 1.02 . . . . 0.0 108.446 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 p -140.73 -57.7 0.52 Allowed 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.031 2.133 . . . . 0.0 106.609 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -104.45 -162.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.21 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -79.8 156.29 27.49 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.267 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -147.99 158.36 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.767 2.027 . . . . 0.0 108.28 -171.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.84 149.75 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 125.699 1.6 . . . . 0.0 108.957 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -82.77 114.17 20.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 157.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.621 1.1 . . . . 0.0 112.004 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 -38.92 85.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.7 1.2 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 m -79.85 -40.06 29.27 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.742 1.217 . . . . 0.0 109.745 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.9 112.04 1.9 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.582 0.628 . . . . 0.0 110.941 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.5 pt -79.76 47.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 121.244 -0.91 . . . . 0.0 111.316 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 14.73 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.609 2.763 . . . . 0.0 114.402 -173.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -5.27 40.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.99 -37.38 1.49 Allowed Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.035 -1.041 . . . . 0.0 114.23 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -46.17 -52.46 12.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -154.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -47.35 -37.7 11.62 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.147 1.779 . . . . 0.0 111.596 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -34.73 61.3 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.52 -0.738 . . . . 0.0 112.29 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -67.69 -44.89 76.69 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.87 0.304 . . . . 0.0 111.004 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.66 -30.37 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.868 -171.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -56.74 118.73 24.74 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.278 -170.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.88 -37.3 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.421 3.414 . . . . 0.0 114.253 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.73 22.65 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.995 0.918 . . . . 0.0 112.246 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.91 64.42 3.27 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.601 0.637 . . . . 0.0 113.039 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.39 -23.4 0.19 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -64.29 83.15 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.374 2.05 . . . . 0.0 108.28 163.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -162.27 151.72 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 -165.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.83 151.05 21.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 127.307 2.879 . . . . 0.0 113.614 -143.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 152.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -123.78 -157.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.604 2.362 . . . . 0.0 105.429 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' C ' HD12 ' A' ' 32' ' ' ILE . 13.1 ptpt -118.17 -179.33 3.74 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 143.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.449 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 48.8 mt -79.1 109.44 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 147.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.93 173.37 11.29 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 122.143 0.973 . . . . 0.0 111.286 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -47.96 -31.09 4.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.035 1.334 . . . . 0.0 113.299 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -65.11 13.19 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.613 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.7 t -74.17 -73.12 0.24 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.627 2.371 . . . . 0.0 112.793 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 8' ' ' CYS 0.274 1.3 m 75.77 137.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 127.197 2.199 . . . . 0.0 110.373 -159.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.25 57.03 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.941 2.096 . . . . 0.0 114.48 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -17.94 25.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.214 0.915 . . . . 0.0 112.903 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 30' ' ' PHE . . . 88.92 -57.96 4.02 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 120.92 -1.112 . . . . 0.0 114.005 167.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -30.38 -57.76 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.283 1.833 . . . . 0.0 114.756 -164.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -63.28 -20.92 65.9 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -169.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.91 -58.3 2.1 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.413 1.006 . . . . 0.0 112.444 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -29.17 67.22 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.287 1.035 . . . . 0.0 112.537 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 111.632 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.31 123.66 83.25 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.519 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -42.4 -37.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.024 3.149 . . . . 0.0 113.938 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.14 14.45 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.24 44.11 6.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.525 1.13 . . . . 0.0 111.759 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.08 36.34 0.62 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.038 0.935 . . . . 0.0 110.598 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mt -137.54 149.31 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 125.212 1.405 . . . . 0.0 107.698 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.9 t -164.23 176.73 8.92 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 124.77 1.228 . . . . 0.0 109.93 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.65 102.74 2.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.3 -65.64 1.77 Allowed Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -119.14 -77.2 0.57 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -108.61 -48.72 3.27 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.412 1.485 . . . . 0.0 110.193 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.82 -169.16 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 122.711 0.405 . . . . 0.0 109.98 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 20.1 m-85 -82.66 148.79 27.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.526 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.61 160.46 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 126.932 2.093 . . . . 0.0 107.734 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 3' ' ' LYS . 71.2 mt -108.73 140.19 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.837 1.255 . . . . 0.0 107.801 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -72.71 76.45 1.11 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.65 67.03 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -44.93 -47.69 11.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.297 1.839 . . . . 0.0 112.343 166.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -96.99 -31.99 12.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.606 2.362 . . . . 0.0 110.847 -165.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.8 t -57.01 136.78 56.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.403 1.001 . . . . 0.0 108.606 160.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.13 -102.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -158.63 135.79 9.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 155.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.06 177.94 8.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 109.663 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.86 -42.26 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.95 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.53 -60.13 3.76 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 117.633 0.716 . . . . 0.0 112.602 -147.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -53.07 -45.15 67.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.024 0.374 . . . . 0.0 111.124 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.08 90.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.886 -0.509 . . . . 0.0 110.343 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.26 -43.84 69.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.485 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.45 -40.27 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 119.351 0.978 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -53.43 118.24 14.01 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.784 -0.627 . . . . 0.0 112.328 -163.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.83 -37.84 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.317 3.344 . . . . 0.0 114.456 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.4 m -118.73 16.17 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.94 50.22 39.22 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.713 0.688 . . . . 0.0 113.036 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.6 -19.73 0.26 Allowed Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.841 1.656 . . . . 0.0 115.061 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -58.36 86.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.036 2.491 . . . . 0.0 110.022 164.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 m -161.53 152.48 4.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -84.12 151.35 24.97 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 127.41 2.944 . . . . 0.0 114.008 -139.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 135.306 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -85.76 -157.46 0.33 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.1 174.96 5.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 144.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 mm -79.02 107.63 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 146.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.34 165.05 25.4 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 122.09 0.948 . . . . 0.0 111.445 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.57 -15.23 10.47 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.918 1.687 . . . . 0.0 113.596 -173.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 m -56.32 -23.49 37.38 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.399 -0.813 . . . . 0.0 112.515 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -54.25 154.16 4.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.096 1.358 . . . . 0.0 110.303 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.98 164.73 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 170.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.4 m -71.74 60.66 0.36 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.949 0.795 . . . . 0.0 111.649 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 -31.22 14.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.999 1.32 . . . . 0.0 111.818 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.25 -28.86 1.68 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.979 172.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -43.43 -48.78 7.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.72 1.208 . . . . 0.0 113.518 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -64.43 -12.57 44.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.78 -65.38 0.51 Allowed 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.106 -0.997 . . . . 0.0 112.89 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 m -69.27 -29.84 67.82 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -59.06 -39.89 83.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.215 1.006 . . . . 0.0 111.737 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.28 120.09 64.73 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.895 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.89 -37.0 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.562 2.841 . . . . 0.0 113.946 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.36 0.86 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.166 0.439 . . . . 0.0 112.011 -174.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.38 57.42 5.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.776 0.83 . . . . 0.0 111.037 -174.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.65 61.75 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.671 -0.643 . . . . 0.0 111.454 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.19 149.86 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.439 1.896 . . . . 0.0 112.132 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 m -161.32 164.13 30.33 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.243 2.617 . . . . 0.0 108.488 154.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -75.15 119.23 19.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.87 -66.91 1.35 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -166.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -116.56 -71.96 0.71 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -113.5 -55.97 2.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.146 1.378 . . . . 0.0 108.745 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -100.94 -167.52 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.086 0.555 . . . . 0.0 110.649 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -84.68 146.96 27.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.412 0.625 . . . . 0.0 111.433 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.1 159.03 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 127.171 2.188 . . . . 0.0 106.153 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.42 149.65 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 C-N-CA 125.296 1.438 . . . . 0.0 109.431 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -65.76 91.96 0.14 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 155.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.79 -29.04 67.95 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.676 -1.265 . . . . 0.0 112.404 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.09 -36.63 84.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.311 0.644 . . . . 0.0 111.368 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -79.77 -43.52 22.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.502 1.121 . . . . 0.0 109.379 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.7 t -54.63 132.31 45.07 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -78.33 -102.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.87 120.38 2.66 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 159.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.39 171.81 19.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.182 0.901 . . . . 0.0 110.796 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.09 -40.51 8.59 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.544 -0.587 . . . . 0.0 113.122 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.61 -56.92 14.77 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.851 0.826 . . . . 0.0 112.995 -147.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 p -55.86 -44.64 78.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.02 -0.425 . . . . 0.0 110.926 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.07 94.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.793 -0.567 . . . . 0.0 110.108 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -62.76 -49.31 75.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.145 0.578 . . . . 0.0 111.413 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -68.25 -40.68 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 118.832 0.742 . . . . 0.0 111.833 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.36 117.95 19.26 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -162.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.92 -26.42 82.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.729 2.286 . . . . 0.0 112.38 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -116.09 21.74 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.967 0.907 . . . . 0.0 111.408 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.05 50.89 7.47 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.521 1.058 . . . . 0.0 113.346 171.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.8 -26.92 0.36 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.265 1.426 . . . . 0.0 114.828 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -63.65 84.56 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.579 2.186 . . . . 0.0 109.443 168.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.1 m -165.77 157.81 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.78 155.33 18.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 127.624 3.077 . . . . 0.0 114.04 -124.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 . . . . . 0 C--O 1.257 1.465 0 C-N-CA 127.82 2.448 . . . . 0.0 106.44 157.486 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 66.6 -175.39 0.19 Allowed 'General case' 0 C--N 1.341 0.239 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -156.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -128.01 179.43 5.58 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 140.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 50.0 mt -79.7 107.69 12.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 156.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.83 15.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.145 0.974 . . . . 0.0 111.673 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -49.15 -23.4 1.26 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.604 2.362 . . . . 0.0 114.82 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -54.08 -24.38 17.24 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.556 -0.715 . . . . 0.0 112.521 171.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 47.7 t -57.72 121.63 10.88 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.291 1.437 . . . . 0.0 110.864 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.94 21.97 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.491 -0.756 . . . . 0.0 111.581 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 m 56.69 36.23 27.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.139 0.976 . . . . 0.0 110.552 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -75.33 152.59 38.14 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 111.21 -169.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.9 57.96 4.93 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.892 -1.13 . . . . 0.0 110.858 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . . . -143.72 -161.33 1.25 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.206 1.003 . . . . 0.0 108.889 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 17' ' ' GLU 0.57 3.7 p 39.25 -120.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.065 -160.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 49.69 -105.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 122.627 2.467 . . . . 0.0 110.904 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 m -58.06 -17.59 18.85 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 23.5 mt-10 -61.12 -29.3 69.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.383 0.992 . . . . 0.0 111.005 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.39 129.25 90.84 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.343 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.97 -34.34 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.135 3.224 . . . . 0.0 114.456 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 p -126.72 26.63 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.797 0.726 . . . . 0.0 112.686 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.31 38.44 21.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.88 0.872 . . . . 0.0 111.9 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.95 32.07 0.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.78 1.232 . . . . 0.0 111.811 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.21 152.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.278 1.431 . . . . 0.0 107.434 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -165.25 173.96 10.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.997 2.119 . . . . 0.0 108.925 164.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 123.68 19.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.75 -105.74 2.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -98.78 -49.05 4.71 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.581 1.152 . . . . 0.0 109.141 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -128.21 -53.05 1.29 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.334 1.854 . . . . 0.0 107.691 -172.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -165.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.05 148.15 31.19 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.417 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 154.24 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 C-N-CA 126.072 1.749 . . . . 0.0 107.817 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.2 mt -104.53 136.65 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 107.674 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -74.6 77.16 2.0 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.58 62.25 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -41.24 -48.36 3.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 165.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -99.63 -37.51 9.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.834 2.454 . . . . 0.0 111.236 -165.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.1 t -53.98 126.9 24.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.805 0.729 . . . . 0.0 111.114 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 pt -91.94 8.88 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.817 0.847 . . . . 0.0 112.754 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 54.64 75.32 0.3 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.903 2.481 . . . . 0.0 111.936 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.51 -13.9 13.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 114.04 -174.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.71 -17.76 10.36 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.335 0.969 . . . . 0.0 115.456 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -55.69 -47.85 76.08 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.719 1.759 . . . . 0.0 112.98 -171.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -58.08 -41.3 83.16 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.533 -0.729 . . . . 0.0 109.481 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.04 -43.38 81.91 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.555 -0.715 . . . . 0.0 110.186 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -62.9 -48.11 80.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.823 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 m -68.88 -39.6 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.88 0.763 . . . . 0.0 111.941 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.1 t -55.51 122.09 42.46 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.946 -167.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.18 -39.0 2.36 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.759 3.64 . . . . 0.0 115.137 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.97 28.22 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.248 0.619 . . . . 0.0 112.055 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.21 40.85 45.67 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 118.132 0.424 . . . . 0.0 113.653 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.26 1.44 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -58.93 78.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.324 2.683 . . . . 0.0 111.773 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 m -160.63 173.34 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 130.262 3.425 . . . . 0.0 105.173 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.72 158.24 20.82 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 124.045 0.84 . . . . 0.0 112.904 -96.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 128.133 2.573 . . . . 0.0 110.182 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.39 -161.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 166.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -120.44 -179.42 3.96 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 141.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 55.5 mt -83.52 111.13 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 152.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.25 25.06 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 122.191 0.996 . . . . 0.0 112.068 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.97 -28.25 2.65 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.733 2.013 . . . . 0.0 114.11 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.42 -24.94 2.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' VAL . 41.7 t -45.08 -73.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.268 2.227 . . . . 0.0 114.791 -174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER 66.5 143.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.473 1.109 . . . . 0.0 110.267 -156.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.73 56.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.125 1.77 . . . . 0.0 113.142 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 158.64 25.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.135 1.374 . . . . 0.0 108.713 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.16 28.9 13.27 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.057 -1.027 . . . . 0.0 112.969 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.65 -57.2 2.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.397 1.098 . . . . 0.0 112.998 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.334 28.5 p -73.1 -90.81 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.329 0.968 . . . . 0.0 112.711 -171.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 31.94 -98.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.815 1.643 . . . . 0.0 113.994 -169.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -46.79 -31.92 3.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.938 2.095 . . . . 0.0 113.497 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -50.32 -32.41 17.07 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.683 1.193 . . . . 0.0 112.895 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HA ' ' S1 ' ' A' ' 57' ' ' SF4 . 42.5 t -64.41 122.36 77.8 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.443 -0.786 . . . . 0.0 110.499 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -50.94 -35.07 48.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.011 2.474 . . . . 0.0 113.502 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.67 5.53 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 118.304 0.502 . . . . 0.0 111.033 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.06 40.94 26.8 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.007 1.723 . . . . 0.0 110.845 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.31 45.23 1.21 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.755 0.822 . . . . 0.0 110.011 -168.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.86 150.42 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.498 1.919 . . . . 0.0 106.434 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -171.48 174.56 4.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.139 2.176 . . . . 0.0 108.477 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.06 123.82 17.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 167.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.29 -98.47 2.41 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -99.27 -46.06 5.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.44 1.496 . . . . 0.0 108.822 -166.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 p -134.61 -56.51 0.84 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.183 1.793 . . . . 0.0 107.28 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 -162.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.339 1.056 . . . . 0.0 110.53 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -78.22 139.8 38.92 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.8 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.46 156.62 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 126.278 1.831 . . . . 0.0 107.616 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.11 142.94 24.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -73.81 78.42 1.59 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.62 56.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 113.022 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -42.1 -49.71 4.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.986 2.114 . . . . 0.0 112.219 165.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.56 -31.26 12.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.578 2.351 . . . . 0.0 111.36 -165.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.0 t -49.95 116.86 2.0 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.211 0.914 . . . . 0.0 110.271 169.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.84 -17.84 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 122.735 0.414 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t0 76.62 118.81 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 127.916 2.486 . . . . 0.0 108.499 -168.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.85 -47.96 0.09 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -168.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.98 -29.59 4.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.526 -1.152 . . . . 0.0 113.274 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -53.33 -51.13 63.39 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.539 1.67 . . . . 0.0 112.593 -164.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.29 -46.91 72.86 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.44 -0.162 . . . . 0.0 110.761 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.92 91.46 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.669 -0.644 . . . . 0.0 110.156 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -51.31 69.53 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.619 0.767 . . . . 0.0 111.806 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -70.13 -39.18 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 119.366 0.985 . . . . 0.0 111.797 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.0 t -55.02 116.65 11.87 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -162.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.09 -38.95 19.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.938 3.092 . . . . 0.0 113.835 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.47 9.26 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.716 1.206 . . . . 0.0 112.147 -173.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.79 50.85 25.25 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.792 0.723 . . . . 0.0 112.94 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.78 -25.35 0.29 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 126.281 1.832 . . . . 0.0 114.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.26 81.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.061 2.507 . . . . 0.0 109.21 167.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -161.08 156.69 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 129.221 3.008 . . . . 0.0 104.006 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.5 174.4 7.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 127.445 2.966 . . . . 0.0 114.069 -121.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.82 158.083 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . 0.411 ' S1 ' ' HA ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.291 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -100.22 178.29 4.82 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 142.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -108.51 170.18 8.18 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 152.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 55.8 mt -79.91 106.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 150.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.09 174.94 10.1 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 122.689 1.233 . . . . 0.0 111.667 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.36 -13.69 9.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 128.563 2.745 . . . . 0.0 113.541 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.29 64.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 111.468 170.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 48.5 t -57.51 153.17 13.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.3 1.44 . . . . 0.0 112.272 -177.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.19 156.68 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 162.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m -61.25 66.59 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.815 1.646 . . . . 0.0 113.348 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 -30.33 9.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.342 1.057 . . . . 0.0 112.833 -168.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.68 60.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.191 1.377 . . . . 0.0 115.772 170.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.88 -61.84 1.83 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.552 1.676 . . . . 0.0 110.789 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.38 -34.09 32.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.275 1.03 . . . . 0.0 111.881 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.97 -45.67 7.89 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -88.02 -6.75 57.81 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -41.27 13.76 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.119 1.768 . . . . 0.0 108.021 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.4 t -49.64 116.99 6.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.333 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.94 -33.28 14.19 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.767 2.978 . . . . 0.0 113.876 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.7 m -111.56 11.53 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.264 0.484 . . . . 0.0 112.065 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 47.89 34.11 3.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.2 40.29 0.62 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.881 1.272 . . . . 0.0 111.199 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mt -133.2 146.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.109 1.364 . . . . 0.0 108.823 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -166.54 167.02 15.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.327 1.851 . . . . 0.0 109.649 167.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.34 119.18 18.18 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.24 -78.44 1.28 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -169.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -99.87 -54.91 2.78 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.941 0.896 . . . . 0.0 108.91 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -140.88 -56.24 0.5 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.867 2.067 . . . . 0.0 107.377 -167.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -102.64 -174.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.059 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -74.25 148.38 41.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.152 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.97 152.55 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 126.346 1.858 . . . . 0.0 106.988 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.27 138.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.516 1.527 . . . . 0.0 107.788 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -74.07 76.2 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.55 60.05 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -167.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -43.97 -47.51 8.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.141 1.776 . . . . 0.0 112.243 167.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -100.27 -30.53 11.84 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.923 2.489 . . . . 0.0 111.393 -165.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -52.29 128.54 25.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.308 0.958 . . . . 0.0 109.793 167.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.0 pt -90.1 130.18 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 161.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 74.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.103 1.361 . . . . 0.0 112.236 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -15.17 16.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.507 1.523 . . . . 0.0 111.341 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.76 -23.63 0.82 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.233 1.873 . . . . 0.0 115.188 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.15 -39.16 71.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.4 p -47.44 -32.68 5.31 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.498 1.119 . . . . 0.0 112.578 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -44.47 32.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.379 0.536 . . . . 0.0 112.403 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -51.76 -39.47 58.61 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -167.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.71 -26.05 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 117.879 0.309 . . . . 0.0 111.749 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.86 119.11 69.27 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.949 -153.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.34 -37.98 7.81 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.175 3.25 . . . . 0.0 114.377 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.67 33.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.729 0.812 . . . . 0.0 111.633 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.48 49.29 11.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.31 0.957 . . . . 0.0 114.078 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.24 -28.34 0.39 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.814 1.645 . . . . 0.0 114.429 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.96 87.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.648 2.232 . . . . 0.0 109.712 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -165.95 158.82 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.909 0 C-N-CA 128.661 2.784 . . . . 0.0 104.296 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -90.67 166.03 13.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 127.266 2.854 . . . . 0.0 112.95 -118.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 C--O 1.249 1.055 0 C-N-CA 124.896 1.279 . . . . 0.0 110.994 -162.039 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 62.32 -152.13 0.36 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -168.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -131.18 -174.49 3.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 145.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 29.1 mm -79.14 110.07 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 153.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.48 162.45 27.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 122.166 0.984 . . . . 0.0 111.188 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -53.0 -21.36 4.35 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.7 2.0 . . . . 0.0 114.257 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -51.36 -25.65 6.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.737 -0.602 . . . . 0.0 112.565 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.3 t -56.08 109.81 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.508 1.123 . . . . 0.0 111.97 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -80.71 13.78 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.334 -0.854 . . . . 0.0 112.03 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.8 m 59.29 43.93 16.15 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.247 1.019 . . . . 0.0 110.772 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.51 -158.01 0.24 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.498 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.43 39.18 1.25 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 120.088 1.313 . . . . 0.0 111.109 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.46 -40.17 13.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 123.384 0.673 . . . . 0.0 110.987 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 p -85.43 -137.35 0.07 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.153 0.581 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.49 -77.72 0.03 OUTLIER 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.04 1.736 . . . . 0.0 113.356 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -56.63 -35.13 67.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.165 0.586 . . . . 0.0 109.952 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -53.38 -31.03 42.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 113.789 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -70.25 127.29 92.33 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.82 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.22 -36.35 5.99 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.689 2.926 . . . . 0.0 113.622 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.79 20.36 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.649 0.38 . . . . 0.0 111.41 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 44.27 39.74 3.2 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.025 1.73 . . . . 0.0 112.912 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.64 40.75 1.2 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.342 1.057 . . . . 0.0 111.296 -165.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.32 149.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.51 1.924 . . . . 0.0 106.085 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -173.07 172.9 3.8 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.658 1.983 . . . . 0.0 109.492 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 129.42 40.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.03 -111.06 3.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 124.728 1.156 . . . . 0.0 111.698 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -99.77 -48.72 4.61 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.965 0.906 . . . . 0.0 109.494 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 p -115.65 -60.83 1.82 Allowed 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.509 2.324 . . . . 0.0 106.783 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.27 -156.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.725 1.61 . . . . 0.0 110.65 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -74.62 157.19 35.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.826 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 169.97 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 127.789 2.436 . . . . 0.0 108.89 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -130.35 143.08 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.539 1.536 . . . . 0.0 107.388 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.55 79.13 2.56 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 164.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.11 63.23 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.224 -0.923 . . . . 0.0 113.262 -171.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.86 -35.91 75.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 110.57 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -84.26 -44.2 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.624 1.57 . . . . 0.0 111.091 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -57.57 139.06 54.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.572 1.078 . . . . 0.0 110.22 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.1 -116.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -140.18 30.46 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.691 1.997 . . . . 0.0 109.853 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.277 0.0 OUTLIER -72.81 177.54 4.77 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.945 -0.472 . . . . 0.0 111.555 -174.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.57 -32.87 4.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.623 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.22 -53.38 54.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.498 1.149 . . . . 0.0 113.516 -150.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.62 -45.2 85.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.566 0.222 . . . . 0.0 110.808 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.53 94.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.884 -0.51 . . . . 0.0 109.847 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -50.57 69.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 111.969 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.09 -38.34 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 119.487 1.04 . . . . 0.0 111.669 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.2 118.12 16.98 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -163.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -60.84 -23.78 77.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.718 2.278 . . . . 0.0 112.55 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.87 31.3 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.381 0.673 . . . . 0.0 111.073 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.62 63.13 1.74 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.646 1.117 . . . . 0.0 113.239 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 -30.9 0.24 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.994 1.718 . . . . 0.0 113.541 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.88 78.58 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.758 2.305 . . . . 0.0 108.684 165.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -160.79 153.36 4.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 128.67 2.788 . . . . 0.0 104.638 -167.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -91.67 149.65 21.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.493 2.995 . . . . 0.0 115.71 -132.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 102.275 -3.231 . . . . 0.0 102.275 131.808 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -92.61 -165.12 1.28 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.04 178.35 5.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 151.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 57.9 mt -84.17 108.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.79 171.11 15.26 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 122.091 0.948 . . . . 0.0 111.469 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -53.98 -20.6 6.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.196 1.798 . . . . 0.0 113.976 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -57.77 -20.68 36.87 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.53 -0.731 . . . . 0.0 112.963 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.5 t -56.1 153.58 8.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.084 1.354 . . . . 0.0 111.32 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.7 156.26 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 161.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 m -67.41 63.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.122 0.874 . . . . 0.0 112.738 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.0 -16.79 21.45 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.184 1.393 . . . . 0.0 111.894 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 -58.97 4.88 Favored Glycine 0 C--N 1.338 0.655 0 O-C-N 121.284 -0.885 . . . . 0.0 112.158 169.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -22.27 -65.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.91 2.084 . . . . 0.0 115.004 -167.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 p -56.7 -25.56 54.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.37 -50.35 1.49 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.028 0.931 . . . . 0.0 113.351 167.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 m -81.84 -23.74 36.23 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.12 -33.78 75.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.513 1.125 . . . . 0.0 110.959 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' HA ' ' S1 ' ' A' ' 57' ' ' SF4 . 42.6 t -63.54 115.73 20.56 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.416 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.01 -18.42 62.03 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.661 1.574 . . . . 0.0 111.478 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.4 14.16 8.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 CA-C-N 119.052 0.842 . . . . 0.0 111.582 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 43.68 48.02 6.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.851 1.26 . . . . 0.0 111.906 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.16 -5.98 51.18 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.897 0.879 . . . . 0.0 112.026 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.51 146.93 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.202 1.001 . . . . 0.0 110.308 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.6 m -164.23 167.88 19.49 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.235 2.214 . . . . 0.0 109.012 163.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -69.97 122.29 19.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.48 -65.02 1.15 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -170.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -115.08 -70.35 0.8 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -118.82 -58.35 1.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.692 1.997 . . . . 0.0 107.759 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -94.67 -174.21 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.866 -176.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -78.16 151.1 33.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.066 0.46 . . . . 0.0 111.189 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.13 142.84 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 126.256 1.823 . . . . 0.0 107.568 -170.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -103.27 139.01 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 127.11 2.164 . . . . 0.0 109.662 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.268 64.3 m-20 -69.82 102.49 1.96 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 159.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.27 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.041 -1.037 . . . . 0.0 112.332 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.55 -37.51 81.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.273 0.558 . . . . 0.0 110.929 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.0 m -80.19 -42.85 22.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.047 0.939 . . . . 0.0 110.6 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.93 127.58 32.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.919 0.781 . . . . 0.0 111.631 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.8 pt -100.64 28.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.863 1.265 . . . . 0.0 112.162 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 51.09 47.45 24.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.918 1.287 . . . . 0.0 111.707 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.256 0.5 OUTLIER -86.11 -164.7 1.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.23 -28.71 3.72 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.704 1.138 . . . . 0.0 114.069 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -54.85 -56.11 22.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.251 1.025 . . . . 0.0 112.885 -153.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.7 p -53.47 -45.6 69.62 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.239 -0.288 . . . . 0.0 110.916 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.62 97.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 110.278 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -61.34 -47.64 84.95 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.661 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.68 -42.13 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.042 0.837 . . . . 0.0 112.266 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.52 121.11 36.34 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.262 -159.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.3 -38.83 3.73 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.597 3.531 . . . . 0.0 115.029 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.97 17.55 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.359 0.663 . . . . 0.0 112.382 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.63 44.06 79.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 118.593 0.633 . . . . 0.0 112.907 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.65 -25.5 0.66 Allowed Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.46 87.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.936 2.424 . . . . 0.0 110.644 170.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 m -162.11 160.14 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.816 0 C-N-CA 128.937 2.895 . . . . 0.0 104.101 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.12 170.18 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 127.375 2.922 . . . . 0.0 115.149 -128.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 . . . . . 0 C--O 1.251 1.181 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.219 169.302 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . 0.405 ' S1 ' ' HA ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -89.31 -162.31 0.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 166.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 -177.18 4.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 149.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.27 110.1 20.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.08 162.04 28.89 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 122.083 0.945 . . . . 0.0 111.337 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -51.38 -26.23 7.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.721 1.609 . . . . 0.0 113.555 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -48.94 -25.45 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.6 t -48.63 -60.25 2.87 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 114.215 -174.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 162.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.725 -1.234 . . . . 0.0 110.856 -163.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 m -75.41 49.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 119.552 -1.968 . . . . 0.0 111.498 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.65 166.17 23.76 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 154.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.71 38.55 0.71 Allowed Glycine 0 CA--C 1.523 0.587 0 CA-C-N 120.557 1.526 . . . . 0.0 112.391 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.79 -63.02 1.51 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.471 0.635 . . . . 0.0 110.988 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 26.2 p -50.53 -24.58 3.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -169.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -33.85 -53.08 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.707 1.203 . . . . 0.0 114.197 166.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 p -76.09 -26.16 56.19 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.472 -0.768 . . . . 0.0 112.124 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 24.5 mm-40 -75.9 -29.65 58.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.817 2.047 . . . . 0.0 110.243 -169.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HA ' ' S1 ' ' A' ' 57' ' ' SF4 . 45.8 t -58.6 119.48 36.89 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.082 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.38 -31.83 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.166 2.577 . . . . 0.0 113.345 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.26 8.17 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.413 0.551 . . . . 0.0 111.653 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 m120 44.98 44.13 7.8 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.831 1.652 . . . . 0.0 111.748 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 33' ' ' ASP . . . -115.14 47.77 1.25 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.976 0.91 . . . . 0.0 110.055 -169.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.43 150.91 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.754 2.022 . . . . 0.0 107.143 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -170.86 174.54 4.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.423 2.289 . . . . 0.0 109.049 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -73.33 132.08 42.65 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.52 -81.79 1.58 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -99.37 -56.13 2.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.921 1.288 . . . . 0.0 109.199 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -138.83 -51.09 0.55 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.968 2.107 . . . . 0.0 107.859 -177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.65 -161.33 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 122.953 0.501 . . . . 0.0 109.844 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.313 5.5 m-85 -79.35 163.63 24.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.418 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.4 163.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 127.774 2.429 . . . . 0.0 108.007 -170.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.35 143.37 38.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 125.248 1.419 . . . . 0.0 108.877 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 26.9 m-20 -75.37 83.71 2.48 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.36 -32.71 62.79 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.79 -48.42 8.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.921 1.688 . . . . 0.0 112.031 166.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -98.86 -30.86 12.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.842 2.057 . . . . 0.0 111.486 -165.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.8 t -55.68 127.64 30.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.586 1.084 . . . . 0.0 111.22 172.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.9 pt -104.63 33.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.594 1.558 . . . . 0.0 111.377 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 5.1 m-20 49.27 32.28 4.27 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.547 1.939 . . . . 0.0 113.491 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -76.43 -9.66 58.81 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -165.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 -23.52 6.3 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.788 -1.007 . . . . 0.0 114.23 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -53.69 -54.77 33.11 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.585 1.692 . . . . 0.0 111.338 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.43 -42.09 73.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.59 87.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.72 -0.613 . . . . 0.0 110.298 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -33.87 64.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 m -73.71 -38.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.813 1.188 . . . . 0.0 110.872 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.6 t -56.11 120.01 31.25 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.605 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -59.79 -29.83 90.55 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.692 2.261 . . . . 0.0 112.031 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.19 17.61 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.323 1.049 . . . . 0.0 111.675 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.03 49.93 5.27 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.818 1.199 . . . . 0.0 113.636 173.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.38 -30.28 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 125.523 1.529 . . . . 0.0 114.76 -174.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.7 90.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.73 2.286 . . . . 0.0 109.942 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 54' ' ' GLN . 28.1 t -165.99 151.05 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 128.788 2.835 . . . . 0.0 103.688 -165.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.558 ' H ' HG12 ' A' ' 53' ' ' VAL . 26.5 tt0 -92.66 157.52 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 128.961 3.913 . . . . 0.0 115.609 -130.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 . . . . . 0 C--O 1.249 1.047 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 150.666 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . 0.45 ' S1 ' ' HA ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -93.31 -160.97 0.8 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 164.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -129.94 -176.73 4.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 148.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 64.6 mt -84.06 107.74 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 152.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.55 170.34 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 122.05 0.928 . . . . 0.0 111.289 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.34 -25.61 1.05 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.015 2.126 . . . . 0.0 114.527 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -55.94 -19.12 10.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 42.3 t -56.93 156.85 6.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.241 1.416 . . . . 0.0 111.253 174.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.53 156.91 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 164.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -67.65 65.03 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.909 0.884 . . . . 0.0 111.832 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.261 0.1 OUTLIER -93.54 -162.2 0.92 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.609 1.563 . . . . 0.0 108.816 -177.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.62 42.45 0.71 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 120.932 1.696 . . . . 0.0 110.708 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.96 -37.46 12.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.436 0.695 . . . . 0.0 111.431 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.332 21.5 p -85.53 -100.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.55 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.68 -119.4 0.62 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 121.406 1.912 . . . . 0.0 112.058 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m -68.69 11.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -40.15 96.91 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.2 t -58.42 120.22 42.59 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.705 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -44.72 -36.98 11.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.774 2.983 . . . . 0.0 113.901 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -107.43 5.53 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 117.97 0.35 . . . . 0.0 111.54 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.11 48.36 12.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.436 1.095 . . . . 0.0 111.573 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.02 -11.96 61.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.085 0.954 . . . . 0.0 111.813 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -99.98 144.3 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.469 1.507 . . . . 0.0 110.484 -170.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -166.67 170.9 12.11 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.824 2.45 . . . . 0.0 108.765 162.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -66.74 130.73 44.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.37 -84.7 1.82 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -173.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.32 -52.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.59 1.156 . . . . 0.0 108.272 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -140.84 -57.58 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.267 2.227 . . . . 0.0 106.37 -171.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -99.91 -158.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.453 0.701 . . . . 0.0 109.828 178.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.18 149.68 21.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 111.814 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.57 137.28 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 126.678 1.991 . . . . 0.0 108.662 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -96.72 136.15 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 127.094 2.157 . . . . 0.0 109.733 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.252 29.1 m-20 -66.89 102.4 0.96 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 156.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.0 -33.53 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.743 -1.223 . . . . 0.0 112.352 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.79 -38.65 82.47 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.499 0.666 . . . . 0.0 110.609 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -79.23 -43.05 24.57 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.498 1.119 . . . . 0.0 110.1 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.2 t -55.88 115.97 2.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.526 0.603 . . . . 0.0 111.527 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.03 -0.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 t0 68.92 79.3 0.21 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 110.332 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.22 -31.43 4.39 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -164.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.78 -35.82 4.77 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.636 1.107 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -53.54 163.89 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.352 5.2 p 60.3 -55.29 0.08 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.535 1.534 . . . . 0.0 112.963 -153.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.5 94.4 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 120.022 1.283 . . . . 0.0 109.806 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.83 -28.34 69.49 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.739 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -88.26 -38.87 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.808 1.185 . . . . 0.0 111.176 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -53.6 118.48 14.96 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -166.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.1 -38.22 10.42 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 124.273 3.315 . . . . 0.0 114.159 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.36 18.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.272 1.029 . . . . 0.0 112.377 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.84 42.49 37.84 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.588 0.631 . . . . 0.0 113.792 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 -22.96 0.38 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.696 1.599 . . . . 0.0 115.183 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.78 84.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.55 2.167 . . . . 0.0 109.621 166.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -159.68 157.2 3.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 128.808 2.843 . . . . 0.0 104.765 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -91.62 155.85 18.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 127.681 3.113 . . . . 0.0 115.12 -133.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 144.749 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -76.84 -177.86 4.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 153.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -118.97 168.69 10.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 102.999 -2.963 . . . . 0.0 102.999 145.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 53.1 mt -80.43 105.34 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 148.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.54 163.83 26.53 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 119.366 -0.933 . . . . 0.0 111.01 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.27 -23.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.624 2.77 . . . . 0.0 114.85 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -25.77 4.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 168.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.8 t -57.62 158.64 5.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 111.764 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.54 160.84 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 164.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -66.12 63.64 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.99 1.316 . . . . 0.0 112.948 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.73 -32.65 8.32 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.531 1.133 . . . . 0.0 112.44 -165.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.49 15.34 57.05 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.014 1.292 . . . . 0.0 114.585 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.59 -33.14 68.77 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.383 1.092 . . . . 0.0 111.376 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.255 29.0 p -74.17 -90.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 44.05 -110.54 0.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 121.149 1.795 . . . . 0.0 112.236 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m -65.7 -5.96 10.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -38.21 64.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.977 0.808 . . . . 0.0 109.063 164.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 t -58.07 123.11 63.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.903 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -45.02 -38.45 13.66 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.752 2.968 . . . . 0.0 113.799 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -101.4 1.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.592 0.357 . . . . 0.0 111.344 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 54.22 33.47 18.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.791 1.236 . . . . 0.0 110.925 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.27 38.67 0.49 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.158 1.383 . . . . 0.0 112.053 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.16 150.48 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 124.292 1.037 . . . . 0.0 109.584 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.4 m -166.5 172.58 10.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.576 2.351 . . . . 0.0 108.136 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.32 127.76 33.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.82 -81.73 1.44 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.84 -53.68 3.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.415 1.086 . . . . 0.0 108.436 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 p -141.39 -54.58 0.47 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.192 2.197 . . . . 0.0 107.319 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.25 -173.91 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 122.919 0.488 . . . . 0.0 110.792 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.24 142.9 32.71 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.022 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.09 155.25 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 126.413 1.885 . . . . 0.0 108.662 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.48 140.78 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.57 1.548 . . . . 0.0 108.604 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.0 91.25 4.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.82 -36.77 72.72 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.921 -1.112 . . . . 0.0 113.864 -168.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.94 -35.86 67.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.122 0.969 . . . . 0.0 110.391 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.0 m -84.41 -47.63 10.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.864 1.666 . . . . 0.0 110.489 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.1 t -57.31 123.16 14.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.989 -0.444 . . . . 0.0 112.119 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.44 23.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.029 0.932 . . . . 0.0 112.498 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.32 39.52 28.39 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.013 1.725 . . . . 0.0 111.539 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.42 -10.07 59.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.03 -33.23 1.28 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.916 1.246 . . . . 0.0 115.056 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -48.93 -46.73 43.58 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -157.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.1 p -46.9 -31.67 3.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.991 1.317 . . . . 0.0 112.679 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -43.23 31.19 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.504 0.593 . . . . 0.0 112.368 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -49.92 -38.96 38.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.71 -24.94 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.44 119.24 71.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.531 -153.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -43.92 -40.16 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.043 3.162 . . . . 0.0 114.41 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.49 16.29 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 112.521 -173.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.52 53.62 19.92 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 118.711 0.687 . . . . 0.0 112.959 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.86 -23.01 0.24 Allowed Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.576 1.951 . . . . 0.0 115.065 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.33 90.15 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.128 1.885 . . . . 0.0 107.603 164.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 m -162.79 152.71 3.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -171.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -90.44 175.11 7.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.986 3.304 . . . . 0.0 112.076 -128.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 115.585 -2.15 . . . . 0.0 110.337 -157.843 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -113.61 -178.27 3.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 103.803 -2.665 . . . . 0.0 103.803 152.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -112.19 168.59 9.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 144.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 36.0 mt -80.58 109.46 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 152.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.38 165.73 24.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.468 1.128 . . . . 0.0 111.259 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.57 -20.98 15.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.571 1.548 . . . . 0.0 113.903 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -55.9 -21.41 20.16 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.584 -0.697 . . . . 0.0 112.829 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.0 t -46.58 -72.78 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.538 1.935 . . . . 0.0 115.107 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 68.05 155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.813 1.245 . . . . 0.0 111.864 -163.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m -66.7 57.39 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.889 1.276 . . . . 0.0 113.431 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -84.41 -38.38 20.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.472 1.033 . . . . 0.0 113.033 -168.074 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.71 -155.85 18.3 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.74 1.162 . . . . 0.0 113.207 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.79 -70.58 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.414 1.886 . . . . 0.0 113.725 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.22 -29.03 63.41 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -161.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.32 -49.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.081 0.953 . . . . 0.0 113.128 166.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.9 m -85.68 -15.74 41.33 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.117 0.567 . . . . 0.0 112.398 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -76.71 -37.11 56.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.471 1.109 . . . . 0.0 110.302 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.09 119.89 38.48 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.498 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.28 -34.44 31.63 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.155 2.57 . . . . 0.0 113.601 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.85 5.72 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.717 0.407 . . . . 0.0 111.238 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.92 31.15 10.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.019 1.327 . . . . 0.0 111.579 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 38.44 0.42 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mt -142.2 146.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.417 1.487 . . . . 0.0 107.342 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.08 163.83 13.49 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.454 1.902 . . . . 0.0 110.032 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -68.57 117.19 9.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.69 -76.8 1.21 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -164.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -110.57 -71.2 0.77 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -104.56 -61.01 1.51 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.362 1.065 . . . . 0.0 108.945 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.76 -160.52 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.064 0.946 . . . . 0.0 110.024 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.88 144.26 41.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.736 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.76 151.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.414 1.885 . . . . 0.0 106.094 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 mt -105.27 140.3 23.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.74 74.44 1.11 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 162.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -33.19 64.59 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -170.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -42.83 -46.48 5.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.805 2.042 . . . . 0.0 112.216 166.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -104.1 -27.29 12.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.116 2.566 . . . . 0.0 112.034 -163.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.6 t -45.2 119.08 1.91 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.622 1.101 . . . . 0.0 110.54 167.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 pt -80.28 34.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.368 -0.833 . . . . 0.0 112.01 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t0 29.38 63.35 0.14 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.152 2.581 . . . . 0.0 113.251 -174.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.28 0.5 OUTLIER -98.36 -141.76 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.291 1.036 . . . . 0.0 108.596 173.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 10.94 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 CA-C-N 121.843 2.11 . . . . 0.0 114.685 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.64 -47.61 76.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.048 1.924 . . . . 0.0 110.876 -172.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.1 p -57.33 -43.93 83.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.028 0.531 . . . . 0.0 110.692 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.35 94.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.465 -0.772 . . . . 0.0 109.505 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -51.71 68.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.71 0.804 . . . . 0.0 112.083 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.66 -39.22 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.527 1.058 . . . . 0.0 112.446 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.2 t -55.7 121.62 40.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -161.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.24 -31.93 82.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.735 2.29 . . . . 0.0 111.961 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.68 11.05 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.893 0.877 . . . . 0.0 111.851 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.69 63.95 3.19 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.18 0.895 . . . . 0.0 112.714 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.56 -28.07 0.19 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 126.382 1.873 . . . . 0.0 114.005 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 78.98 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.962 2.441 . . . . 0.0 108.437 164.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.8 m -158.65 153.65 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 128.562 2.745 . . . . 0.0 104.361 -168.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.16 174.18 7.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 128.555 3.66 . . . . 0.0 112.551 -113.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.254 1.308 0 CA-C-O 115.686 -2.102 . . . . 0.0 109.256 -164.307 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.291 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -68.08 -160.13 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.475 1.11 . . . . 0.0 108.299 150.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -122.0 178.31 4.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 146.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.76 107.55 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 151.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.64 168.0 20.85 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.371 1.081 . . . . 0.0 111.268 171.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.57 -9.28 5.62 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.305 1.842 . . . . 0.0 113.888 -173.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -23.58 61.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.863 -1.148 . . . . 0.0 111.861 166.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.3 t -63.17 158.83 18.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.006 0.923 . . . . 0.0 110.822 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -136.87 -175.44 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.9 p -73.28 64.08 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.75 175.2 5.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.853 1.661 . . . . 0.0 108.093 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.81 38.36 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 CA-C-N 120.143 1.338 . . . . 0.0 110.868 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -15.18 30.68 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.52 0.728 . . . . 0.0 112.29 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.305 29.9 p -101.41 -95.22 0.28 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 118.589 -0.72 . . . . 0.0 111.219 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 39.7 -99.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 113.689 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -49.49 -29.62 6.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.507 1.523 . . . . 0.0 112.864 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -52.02 -33.39 38.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.316 1.046 . . . . 0.0 112.877 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -64.26 119.89 60.01 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.483 -0.76 . . . . 0.0 109.781 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.04 -32.29 23.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.236 2.624 . . . . 0.0 113.147 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.7 19.85 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 122.706 0.403 . . . . 0.0 110.947 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.45 22.8 0.77 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.339 1.855 . . . . 0.0 114.231 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.5 44.19 1.02 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.878 1.271 . . . . 0.0 111.322 -166.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.05 147.34 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.818 1.247 . . . . 0.0 107.934 -174.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -170.7 169.31 7.12 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.171 2.188 . . . . 0.0 109.49 167.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -67.5 125.66 26.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.69 -84.22 1.68 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -168.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -102.3 -48.04 4.31 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.942 1.297 . . . . 0.0 108.463 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 p -140.21 -59.71 0.53 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.615 1.966 . . . . 0.0 106.854 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -155.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.12 0.968 . . . . 0.0 109.642 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -82.38 157.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.98 0.419 . . . . 0.0 110.672 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.23 160.91 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.099 1.759 . . . . 0.0 106.887 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -119.48 146.74 23.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 125.259 1.424 . . . . 0.0 108.486 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.14 76.29 1.26 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 165.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.68 -35.34 60.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -167.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.4 -37.79 73.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.175 1.39 . . . . 0.0 110.384 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 m -79.9 -49.49 11.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.513 1.525 . . . . 0.0 110.815 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.3 t -61.33 111.8 1.91 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.697 1.237 . . . . 0.0 113.434 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.0 pt -83.45 142.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 156.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 60.68 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.54 2.336 . . . . 0.0 112.412 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -27.79 48.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.789 0.836 . . . . 0.0 112.806 -166.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.8 -34.03 5.32 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.38 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -54.61 -55.77 25.97 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.674 1.737 . . . . 0.0 112.051 -162.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 p -52.56 -43.04 64.97 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.719 0.295 . . . . 0.0 111.226 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.43 77.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.522 -0.736 . . . . 0.0 110.719 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -70.49 -47.32 61.1 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.407 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -68.82 -38.41 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.62 0.646 . . . . 0.0 112.167 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -55.94 120.06 30.83 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.318 -0.373 . . . . 0.0 111.958 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -59.59 -26.6 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.905 2.404 . . . . 0.0 112.37 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.04 24.49 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.705 0.802 . . . . 0.0 111.682 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.79 62.72 2.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.113 0.864 . . . . 0.0 113.07 172.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.69 -28.03 0.24 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 126.027 1.731 . . . . 0.0 113.998 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.6 80.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.634 2.223 . . . . 0.0 108.009 164.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -157.67 149.01 9.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -92.7 153.88 18.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 128.974 3.921 . . . . 0.0 115.714 -133.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 144.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 CA--C 1.508 -0.673 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -128.32 161.84 28.46 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 27.6 mm -79.78 100.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 153.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.28 174.0 10.71 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.2 -0.938 . . . . 0.0 111.474 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.31 -16.47 2.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.835 2.054 . . . . 0.0 114.787 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -51.25 -33.01 26.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.433 -0.792 . . . . 0.0 111.761 166.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 47.3 t -55.71 130.26 42.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.251 1.82 . . . . 0.0 112.086 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.2 150.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -67.56 70.53 0.12 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.334 0.97 . . . . 0.0 111.993 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.22 -22.74 20.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.713 1.205 . . . . 0.0 111.42 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.95 -30.68 5.7 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 113.698 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.1 56.48 2.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.359 1.079 . . . . 0.0 113.309 -164.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 23.0 p -155.59 -31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.306 1.042 . . . . 0.0 112.282 171.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -36.02 -60.4 0.55 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -75.92 -15.2 60.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.296 1.039 . . . . 0.0 112.494 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 23.7 mm-40 -81.42 -34.17 31.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.967 1.307 . . . . 0.0 109.339 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.23 122.35 58.43 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.587 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -33.47 73.84 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.711 2.274 . . . . 0.0 112.493 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.06 7.42 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 122.818 0.447 . . . . 0.0 110.8 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 49.09 35.22 6.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.117 1.367 . . . . 0.0 111.866 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 36.41 0.42 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.052 1.341 . . . . 0.0 111.075 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mt -142.27 147.64 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.311 1.044 . . . . 0.0 109.489 -170.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -169.79 174.24 5.8 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 127.331 2.252 . . . . 0.0 108.522 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -85.42 128.66 34.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.481 1.037 . . . . 0.0 108.368 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.98 -67.86 0.14 Allowed Glycine 0 C--N 1.339 0.721 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.434 -161.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -98.96 -52.52 3.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -166.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.8 m -141.78 -50.51 0.4 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 109.181 156.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -161.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.225 1.01 . . . . 0.0 109.62 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.289 17.1 m-85 -68.69 161.94 27.15 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 117.714 -1.594 . . . . 0.0 110.906 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.87 162.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 126.783 2.033 . . . . 0.0 107.437 -170.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -128.92 138.6 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.651 1.18 . . . . 0.0 108.695 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -73.58 76.12 1.49 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 165.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -32.99 64.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -168.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.9 -48.08 8.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.443 1.897 . . . . 0.0 112.171 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.82 -29.95 12.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.655 2.382 . . . . 0.0 111.247 -165.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.8 t -52.85 134.65 37.0 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.288 0.949 . . . . 0.0 110.141 165.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 pt -107.89 137.92 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 159.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.96 74.11 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.56 -20.03 18.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.853 0.861 . . . . 0.0 113.041 -169.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.28 4.1 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.525 -0.734 . . . . 0.0 112.511 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -54.63 165.45 0.59 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 163.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.372 6.9 p 60.61 -57.56 0.08 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.373 1.469 . . . . 0.0 112.386 -152.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.44 96.61 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.234 1.379 . . . . 0.0 109.571 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -37.29 78.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.082 0.953 . . . . 0.0 111.914 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.94 -40.59 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.894 0.77 . . . . 0.0 111.007 -169.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.8 t -54.67 118.84 18.16 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.269 -170.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.1 -36.18 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.975 3.116 . . . . 0.0 114.216 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.42 14.27 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.68 50.67 36.07 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.746 0.703 . . . . 0.0 112.791 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 52' ' ' PRO . . . -80.02 -23.75 0.39 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 114.916 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 51' ' ' ALA . 55.5 Cg_exo -60.14 82.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.747 2.298 . . . . 0.0 110.764 168.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 m -159.85 153.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 128.901 2.88 . . . . 0.0 104.068 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -90.0 149.74 22.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.674 1.859 . . . . 0.0 114.299 -138.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 116.689 -1.625 . . . . 0.0 107.434 146.662 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -142.43 -168.93 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 156.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.478 HG12 ' CG1' ' A' ' 32' ' ' ILE . 4.2 mm -79.45 105.55 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 156.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.86 165.19 25.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.961 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.48 -15.87 3.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -53.18 -25.66 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.327 -0.858 . . . . 0.0 113.27 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -59.31 162.15 4.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.267 1.427 . . . . 0.0 111.669 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.65 173.2 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 m -70.6 64.03 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.299 -0.875 . . . . 0.0 111.011 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -179.78 4.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.04 2.136 . . . . 0.0 106.695 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.39 37.6 0.84 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 120.446 1.476 . . . . 0.0 111.315 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 -31.0 43.74 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.861 0.464 . . . . 0.0 111.537 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.286 29.9 p -80.43 -97.4 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.595 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.57 -99.01 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 121.157 1.799 . . . . 0.0 113.611 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 m -48.4 -31.73 6.61 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.926 1.691 . . . . 0.0 112.461 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -53.25 -28.23 26.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.407 1.083 . . . . 0.0 112.898 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.55 120.65 81.11 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 119.11 0.868 . . . . 0.0 110.739 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.45 -34.79 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.64 6.98 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 117.937 0.335 . . . . 0.0 111.022 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 22.69 4.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.289 1.835 . . . . 0.0 111.816 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.3 50.18 1.89 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.2 -0.938 . . . . 0.0 110.538 -164.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mt -136.72 147.71 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.608 1.563 . . . . 0.0 107.985 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -169.08 168.36 10.06 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.31 2.244 . . . . 0.0 109.327 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -71.74 117.12 12.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.06 -66.67 1.12 Allowed Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -114.8 -72.14 0.71 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -108.65 -61.09 1.65 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.611 1.165 . . . . 0.0 108.326 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.9 -166.55 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.182 0.593 . . . . 0.0 110.35 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.88 155.7 40.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 110.66 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.77 156.42 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 126.976 2.11 . . . . 0.0 106.381 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.478 ' CG1' HG12 ' A' ' 4' ' ' ILE . 3.2 mt -126.12 146.34 32.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.42 84.19 0.58 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 164.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.74 -29.66 62.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.439 -0.788 . . . . 0.0 112.689 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -41.66 -47.6 3.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.54 1.936 . . . . 0.0 112.071 164.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -102.84 -34.13 9.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.095 2.158 . . . . 0.0 111.981 -164.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.6 t -52.45 129.2 28.06 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.677 1.126 . . . . 0.0 111.966 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 pt -107.64 34.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.256 1.423 . . . . 0.0 111.78 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.27 35.9 14.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.96 1.704 . . . . 0.0 112.758 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.47 -16.35 57.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.31 -27.97 7.95 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.454 1.026 . . . . 0.0 114.816 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -54.64 -50.81 67.25 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.947 1.874 . . . . 0.0 113.205 -165.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.5 p -55.01 -44.93 75.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.915 -0.49 . . . . 0.0 110.675 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.97 82.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.752 -0.592 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -39.59 75.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.7 -0.667 . . . . 0.0 111.559 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.56 -40.41 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.128 0.876 . . . . 0.0 111.869 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -53.94 121.65 30.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -164.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.93 -26.97 83.23 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.746 2.298 . . . . 0.0 112.736 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.95 19.05 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.553 0.741 . . . . 0.0 112.099 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.55 54.19 9.12 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.476 0.56 . . . . 0.0 113.122 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.65 -27.48 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.581 . . . . 0.0 114.58 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.67 82.48 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.274 1.983 . . . . 0.0 108.67 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -162.23 155.76 2.74 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -168.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -90.16 148.12 23.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 127.205 2.816 . . . . 0.0 112.671 -148.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 163.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.457 ' H ' ' HA ' ' A' ' 54' ' ' GLN . 2.5 ptpp? -122.41 -179.22 4.12 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 146.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 71.2 mt -85.33 104.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 155.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.7 176.41 8.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.088 0.946 . . . . 0.0 112.895 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.75 -31.59 2.09 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.66 1.984 . . . . 0.0 114.985 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -54.75 -16.37 2.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' VAL . 53.9 t -55.55 -33.75 64.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.923 2.089 . . . . 0.0 115.607 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 8' ' ' CYS 0.288 1.8 m 71.35 -53.32 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 119.473 -2.017 . . . . 0.0 113.988 -173.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p 129.08 29.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 131.399 3.88 . . . . 0.0 111.307 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -19.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -162.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' CZ ' ' A' ' 30' ' ' PHE . . . 88.41 -53.0 4.08 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.109 -0.994 . . . . 0.0 114.24 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -33.11 -63.32 0.23 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.34 1.456 . . . . 0.0 114.633 -160.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 23.0 p -56.36 -21.46 24.8 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.39 -47.04 3.5 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.754 0.821 . . . . 0.0 112.657 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.5 m -82.72 -24.26 33.68 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 75.8 mm-40 -74.0 -34.65 64.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.756 1.223 . . . . 0.0 111.075 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.88 123.28 51.93 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.428 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.56 -37.4 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.294 3.329 . . . . 0.0 113.694 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.31 20.48 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.1 0.56 . . . . 0.0 112.163 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 44.72 49.37 8.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 0.0 112.432 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.18 31.61 1.66 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.389 1.076 . . . . 0.0 111.157 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.48 146.25 30.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.763 0.825 . . . . 0.0 109.107 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.47 169.24 10.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.135 2.174 . . . . 0.0 109.897 172.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -75.22 125.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.72 -73.88 1.06 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.99 -70.04 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -115.08 -62.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.71 2.004 . . . . 0.0 107.232 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -167.24 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.529 1.132 . . . . 0.0 111.075 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 20.9 m-85 -73.32 151.8 41.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.427 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 159.75 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 127.677 2.391 . . . . 0.0 106.008 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.64 131.45 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.41 79.55 0.76 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.27 66.58 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -163.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.89 -34.34 77.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.795 1.238 . . . . 0.0 110.694 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -84.81 -40.83 16.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 110.433 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 t -61.27 149.67 37.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.128 0.876 . . . . 0.0 108.743 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 pt -90.84 -112.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 167.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.89 129.1 11.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 155.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -161.03 161.8 31.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.052 0.842 . . . . 0.0 109.848 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.25 -26.93 56.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.489 -0.757 . . . . 0.0 112.392 -173.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -47.8 -60.68 2.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.272 1.029 . . . . 0.0 113.207 -159.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.5 p -60.71 -41.55 95.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.651 0.659 . . . . 0.0 110.465 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.38 81.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.505 -0.747 . . . . 0.0 110.307 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -46.02 72.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.403 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.86 -37.35 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.405 1.002 . . . . 0.0 111.408 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -53.77 118.57 15.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.649 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.44 -38.17 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.65 3.567 . . . . 0.0 114.813 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.06 24.34 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 112.15 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.59 62.09 5.09 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.385 0.539 . . . . 0.0 112.962 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.17 -23.74 0.21 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 126.722 2.009 . . . . 0.0 114.699 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -60.95 90.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.82 2.347 . . . . 0.0 108.038 162.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 m -159.19 144.54 6.69 Favored 'Isoleucine or valine' 0 C--O 1.252 1.209 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HA ' ' H ' ' A' ' 3' ' ' LYS . 35.3 tt0 -91.1 131.5 36.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 128.359 3.537 . . . . 0.0 114.23 -144.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 157.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -142.32 -163.36 1.59 Allowed 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 115.845 -2.342 . . . . 0.0 105.465 135.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.09 108.97 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 156.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.25 163.25 27.22 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.274 -0.891 . . . . 0.0 110.848 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.07 -12.31 4.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -52.43 -29.18 23.15 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.336 -0.852 . . . . 0.0 112.228 166.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 49.8 t -58.87 156.27 11.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.997 1.319 . . . . 0.0 111.653 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.59 167.67 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 164.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -65.39 64.48 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.012 1.325 . . . . 0.0 111.997 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -34.05 7.2 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.585 1.154 . . . . 0.0 112.716 -165.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.92 21.68 56.14 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.879 1.228 . . . . 0.0 114.742 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.79 -28.43 58.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.162 0.981 . . . . 0.0 111.46 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 p -79.31 -108.62 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 53.76 -101.65 0.12 Allowed 'General case' 0 C--N 1.34 0.174 0 CA-C-N 121.49 1.95 . . . . 0.0 111.799 170.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m -41.32 -36.29 0.78 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.409 1.884 . . . . 0.0 112.832 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -41.79 62.33 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 111.569 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.54 125.0 81.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.262 -166.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.53 -35.03 11.87 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.59 2.86 . . . . 0.0 114.096 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.4 m -107.08 5.19 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 48.69 37.43 9.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.032 1.333 . . . . 0.0 111.64 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.83 32.46 0.42 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.697 1.199 . . . . 0.0 111.958 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -132.1 151.14 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.885 1.274 . . . . 0.0 108.786 -172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 p -164.67 174.15 11.11 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.395 1.478 . . . . 0.0 109.195 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -77.38 125.24 29.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.77 -83.44 1.7 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -167.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -99.87 -50.33 4.05 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.25 1.02 . . . . 0.0 108.446 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 p -140.73 -57.7 0.52 Allowed 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.031 2.133 . . . . 0.0 106.609 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -104.45 -162.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.21 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -79.8 156.29 27.49 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.267 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -147.99 158.36 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.767 2.027 . . . . 0.0 108.28 -171.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.84 149.75 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 125.699 1.6 . . . . 0.0 108.957 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -82.77 114.17 20.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 157.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.621 1.1 . . . . 0.0 112.004 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 -38.92 85.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.7 1.2 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 m -79.85 -40.06 29.27 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.742 1.217 . . . . 0.0 109.745 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.9 112.04 1.9 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.582 0.628 . . . . 0.0 110.941 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.5 pt -79.76 47.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 121.244 -0.91 . . . . 0.0 111.316 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 14.73 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.609 2.763 . . . . 0.0 114.402 -173.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -5.27 40.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.99 -37.38 1.49 Allowed Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.035 -1.041 . . . . 0.0 114.23 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -46.17 -52.46 12.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -154.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -47.35 -37.7 11.62 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.147 1.779 . . . . 0.0 111.596 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -34.73 61.3 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.52 -0.738 . . . . 0.0 112.29 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -67.69 -44.89 76.69 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.87 0.304 . . . . 0.0 111.004 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.66 -30.37 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.868 -171.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -56.74 118.73 24.74 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.278 -170.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.88 -37.3 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.421 3.414 . . . . 0.0 114.253 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.73 22.65 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.995 0.918 . . . . 0.0 112.246 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.91 64.42 3.27 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.601 0.637 . . . . 0.0 113.039 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.39 -23.4 0.19 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -64.29 83.15 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.374 2.05 . . . . 0.0 108.28 163.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -162.27 151.72 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 -165.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.83 151.05 21.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 127.307 2.879 . . . . 0.0 113.614 -143.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 152.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 . . . . . 0 CA--C 1.517 -0.311 0 N-CA-C 105.429 -2.064 . . . . 0.0 105.429 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' C ' HD12 ' A' ' 32' ' ' ILE . 13.1 ptpt -118.17 -179.33 3.74 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 143.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.449 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 48.8 mt -79.1 109.44 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 147.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.93 173.37 11.29 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 122.143 0.973 . . . . 0.0 111.286 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -47.96 -31.09 4.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.035 1.334 . . . . 0.0 113.299 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -65.11 13.19 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.613 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.7 t -74.17 -73.12 0.24 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.627 2.371 . . . . 0.0 112.793 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 8' ' ' CYS 0.274 1.3 m 75.77 137.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 127.197 2.199 . . . . 0.0 110.373 -159.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.25 57.03 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.941 2.096 . . . . 0.0 114.48 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -17.94 25.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.214 0.915 . . . . 0.0 112.903 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 30' ' ' PHE . . . 88.92 -57.96 4.02 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 120.92 -1.112 . . . . 0.0 114.005 167.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -30.38 -57.76 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.283 1.833 . . . . 0.0 114.756 -164.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -63.28 -20.92 65.9 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -169.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.91 -58.3 2.1 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.413 1.006 . . . . 0.0 112.444 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -29.17 67.22 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.287 1.035 . . . . 0.0 112.537 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 111.632 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.31 123.66 83.25 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.519 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -42.4 -37.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.024 3.149 . . . . 0.0 113.938 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.14 14.45 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.24 44.11 6.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.525 1.13 . . . . 0.0 111.759 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.08 36.34 0.62 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.038 0.935 . . . . 0.0 110.598 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mt -137.54 149.31 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 125.212 1.405 . . . . 0.0 107.698 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.9 t -164.23 176.73 8.92 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 124.77 1.228 . . . . 0.0 109.93 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.65 102.74 2.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.3 -65.64 1.77 Allowed Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -119.14 -77.2 0.57 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -108.61 -48.72 3.27 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.412 1.485 . . . . 0.0 110.193 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.82 -169.16 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 122.711 0.405 . . . . 0.0 109.98 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 20.1 m-85 -82.66 148.79 27.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.526 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.61 160.46 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 126.932 2.093 . . . . 0.0 107.734 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 3' ' ' LYS . 71.2 mt -108.73 140.19 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.837 1.255 . . . . 0.0 107.801 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -72.71 76.45 1.11 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.65 67.03 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -44.93 -47.69 11.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.297 1.839 . . . . 0.0 112.343 166.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -96.99 -31.99 12.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.606 2.362 . . . . 0.0 110.847 -165.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.8 t -57.01 136.78 56.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.403 1.001 . . . . 0.0 108.606 160.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.13 -102.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -158.63 135.79 9.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 155.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.06 177.94 8.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 109.663 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.86 -42.26 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.95 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.53 -60.13 3.76 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 117.633 0.716 . . . . 0.0 112.602 -147.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -53.07 -45.15 67.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.024 0.374 . . . . 0.0 111.124 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.08 90.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.886 -0.509 . . . . 0.0 110.343 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.26 -43.84 69.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.485 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.45 -40.27 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 119.351 0.978 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -53.43 118.24 14.01 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.784 -0.627 . . . . 0.0 112.328 -163.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.83 -37.84 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.317 3.344 . . . . 0.0 114.456 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.4 m -118.73 16.17 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.94 50.22 39.22 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.713 0.688 . . . . 0.0 113.036 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.6 -19.73 0.26 Allowed Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.841 1.656 . . . . 0.0 115.061 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -58.36 86.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.036 2.491 . . . . 0.0 110.022 164.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 m -161.53 152.48 4.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -84.12 151.35 24.97 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 127.41 2.944 . . . . 0.0 114.008 -139.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 135.306 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.1 174.96 5.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 144.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 mm -79.02 107.63 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 146.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.34 165.05 25.4 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 122.09 0.948 . . . . 0.0 111.445 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.57 -15.23 10.47 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.918 1.687 . . . . 0.0 113.596 -173.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 m -56.32 -23.49 37.38 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.399 -0.813 . . . . 0.0 112.515 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -54.25 154.16 4.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.096 1.358 . . . . 0.0 110.303 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.98 164.73 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 170.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.4 m -71.74 60.66 0.36 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.949 0.795 . . . . 0.0 111.649 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 -31.22 14.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.999 1.32 . . . . 0.0 111.818 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.25 -28.86 1.68 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.979 172.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -43.43 -48.78 7.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.72 1.208 . . . . 0.0 113.518 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -64.43 -12.57 44.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.78 -65.38 0.51 Allowed 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.106 -0.997 . . . . 0.0 112.89 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 m -69.27 -29.84 67.82 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -59.06 -39.89 83.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.215 1.006 . . . . 0.0 111.737 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.28 120.09 64.73 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.895 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.89 -37.0 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.562 2.841 . . . . 0.0 113.946 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.36 0.86 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.166 0.439 . . . . 0.0 112.011 -174.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.38 57.42 5.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.776 0.83 . . . . 0.0 111.037 -174.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.65 61.75 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.671 -0.643 . . . . 0.0 111.454 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.19 149.86 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.439 1.896 . . . . 0.0 112.132 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 m -161.32 164.13 30.33 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.243 2.617 . . . . 0.0 108.488 154.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -75.15 119.23 19.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.87 -66.91 1.35 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -166.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -116.56 -71.96 0.71 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -113.5 -55.97 2.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.146 1.378 . . . . 0.0 108.745 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -100.94 -167.52 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.086 0.555 . . . . 0.0 110.649 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -84.68 146.96 27.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.412 0.625 . . . . 0.0 111.433 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.1 159.03 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 127.171 2.188 . . . . 0.0 106.153 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.42 149.65 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 C-N-CA 125.296 1.438 . . . . 0.0 109.431 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -65.76 91.96 0.14 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 155.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.79 -29.04 67.95 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.676 -1.265 . . . . 0.0 112.404 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.09 -36.63 84.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.311 0.644 . . . . 0.0 111.368 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -79.77 -43.52 22.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.502 1.121 . . . . 0.0 109.379 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.7 t -54.63 132.31 45.07 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -78.33 -102.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.87 120.38 2.66 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 159.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.39 171.81 19.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.182 0.901 . . . . 0.0 110.796 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.09 -40.51 8.59 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.544 -0.587 . . . . 0.0 113.122 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.61 -56.92 14.77 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.851 0.826 . . . . 0.0 112.995 -147.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 p -55.86 -44.64 78.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.02 -0.425 . . . . 0.0 110.926 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.07 94.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.793 -0.567 . . . . 0.0 110.108 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -62.76 -49.31 75.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.145 0.578 . . . . 0.0 111.413 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -68.25 -40.68 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 118.832 0.742 . . . . 0.0 111.833 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.36 117.95 19.26 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -162.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.92 -26.42 82.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.729 2.286 . . . . 0.0 112.38 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -116.09 21.74 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.967 0.907 . . . . 0.0 111.408 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.05 50.89 7.47 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.521 1.058 . . . . 0.0 113.346 171.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.8 -26.92 0.36 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.265 1.426 . . . . 0.0 114.828 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -63.65 84.56 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.579 2.186 . . . . 0.0 109.443 168.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.1 m -165.77 157.81 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.78 155.33 18.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 127.624 3.077 . . . . 0.0 114.04 -124.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 . . . . . 0 C--O 1.257 1.465 0 C-N-CA 127.82 2.448 . . . . 0.0 106.44 157.486 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 . . . . . 0 C--O 1.232 0.156 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -128.01 179.43 5.58 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 140.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 50.0 mt -79.7 107.69 12.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 156.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.83 15.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.145 0.974 . . . . 0.0 111.673 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -49.15 -23.4 1.26 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.604 2.362 . . . . 0.0 114.82 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -54.08 -24.38 17.24 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.556 -0.715 . . . . 0.0 112.521 171.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 47.7 t -57.72 121.63 10.88 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.291 1.437 . . . . 0.0 110.864 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.94 21.97 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.491 -0.756 . . . . 0.0 111.581 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 m 56.69 36.23 27.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.139 0.976 . . . . 0.0 110.552 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -75.33 152.59 38.14 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 111.21 -169.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.9 57.96 4.93 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.892 -1.13 . . . . 0.0 110.858 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . . . -143.72 -161.33 1.25 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.206 1.003 . . . . 0.0 108.889 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 17' ' ' GLU 0.57 3.7 p 39.25 -120.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.065 -160.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 49.69 -105.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 122.627 2.467 . . . . 0.0 110.904 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 m -58.06 -17.59 18.85 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 23.5 mt-10 -61.12 -29.3 69.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.383 0.992 . . . . 0.0 111.005 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.39 129.25 90.84 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.343 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.97 -34.34 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.135 3.224 . . . . 0.0 114.456 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 p -126.72 26.63 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.797 0.726 . . . . 0.0 112.686 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.31 38.44 21.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.88 0.872 . . . . 0.0 111.9 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.95 32.07 0.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.78 1.232 . . . . 0.0 111.811 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.21 152.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.278 1.431 . . . . 0.0 107.434 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -165.25 173.96 10.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.997 2.119 . . . . 0.0 108.925 164.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 123.68 19.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.75 -105.74 2.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -98.78 -49.05 4.71 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.581 1.152 . . . . 0.0 109.141 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -128.21 -53.05 1.29 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.334 1.854 . . . . 0.0 107.691 -172.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -165.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.05 148.15 31.19 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.417 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 154.24 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 C-N-CA 126.072 1.749 . . . . 0.0 107.817 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.2 mt -104.53 136.65 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 107.674 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -74.6 77.16 2.0 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.58 62.25 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -41.24 -48.36 3.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 165.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -99.63 -37.51 9.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.834 2.454 . . . . 0.0 111.236 -165.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.1 t -53.98 126.9 24.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.805 0.729 . . . . 0.0 111.114 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 pt -91.94 8.88 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.817 0.847 . . . . 0.0 112.754 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 54.64 75.32 0.3 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.903 2.481 . . . . 0.0 111.936 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.51 -13.9 13.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 114.04 -174.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.71 -17.76 10.36 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.335 0.969 . . . . 0.0 115.456 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -55.69 -47.85 76.08 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.719 1.759 . . . . 0.0 112.98 -171.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -58.08 -41.3 83.16 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.533 -0.729 . . . . 0.0 109.481 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.04 -43.38 81.91 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.555 -0.715 . . . . 0.0 110.186 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -62.9 -48.11 80.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.823 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 m -68.88 -39.6 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.88 0.763 . . . . 0.0 111.941 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.1 t -55.51 122.09 42.46 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.946 -167.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.18 -39.0 2.36 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.759 3.64 . . . . 0.0 115.137 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.97 28.22 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.248 0.619 . . . . 0.0 112.055 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.21 40.85 45.67 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 118.132 0.424 . . . . 0.0 113.653 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.26 1.44 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -58.93 78.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.324 2.683 . . . . 0.0 111.773 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 m -160.63 173.34 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 130.262 3.425 . . . . 0.0 105.173 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.72 158.24 20.82 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 124.045 0.84 . . . . 0.0 112.904 -96.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 128.133 2.573 . . . . 0.0 110.182 -179.809 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.232 0.146 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -120.44 -179.42 3.96 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 141.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 55.5 mt -83.52 111.13 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 152.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.25 25.06 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 122.191 0.996 . . . . 0.0 112.068 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.97 -28.25 2.65 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.733 2.013 . . . . 0.0 114.11 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.42 -24.94 2.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' VAL . 41.7 t -45.08 -73.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.268 2.227 . . . . 0.0 114.791 -174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER 66.5 143.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.473 1.109 . . . . 0.0 110.267 -156.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.73 56.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.125 1.77 . . . . 0.0 113.142 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 158.64 25.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.135 1.374 . . . . 0.0 108.713 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.16 28.9 13.27 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.057 -1.027 . . . . 0.0 112.969 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.65 -57.2 2.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.397 1.098 . . . . 0.0 112.998 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.334 28.5 p -73.1 -90.81 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.329 0.968 . . . . 0.0 112.711 -171.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 31.94 -98.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.815 1.643 . . . . 0.0 113.994 -169.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -46.79 -31.92 3.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.938 2.095 . . . . 0.0 113.497 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -50.32 -32.41 17.07 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.683 1.193 . . . . 0.0 112.895 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.41 122.36 77.8 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.443 -0.786 . . . . 0.0 110.499 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -50.94 -35.07 48.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.011 2.474 . . . . 0.0 113.502 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.67 5.53 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 118.304 0.502 . . . . 0.0 111.033 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.06 40.94 26.8 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.007 1.723 . . . . 0.0 110.845 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.31 45.23 1.21 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.755 0.822 . . . . 0.0 110.011 -168.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.86 150.42 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.498 1.919 . . . . 0.0 106.434 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -171.48 174.56 4.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.139 2.176 . . . . 0.0 108.477 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.06 123.82 17.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 167.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.29 -98.47 2.41 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -99.27 -46.06 5.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.44 1.496 . . . . 0.0 108.822 -166.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 p -134.61 -56.51 0.84 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.183 1.793 . . . . 0.0 107.28 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 -162.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.339 1.056 . . . . 0.0 110.53 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -78.22 139.8 38.92 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.8 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.46 156.62 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 126.278 1.831 . . . . 0.0 107.616 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.11 142.94 24.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -73.81 78.42 1.59 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.62 56.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 113.022 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -42.1 -49.71 4.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.986 2.114 . . . . 0.0 112.219 165.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.56 -31.26 12.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.578 2.351 . . . . 0.0 111.36 -165.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.0 t -49.95 116.86 2.0 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.211 0.914 . . . . 0.0 110.271 169.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.84 -17.84 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 122.735 0.414 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t0 76.62 118.81 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 127.916 2.486 . . . . 0.0 108.499 -168.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.85 -47.96 0.09 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -168.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.98 -29.59 4.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.526 -1.152 . . . . 0.0 113.274 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -53.33 -51.13 63.39 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.539 1.67 . . . . 0.0 112.593 -164.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.29 -46.91 72.86 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.44 -0.162 . . . . 0.0 110.761 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.92 91.46 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.669 -0.644 . . . . 0.0 110.156 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -51.31 69.53 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.619 0.767 . . . . 0.0 111.806 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -70.13 -39.18 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 119.366 0.985 . . . . 0.0 111.797 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.0 t -55.02 116.65 11.87 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -162.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.09 -38.95 19.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.938 3.092 . . . . 0.0 113.835 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.47 9.26 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.716 1.206 . . . . 0.0 112.147 -173.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.79 50.85 25.25 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.792 0.723 . . . . 0.0 112.94 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.78 -25.35 0.29 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 126.281 1.832 . . . . 0.0 114.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.26 81.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.061 2.507 . . . . 0.0 109.21 167.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -161.08 156.69 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 129.221 3.008 . . . . 0.0 104.006 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.5 174.4 7.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 127.445 2.966 . . . . 0.0 114.069 -121.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.82 158.083 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -108.51 170.18 8.18 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 152.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 55.8 mt -79.91 106.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 150.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.09 174.94 10.1 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 122.689 1.233 . . . . 0.0 111.667 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.36 -13.69 9.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 128.563 2.745 . . . . 0.0 113.541 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.29 64.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 111.468 170.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 48.5 t -57.51 153.17 13.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.3 1.44 . . . . 0.0 112.272 -177.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.19 156.68 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 162.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m -61.25 66.59 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.815 1.646 . . . . 0.0 113.348 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 -30.33 9.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.342 1.057 . . . . 0.0 112.833 -168.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.68 60.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.191 1.377 . . . . 0.0 115.772 170.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.88 -61.84 1.83 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.552 1.676 . . . . 0.0 110.789 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.38 -34.09 32.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.275 1.03 . . . . 0.0 111.881 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.97 -45.67 7.89 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -88.02 -6.75 57.81 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -41.27 13.76 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.119 1.768 . . . . 0.0 108.021 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.4 t -49.64 116.99 6.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.333 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.94 -33.28 14.19 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.767 2.978 . . . . 0.0 113.876 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.7 m -111.56 11.53 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.264 0.484 . . . . 0.0 112.065 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 47.89 34.11 3.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.2 40.29 0.62 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.881 1.272 . . . . 0.0 111.199 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mt -133.2 146.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.109 1.364 . . . . 0.0 108.823 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -166.54 167.02 15.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.327 1.851 . . . . 0.0 109.649 167.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.34 119.18 18.18 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.24 -78.44 1.28 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -169.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -99.87 -54.91 2.78 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.941 0.896 . . . . 0.0 108.91 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -140.88 -56.24 0.5 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.867 2.067 . . . . 0.0 107.377 -167.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -102.64 -174.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.059 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -74.25 148.38 41.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.152 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.97 152.55 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 126.346 1.858 . . . . 0.0 106.988 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.27 138.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.516 1.527 . . . . 0.0 107.788 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -74.07 76.2 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.55 60.05 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -167.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -43.97 -47.51 8.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.141 1.776 . . . . 0.0 112.243 167.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -100.27 -30.53 11.84 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.923 2.489 . . . . 0.0 111.393 -165.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -52.29 128.54 25.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.308 0.958 . . . . 0.0 109.793 167.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.0 pt -90.1 130.18 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 161.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 74.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.103 1.361 . . . . 0.0 112.236 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -15.17 16.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.507 1.523 . . . . 0.0 111.341 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.76 -23.63 0.82 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.233 1.873 . . . . 0.0 115.188 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.15 -39.16 71.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.4 p -47.44 -32.68 5.31 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.498 1.119 . . . . 0.0 112.578 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -44.47 32.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.379 0.536 . . . . 0.0 112.403 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -51.76 -39.47 58.61 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -167.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.71 -26.05 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 117.879 0.309 . . . . 0.0 111.749 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.86 119.11 69.27 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.949 -153.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.34 -37.98 7.81 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.175 3.25 . . . . 0.0 114.377 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.67 33.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.729 0.812 . . . . 0.0 111.633 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.48 49.29 11.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.31 0.957 . . . . 0.0 114.078 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.24 -28.34 0.39 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.814 1.645 . . . . 0.0 114.429 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.96 87.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.648 2.232 . . . . 0.0 109.712 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -165.95 158.82 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.909 0 C-N-CA 128.661 2.784 . . . . 0.0 104.296 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -90.67 166.03 13.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 127.266 2.854 . . . . 0.0 112.95 -118.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 C--O 1.249 1.055 0 C-N-CA 124.896 1.279 . . . . 0.0 110.994 -162.039 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -131.18 -174.49 3.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 145.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 29.1 mm -79.14 110.07 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 153.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.48 162.45 27.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 122.166 0.984 . . . . 0.0 111.188 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -53.0 -21.36 4.35 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.7 2.0 . . . . 0.0 114.257 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -51.36 -25.65 6.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.737 -0.602 . . . . 0.0 112.565 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.3 t -56.08 109.81 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.508 1.123 . . . . 0.0 111.97 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -80.71 13.78 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.334 -0.854 . . . . 0.0 112.03 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.8 m 59.29 43.93 16.15 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.247 1.019 . . . . 0.0 110.772 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.51 -158.01 0.24 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.498 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.43 39.18 1.25 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 120.088 1.313 . . . . 0.0 111.109 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.46 -40.17 13.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 123.384 0.673 . . . . 0.0 110.987 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 p -85.43 -137.35 0.07 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.153 0.581 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.49 -77.72 0.03 OUTLIER 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.04 1.736 . . . . 0.0 113.356 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -56.63 -35.13 67.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.165 0.586 . . . . 0.0 109.952 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -53.38 -31.03 42.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 113.789 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -70.25 127.29 92.33 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.82 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.22 -36.35 5.99 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.689 2.926 . . . . 0.0 113.622 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.79 20.36 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.649 0.38 . . . . 0.0 111.41 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 44.27 39.74 3.2 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.025 1.73 . . . . 0.0 112.912 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.64 40.75 1.2 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.342 1.057 . . . . 0.0 111.296 -165.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.32 149.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.51 1.924 . . . . 0.0 106.085 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -173.07 172.9 3.8 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.658 1.983 . . . . 0.0 109.492 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 129.42 40.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.03 -111.06 3.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 124.728 1.156 . . . . 0.0 111.698 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -99.77 -48.72 4.61 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.965 0.906 . . . . 0.0 109.494 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 p -115.65 -60.83 1.82 Allowed 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.509 2.324 . . . . 0.0 106.783 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.27 -156.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.725 1.61 . . . . 0.0 110.65 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -74.62 157.19 35.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.826 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 169.97 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 127.789 2.436 . . . . 0.0 108.89 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -130.35 143.08 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.539 1.536 . . . . 0.0 107.388 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.55 79.13 2.56 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 164.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.11 63.23 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.224 -0.923 . . . . 0.0 113.262 -171.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.86 -35.91 75.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 110.57 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -84.26 -44.2 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.624 1.57 . . . . 0.0 111.091 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -57.57 139.06 54.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.572 1.078 . . . . 0.0 110.22 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.1 -116.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -140.18 30.46 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.691 1.997 . . . . 0.0 109.853 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.277 0.0 OUTLIER -72.81 177.54 4.77 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.945 -0.472 . . . . 0.0 111.555 -174.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.57 -32.87 4.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.623 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.22 -53.38 54.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.498 1.149 . . . . 0.0 113.516 -150.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.62 -45.2 85.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.566 0.222 . . . . 0.0 110.808 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.53 94.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.884 -0.51 . . . . 0.0 109.847 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -50.57 69.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 111.969 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.09 -38.34 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 119.487 1.04 . . . . 0.0 111.669 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.2 118.12 16.98 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -163.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -60.84 -23.78 77.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.718 2.278 . . . . 0.0 112.55 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.87 31.3 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.381 0.673 . . . . 0.0 111.073 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.62 63.13 1.74 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.646 1.117 . . . . 0.0 113.239 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 -30.9 0.24 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.994 1.718 . . . . 0.0 113.541 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.88 78.58 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.758 2.305 . . . . 0.0 108.684 165.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -160.79 153.36 4.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 128.67 2.788 . . . . 0.0 104.638 -167.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -91.67 149.65 21.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.493 2.995 . . . . 0.0 115.71 -132.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 102.275 -3.231 . . . . 0.0 102.275 131.808 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.04 178.35 5.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 151.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 57.9 mt -84.17 108.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.79 171.11 15.26 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 122.091 0.948 . . . . 0.0 111.469 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -53.98 -20.6 6.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.196 1.798 . . . . 0.0 113.976 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -57.77 -20.68 36.87 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.53 -0.731 . . . . 0.0 112.963 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.5 t -56.1 153.58 8.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.084 1.354 . . . . 0.0 111.32 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.7 156.26 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 161.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 m -67.41 63.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.122 0.874 . . . . 0.0 112.738 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.0 -16.79 21.45 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.184 1.393 . . . . 0.0 111.894 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 -58.97 4.88 Favored Glycine 0 C--N 1.338 0.655 0 O-C-N 121.284 -0.885 . . . . 0.0 112.158 169.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -22.27 -65.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.91 2.084 . . . . 0.0 115.004 -167.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 p -56.7 -25.56 54.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.37 -50.35 1.49 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.028 0.931 . . . . 0.0 113.351 167.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 m -81.84 -23.74 36.23 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.12 -33.78 75.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.513 1.125 . . . . 0.0 110.959 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.54 115.73 20.56 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.416 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.01 -18.42 62.03 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.661 1.574 . . . . 0.0 111.478 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.4 14.16 8.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 CA-C-N 119.052 0.842 . . . . 0.0 111.582 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 43.68 48.02 6.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.851 1.26 . . . . 0.0 111.906 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.16 -5.98 51.18 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.897 0.879 . . . . 0.0 112.026 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.51 146.93 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.202 1.001 . . . . 0.0 110.308 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.6 m -164.23 167.88 19.49 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.235 2.214 . . . . 0.0 109.012 163.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -69.97 122.29 19.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.48 -65.02 1.15 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -170.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -115.08 -70.35 0.8 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -118.82 -58.35 1.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.692 1.997 . . . . 0.0 107.759 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -94.67 -174.21 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.866 -176.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -78.16 151.1 33.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.066 0.46 . . . . 0.0 111.189 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.13 142.84 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 126.256 1.823 . . . . 0.0 107.568 -170.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -103.27 139.01 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 127.11 2.164 . . . . 0.0 109.662 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.268 64.3 m-20 -69.82 102.49 1.96 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 159.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.27 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.041 -1.037 . . . . 0.0 112.332 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.55 -37.51 81.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.273 0.558 . . . . 0.0 110.929 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.0 m -80.19 -42.85 22.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.047 0.939 . . . . 0.0 110.6 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.93 127.58 32.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.919 0.781 . . . . 0.0 111.631 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.8 pt -100.64 28.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.863 1.265 . . . . 0.0 112.162 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 51.09 47.45 24.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.918 1.287 . . . . 0.0 111.707 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.256 0.5 OUTLIER -86.11 -164.7 1.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.23 -28.71 3.72 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.704 1.138 . . . . 0.0 114.069 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -54.85 -56.11 22.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.251 1.025 . . . . 0.0 112.885 -153.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.7 p -53.47 -45.6 69.62 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.239 -0.288 . . . . 0.0 110.916 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.62 97.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 110.278 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -61.34 -47.64 84.95 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.661 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.68 -42.13 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.042 0.837 . . . . 0.0 112.266 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.52 121.11 36.34 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.262 -159.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.3 -38.83 3.73 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.597 3.531 . . . . 0.0 115.029 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.97 17.55 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.359 0.663 . . . . 0.0 112.382 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.63 44.06 79.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 118.593 0.633 . . . . 0.0 112.907 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.65 -25.5 0.66 Allowed Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.46 87.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.936 2.424 . . . . 0.0 110.644 170.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 m -162.11 160.14 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.816 0 C-N-CA 128.937 2.895 . . . . 0.0 104.101 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.12 170.18 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 127.375 2.922 . . . . 0.0 115.149 -128.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 . . . . . 0 C--O 1.251 1.181 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.219 169.302 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 -177.18 4.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 149.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.27 110.1 20.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.08 162.04 28.89 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 122.083 0.945 . . . . 0.0 111.337 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -51.38 -26.23 7.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.721 1.609 . . . . 0.0 113.555 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -48.94 -25.45 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.6 t -48.63 -60.25 2.87 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 114.215 -174.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 162.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.725 -1.234 . . . . 0.0 110.856 -163.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 m -75.41 49.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 119.552 -1.968 . . . . 0.0 111.498 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.65 166.17 23.76 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 154.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.71 38.55 0.71 Allowed Glycine 0 CA--C 1.523 0.587 0 CA-C-N 120.557 1.526 . . . . 0.0 112.391 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.79 -63.02 1.51 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.471 0.635 . . . . 0.0 110.988 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 26.2 p -50.53 -24.58 3.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -169.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -33.85 -53.08 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.707 1.203 . . . . 0.0 114.197 166.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 p -76.09 -26.16 56.19 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.472 -0.768 . . . . 0.0 112.124 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 24.5 mm-40 -75.9 -29.65 58.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.817 2.047 . . . . 0.0 110.243 -169.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.8 t -58.6 119.48 36.89 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.082 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.38 -31.83 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.166 2.577 . . . . 0.0 113.345 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.26 8.17 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.413 0.551 . . . . 0.0 111.653 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 m120 44.98 44.13 7.8 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.831 1.652 . . . . 0.0 111.748 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 33' ' ' ASP . . . -115.14 47.77 1.25 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.976 0.91 . . . . 0.0 110.055 -169.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.43 150.91 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.754 2.022 . . . . 0.0 107.143 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -170.86 174.54 4.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.423 2.289 . . . . 0.0 109.049 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -73.33 132.08 42.65 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.52 -81.79 1.58 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -99.37 -56.13 2.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.921 1.288 . . . . 0.0 109.199 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -138.83 -51.09 0.55 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.968 2.107 . . . . 0.0 107.859 -177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.65 -161.33 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 122.953 0.501 . . . . 0.0 109.844 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.313 5.5 m-85 -79.35 163.63 24.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.418 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.4 163.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 127.774 2.429 . . . . 0.0 108.007 -170.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.35 143.37 38.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 125.248 1.419 . . . . 0.0 108.877 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 26.9 m-20 -75.37 83.71 2.48 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.36 -32.71 62.79 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.79 -48.42 8.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.921 1.688 . . . . 0.0 112.031 166.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -98.86 -30.86 12.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.842 2.057 . . . . 0.0 111.486 -165.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.8 t -55.68 127.64 30.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.586 1.084 . . . . 0.0 111.22 172.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.9 pt -104.63 33.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.594 1.558 . . . . 0.0 111.377 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 49.27 32.28 4.27 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.547 1.939 . . . . 0.0 113.491 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -76.43 -9.66 58.81 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -165.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 -23.52 6.3 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.788 -1.007 . . . . 0.0 114.23 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -53.69 -54.77 33.11 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.585 1.692 . . . . 0.0 111.338 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.43 -42.09 73.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.59 87.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.72 -0.613 . . . . 0.0 110.298 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -33.87 64.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 m -73.71 -38.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.813 1.188 . . . . 0.0 110.872 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.6 t -56.11 120.01 31.25 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.605 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -59.79 -29.83 90.55 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.692 2.261 . . . . 0.0 112.031 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.19 17.61 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.323 1.049 . . . . 0.0 111.675 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.03 49.93 5.27 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.818 1.199 . . . . 0.0 113.636 173.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.38 -30.28 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 125.523 1.529 . . . . 0.0 114.76 -174.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.7 90.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.73 2.286 . . . . 0.0 109.942 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 54' ' ' GLN . 28.1 t -165.99 151.05 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 128.788 2.835 . . . . 0.0 103.688 -165.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.558 ' H ' HG12 ' A' ' 53' ' ' VAL . 26.5 tt0 -92.66 157.52 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 128.961 3.913 . . . . 0.0 115.609 -130.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 . . . . . 0 C--O 1.249 1.047 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 150.666 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 CA--C 1.517 -0.3 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -129.94 -176.73 4.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 148.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 64.6 mt -84.06 107.74 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 152.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.55 170.34 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 122.05 0.928 . . . . 0.0 111.289 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.34 -25.61 1.05 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.015 2.126 . . . . 0.0 114.527 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -55.94 -19.12 10.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 42.3 t -56.93 156.85 6.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.241 1.416 . . . . 0.0 111.253 174.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.53 156.91 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 164.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -67.65 65.03 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.909 0.884 . . . . 0.0 111.832 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.261 0.1 OUTLIER -93.54 -162.2 0.92 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.609 1.563 . . . . 0.0 108.816 -177.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.62 42.45 0.71 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 120.932 1.696 . . . . 0.0 110.708 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.96 -37.46 12.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.436 0.695 . . . . 0.0 111.431 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.332 21.5 p -85.53 -100.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.55 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.68 -119.4 0.62 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 121.406 1.912 . . . . 0.0 112.058 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m -68.69 11.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -40.15 96.91 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.2 t -58.42 120.22 42.59 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.705 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -44.72 -36.98 11.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.774 2.983 . . . . 0.0 113.901 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -107.43 5.53 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 117.97 0.35 . . . . 0.0 111.54 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.11 48.36 12.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.436 1.095 . . . . 0.0 111.573 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.02 -11.96 61.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.085 0.954 . . . . 0.0 111.813 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -99.98 144.3 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.469 1.507 . . . . 0.0 110.484 -170.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -166.67 170.9 12.11 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.824 2.45 . . . . 0.0 108.765 162.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -66.74 130.73 44.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.37 -84.7 1.82 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -173.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.32 -52.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.59 1.156 . . . . 0.0 108.272 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -140.84 -57.58 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.267 2.227 . . . . 0.0 106.37 -171.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -99.91 -158.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.453 0.701 . . . . 0.0 109.828 178.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.18 149.68 21.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 111.814 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.57 137.28 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 126.678 1.991 . . . . 0.0 108.662 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -96.72 136.15 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 127.094 2.157 . . . . 0.0 109.733 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.252 29.1 m-20 -66.89 102.4 0.96 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 156.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.0 -33.53 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.743 -1.223 . . . . 0.0 112.352 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.79 -38.65 82.47 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.499 0.666 . . . . 0.0 110.609 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -79.23 -43.05 24.57 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.498 1.119 . . . . 0.0 110.1 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.2 t -55.88 115.97 2.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.526 0.603 . . . . 0.0 111.527 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.03 -0.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 t0 68.92 79.3 0.21 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 110.332 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.22 -31.43 4.39 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -164.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.78 -35.82 4.77 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.636 1.107 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -53.54 163.89 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.352 5.2 p 60.3 -55.29 0.08 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.535 1.534 . . . . 0.0 112.963 -153.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.5 94.4 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 120.022 1.283 . . . . 0.0 109.806 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.83 -28.34 69.49 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.739 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -88.26 -38.87 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.808 1.185 . . . . 0.0 111.176 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -53.6 118.48 14.96 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -166.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.1 -38.22 10.42 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 124.273 3.315 . . . . 0.0 114.159 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.36 18.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.272 1.029 . . . . 0.0 112.377 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.84 42.49 37.84 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.588 0.631 . . . . 0.0 113.792 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 -22.96 0.38 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.696 1.599 . . . . 0.0 115.183 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.78 84.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.55 2.167 . . . . 0.0 109.621 166.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -159.68 157.2 3.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 128.808 2.843 . . . . 0.0 104.765 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -91.62 155.85 18.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 127.681 3.113 . . . . 0.0 115.12 -133.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 144.749 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -118.97 168.69 10.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 102.999 -2.963 . . . . 0.0 102.999 145.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 53.1 mt -80.43 105.34 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 148.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.54 163.83 26.53 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 119.366 -0.933 . . . . 0.0 111.01 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.27 -23.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.624 2.77 . . . . 0.0 114.85 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -25.77 4.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 168.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.8 t -57.62 158.64 5.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 111.764 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.54 160.84 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 164.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -66.12 63.64 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.99 1.316 . . . . 0.0 112.948 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.73 -32.65 8.32 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.531 1.133 . . . . 0.0 112.44 -165.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.49 15.34 57.05 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.014 1.292 . . . . 0.0 114.585 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.59 -33.14 68.77 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.383 1.092 . . . . 0.0 111.376 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.255 29.0 p -74.17 -90.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 44.05 -110.54 0.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 121.149 1.795 . . . . 0.0 112.236 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m -65.7 -5.96 10.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -38.21 64.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.977 0.808 . . . . 0.0 109.063 164.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 t -58.07 123.11 63.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.903 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -45.02 -38.45 13.66 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.752 2.968 . . . . 0.0 113.799 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -101.4 1.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.592 0.357 . . . . 0.0 111.344 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 54.22 33.47 18.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.791 1.236 . . . . 0.0 110.925 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.27 38.67 0.49 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.158 1.383 . . . . 0.0 112.053 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.16 150.48 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 124.292 1.037 . . . . 0.0 109.584 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.4 m -166.5 172.58 10.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.576 2.351 . . . . 0.0 108.136 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.32 127.76 33.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.82 -81.73 1.44 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.84 -53.68 3.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.415 1.086 . . . . 0.0 108.436 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 p -141.39 -54.58 0.47 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.192 2.197 . . . . 0.0 107.319 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.25 -173.91 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 122.919 0.488 . . . . 0.0 110.792 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.24 142.9 32.71 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.022 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.09 155.25 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 126.413 1.885 . . . . 0.0 108.662 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.48 140.78 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.57 1.548 . . . . 0.0 108.604 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.0 91.25 4.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.82 -36.77 72.72 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.921 -1.112 . . . . 0.0 113.864 -168.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.94 -35.86 67.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.122 0.969 . . . . 0.0 110.391 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.0 m -84.41 -47.63 10.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.864 1.666 . . . . 0.0 110.489 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.1 t -57.31 123.16 14.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.989 -0.444 . . . . 0.0 112.119 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.44 23.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.029 0.932 . . . . 0.0 112.498 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.32 39.52 28.39 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.013 1.725 . . . . 0.0 111.539 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.42 -10.07 59.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.03 -33.23 1.28 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.916 1.246 . . . . 0.0 115.056 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -48.93 -46.73 43.58 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -157.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.1 p -46.9 -31.67 3.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.991 1.317 . . . . 0.0 112.679 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -43.23 31.19 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.504 0.593 . . . . 0.0 112.368 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -49.92 -38.96 38.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.71 -24.94 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.44 119.24 71.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.531 -153.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -43.92 -40.16 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.043 3.162 . . . . 0.0 114.41 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.49 16.29 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 112.521 -173.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.52 53.62 19.92 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 118.711 0.687 . . . . 0.0 112.959 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.86 -23.01 0.24 Allowed Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.576 1.951 . . . . 0.0 115.065 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.33 90.15 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.128 1.885 . . . . 0.0 107.603 164.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 m -162.79 152.71 3.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -171.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -90.44 175.11 7.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.986 3.304 . . . . 0.0 112.076 -128.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 115.585 -2.15 . . . . 0.0 110.337 -157.843 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 103.803 -2.665 . . . . 0.0 103.803 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -112.19 168.59 9.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 144.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 36.0 mt -80.58 109.46 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 152.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.38 165.73 24.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.468 1.128 . . . . 0.0 111.259 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.57 -20.98 15.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.571 1.548 . . . . 0.0 113.903 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -55.9 -21.41 20.16 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.584 -0.697 . . . . 0.0 112.829 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.0 t -46.58 -72.78 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.538 1.935 . . . . 0.0 115.107 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 68.05 155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.813 1.245 . . . . 0.0 111.864 -163.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m -66.7 57.39 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.889 1.276 . . . . 0.0 113.431 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -84.41 -38.38 20.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.472 1.033 . . . . 0.0 113.033 -168.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.71 -155.85 18.3 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.74 1.162 . . . . 0.0 113.207 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.79 -70.58 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.414 1.886 . . . . 0.0 113.725 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.22 -29.03 63.41 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -161.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.32 -49.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.081 0.953 . . . . 0.0 113.128 166.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.9 m -85.68 -15.74 41.33 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.117 0.567 . . . . 0.0 112.398 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -76.71 -37.11 56.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.471 1.109 . . . . 0.0 110.302 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.09 119.89 38.48 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.498 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.28 -34.44 31.63 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.155 2.57 . . . . 0.0 113.601 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.85 5.72 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.717 0.407 . . . . 0.0 111.238 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.92 31.15 10.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.019 1.327 . . . . 0.0 111.579 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 38.44 0.42 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mt -142.2 146.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.417 1.487 . . . . 0.0 107.342 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.08 163.83 13.49 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.454 1.902 . . . . 0.0 110.032 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -68.57 117.19 9.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.69 -76.8 1.21 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -164.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -110.57 -71.2 0.77 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -104.56 -61.01 1.51 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.362 1.065 . . . . 0.0 108.945 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.76 -160.52 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.064 0.946 . . . . 0.0 110.024 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.88 144.26 41.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.736 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.76 151.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.414 1.885 . . . . 0.0 106.094 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 mt -105.27 140.3 23.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.74 74.44 1.11 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 162.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -33.19 64.59 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -170.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -42.83 -46.48 5.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.805 2.042 . . . . 0.0 112.216 166.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -104.1 -27.29 12.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.116 2.566 . . . . 0.0 112.034 -163.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.6 t -45.2 119.08 1.91 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.622 1.101 . . . . 0.0 110.54 167.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 pt -80.28 34.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.368 -0.833 . . . . 0.0 112.01 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t0 29.38 63.35 0.14 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.152 2.581 . . . . 0.0 113.251 -174.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.28 0.5 OUTLIER -98.36 -141.76 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.291 1.036 . . . . 0.0 108.596 173.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 10.94 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 CA-C-N 121.843 2.11 . . . . 0.0 114.685 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.64 -47.61 76.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.048 1.924 . . . . 0.0 110.876 -172.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.1 p -57.33 -43.93 83.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.028 0.531 . . . . 0.0 110.692 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.35 94.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.465 -0.772 . . . . 0.0 109.505 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -51.71 68.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.71 0.804 . . . . 0.0 112.083 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.66 -39.22 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.527 1.058 . . . . 0.0 112.446 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.2 t -55.7 121.62 40.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -161.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.24 -31.93 82.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.735 2.29 . . . . 0.0 111.961 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.68 11.05 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.893 0.877 . . . . 0.0 111.851 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.69 63.95 3.19 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.18 0.895 . . . . 0.0 112.714 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.56 -28.07 0.19 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 126.382 1.873 . . . . 0.0 114.005 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 78.98 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.962 2.441 . . . . 0.0 108.437 164.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.8 m -158.65 153.65 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 128.562 2.745 . . . . 0.0 104.361 -168.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.16 174.18 7.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 128.555 3.66 . . . . 0.0 112.551 -113.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.254 1.308 0 CA-C-O 115.686 -2.102 . . . . 0.0 109.256 -164.307 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -122.0 178.31 4.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 146.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.76 107.55 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 151.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.64 168.0 20.85 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.371 1.081 . . . . 0.0 111.268 171.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.57 -9.28 5.62 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.305 1.842 . . . . 0.0 113.888 -173.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -23.58 61.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.863 -1.148 . . . . 0.0 111.861 166.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.3 t -63.17 158.83 18.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.006 0.923 . . . . 0.0 110.822 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -136.87 -175.44 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.9 p -73.28 64.08 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.75 175.2 5.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.853 1.661 . . . . 0.0 108.093 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.81 38.36 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 CA-C-N 120.143 1.338 . . . . 0.0 110.868 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -15.18 30.68 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.52 0.728 . . . . 0.0 112.29 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.305 29.9 p -101.41 -95.22 0.28 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 118.589 -0.72 . . . . 0.0 111.219 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 39.7 -99.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 113.689 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -49.49 -29.62 6.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.507 1.523 . . . . 0.0 112.864 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -52.02 -33.39 38.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.316 1.046 . . . . 0.0 112.877 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -64.26 119.89 60.01 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.483 -0.76 . . . . 0.0 109.781 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.04 -32.29 23.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.236 2.624 . . . . 0.0 113.147 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.7 19.85 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 122.706 0.403 . . . . 0.0 110.947 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.45 22.8 0.77 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.339 1.855 . . . . 0.0 114.231 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.5 44.19 1.02 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.878 1.271 . . . . 0.0 111.322 -166.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.05 147.34 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.818 1.247 . . . . 0.0 107.934 -174.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -170.7 169.31 7.12 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.171 2.188 . . . . 0.0 109.49 167.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -67.5 125.66 26.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.69 -84.22 1.68 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -168.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -102.3 -48.04 4.31 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.942 1.297 . . . . 0.0 108.463 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 p -140.21 -59.71 0.53 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.615 1.966 . . . . 0.0 106.854 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -155.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.12 0.968 . . . . 0.0 109.642 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -82.38 157.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.98 0.419 . . . . 0.0 110.672 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.23 160.91 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.099 1.759 . . . . 0.0 106.887 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -119.48 146.74 23.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 125.259 1.424 . . . . 0.0 108.486 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.14 76.29 1.26 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 165.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.68 -35.34 60.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -167.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.4 -37.79 73.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.175 1.39 . . . . 0.0 110.384 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 m -79.9 -49.49 11.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.513 1.525 . . . . 0.0 110.815 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.3 t -61.33 111.8 1.91 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.697 1.237 . . . . 0.0 113.434 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.0 pt -83.45 142.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 156.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 60.68 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.54 2.336 . . . . 0.0 112.412 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -27.79 48.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.789 0.836 . . . . 0.0 112.806 -166.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.8 -34.03 5.32 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.38 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -54.61 -55.77 25.97 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.674 1.737 . . . . 0.0 112.051 -162.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 p -52.56 -43.04 64.97 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.719 0.295 . . . . 0.0 111.226 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.43 77.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.522 -0.736 . . . . 0.0 110.719 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -70.49 -47.32 61.1 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.407 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -68.82 -38.41 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.62 0.646 . . . . 0.0 112.167 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -55.94 120.06 30.83 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.318 -0.373 . . . . 0.0 111.958 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -59.59 -26.6 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.905 2.404 . . . . 0.0 112.37 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.04 24.49 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.705 0.802 . . . . 0.0 111.682 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.79 62.72 2.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.113 0.864 . . . . 0.0 113.07 172.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.69 -28.03 0.24 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 126.027 1.731 . . . . 0.0 113.998 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.6 80.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.634 2.223 . . . . 0.0 108.009 164.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -157.67 149.01 9.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -92.7 153.88 18.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 128.974 3.921 . . . . 0.0 115.714 -133.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 144.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -129.62 -159.59 0.97 Allowed 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 126.505 1.922 . . . . 0.0 106.532 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -128.32 161.84 28.46 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 27.6 mm -79.78 100.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 153.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.28 174.0 10.71 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.2 -0.938 . . . . 0.0 111.474 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -54.31 -16.47 2.2 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.835 2.054 . . . . 0.0 114.787 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -51.25 -33.01 26.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.433 -0.792 . . . . 0.0 111.761 166.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 47.3 t -55.71 130.26 42.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.251 1.82 . . . . 0.0 112.086 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.2 150.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.4 m -67.56 70.53 0.12 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.334 0.97 . . . . 0.0 111.993 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.22 -22.74 20.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.713 1.205 . . . . 0.0 111.42 -172.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.95 -30.68 5.7 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 113.698 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.1 56.48 2.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.359 1.079 . . . . 0.0 113.309 -164.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 23.0 p -155.59 -31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.306 1.042 . . . . 0.0 112.282 171.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -36.02 -60.4 0.55 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 170.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -75.92 -15.2 60.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.296 1.039 . . . . 0.0 112.494 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 23.7 mm-40 -81.42 -34.17 31.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.967 1.307 . . . . 0.0 109.339 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.23 122.35 58.43 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.587 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.08 -33.47 73.84 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.711 2.274 . . . . 0.0 112.493 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.06 7.42 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 122.818 0.447 . . . . 0.0 110.8 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 49.09 35.22 6.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.117 1.367 . . . . 0.0 111.866 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 36.41 0.42 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.052 1.341 . . . . 0.0 111.075 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mt -142.27 147.64 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.311 1.044 . . . . 0.0 109.489 -170.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.0 p -169.79 174.24 5.8 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 127.331 2.252 . . . . 0.0 108.522 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -85.42 128.66 34.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.481 1.037 . . . . 0.0 108.368 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.98 -67.86 0.14 Allowed Glycine 0 C--N 1.339 0.721 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.434 -161.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -98.96 -52.52 3.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -166.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.8 m -141.78 -50.51 0.4 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 109.181 156.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -161.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.225 1.01 . . . . 0.0 109.62 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.289 17.1 m-85 -68.69 161.94 27.15 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 117.714 -1.594 . . . . 0.0 110.906 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.87 162.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 126.783 2.033 . . . . 0.0 107.437 -170.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -128.92 138.6 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.651 1.18 . . . . 0.0 108.695 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -73.58 76.12 1.49 Allowed 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 165.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -32.99 64.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -168.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.9 -48.08 8.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.443 1.897 . . . . 0.0 112.171 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.82 -29.95 12.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.655 2.382 . . . . 0.0 111.247 -165.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.8 t -52.85 134.65 37.0 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.288 0.949 . . . . 0.0 110.141 165.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 pt -107.89 137.92 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 159.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.96 74.11 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.56 -20.03 18.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.853 0.861 . . . . 0.0 113.041 -169.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.28 4.1 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.525 -0.734 . . . . 0.0 112.511 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -54.63 165.45 0.59 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 163.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.372 6.9 p 60.61 -57.56 0.08 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.373 1.469 . . . . 0.0 112.386 -152.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.44 96.61 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 120.234 1.379 . . . . 0.0 109.571 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -37.29 78.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.082 0.953 . . . . 0.0 111.914 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.94 -40.59 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 118.894 0.77 . . . . 0.0 111.007 -169.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.8 t -54.67 118.84 18.16 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.269 -170.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.1 -36.18 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.975 3.116 . . . . 0.0 114.216 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.42 14.27 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 112.213 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.68 50.67 36.07 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.746 0.703 . . . . 0.0 112.791 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 52' ' ' PRO . . . -80.02 -23.75 0.39 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 114.916 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 51' ' ' ALA . 55.5 Cg_exo -60.14 82.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.747 2.298 . . . . 0.0 110.764 168.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 m -159.85 153.24 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 128.901 2.88 . . . . 0.0 104.068 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -90.0 149.74 22.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.674 1.859 . . . . 0.0 114.299 -138.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.254 1.319 0 CA-C-O 116.689 -1.625 . . . . 0.0 107.434 146.662 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -76.25 -158.35 0.09 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 160.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -142.43 -168.93 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 156.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.478 HG12 ' CG1' ' A' ' 32' ' ' ILE . 4.2 mm -79.45 105.55 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 156.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.86 165.19 25.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.961 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.48 -15.87 3.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -53.18 -25.66 14.54 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.327 -0.858 . . . . 0.0 113.27 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -59.31 162.15 4.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.267 1.427 . . . . 0.0 111.669 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.65 173.2 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 168.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 m -70.6 64.03 0.28 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.299 -0.875 . . . . 0.0 111.011 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -179.78 4.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.04 2.136 . . . . 0.0 106.695 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.39 37.6 0.84 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 120.446 1.476 . . . . 0.0 111.315 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 -31.0 43.74 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.861 0.464 . . . . 0.0 111.537 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.286 29.9 p -80.43 -97.4 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.595 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 45.57 -99.01 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 121.157 1.799 . . . . 0.0 113.611 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 m -48.4 -31.73 6.61 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.926 1.691 . . . . 0.0 112.461 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -53.25 -28.23 26.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.407 1.083 . . . . 0.0 112.898 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.502 ' HA ' ' S1 ' ' A' ' 57' ' ' SF4 . 51.4 t -71.55 120.65 81.11 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 119.11 0.868 . . . . 0.0 110.739 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.45 -34.79 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.64 6.98 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 117.937 0.335 . . . . 0.0 111.022 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 22.69 4.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.289 1.835 . . . . 0.0 111.816 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.3 50.18 1.89 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.2 -0.938 . . . . 0.0 110.538 -164.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 mt -136.72 147.71 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.608 1.563 . . . . 0.0 107.985 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -169.08 168.36 10.06 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.31 2.244 . . . . 0.0 109.327 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -71.74 117.12 12.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.06 -66.67 1.12 Allowed Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -114.8 -72.14 0.71 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -108.65 -61.09 1.65 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.611 1.165 . . . . 0.0 108.326 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.9 -166.55 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.182 0.593 . . . . 0.0 110.35 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.88 155.7 40.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 110.66 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.77 156.42 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 126.976 2.11 . . . . 0.0 106.381 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.478 ' CG1' HG12 ' A' ' 4' ' ' ILE . 3.2 mt -126.12 146.34 32.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.42 84.19 0.58 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 164.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.74 -29.66 62.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.439 -0.788 . . . . 0.0 112.689 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -41.66 -47.6 3.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.54 1.936 . . . . 0.0 112.071 164.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -102.84 -34.13 9.1 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.095 2.158 . . . . 0.0 111.981 -164.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.6 t -52.45 129.2 28.06 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.677 1.126 . . . . 0.0 111.966 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 pt -107.64 34.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.256 1.423 . . . . 0.0 111.78 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 5.4 m-20 51.27 35.9 14.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.96 1.704 . . . . 0.0 112.758 170.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.47 -16.35 57.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.31 -27.97 7.95 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.454 1.026 . . . . 0.0 114.816 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -54.64 -50.81 67.25 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.947 1.874 . . . . 0.0 113.205 -165.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.5 p -55.01 -44.93 75.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.915 -0.49 . . . . 0.0 110.675 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.97 82.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.752 -0.592 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -39.59 75.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.7 -0.667 . . . . 0.0 111.559 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.56 -40.41 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.128 0.876 . . . . 0.0 111.869 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -53.94 121.65 30.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -164.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.93 -26.97 83.23 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.746 2.298 . . . . 0.0 112.736 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.95 19.05 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.553 0.741 . . . . 0.0 112.099 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 46.55 54.19 9.12 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 123.476 0.56 . . . . 0.0 113.122 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.65 -27.48 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.581 . . . . 0.0 114.58 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.67 82.48 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.274 1.983 . . . . 0.0 108.67 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -162.23 155.76 2.74 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -168.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -90.16 148.12 23.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 127.205 2.816 . . . . 0.0 112.671 -148.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.243 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 163.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . 0.502 ' S1 ' ' HA ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.531 0.205 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -74.25 -154.17 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 126.479 1.912 . . . . 0.0 106.767 156.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.457 ' H ' ' HA ' ' A' ' 54' ' ' GLN . 2.5 ptpp? -122.41 -179.22 4.12 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 146.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 71.2 mt -85.33 104.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 155.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.7 176.41 8.45 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.088 0.946 . . . . 0.0 112.895 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.75 -31.59 2.09 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 126.66 1.984 . . . . 0.0 114.985 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -54.75 -16.37 2.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' VAL . 53.9 t -55.55 -33.75 64.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.923 2.089 . . . . 0.0 115.607 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 8' ' ' CYS 0.288 1.8 m 71.35 -53.32 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 119.473 -2.017 . . . . 0.0 113.988 -173.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.8 p 129.08 29.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 131.399 3.88 . . . . 0.0 111.307 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -19.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -162.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' CZ ' ' A' ' 30' ' ' PHE . . . 88.41 -53.0 4.08 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.109 -0.994 . . . . 0.0 114.24 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -33.11 -63.32 0.23 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.34 1.456 . . . . 0.0 114.633 -160.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 23.0 p -56.36 -21.46 24.8 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.39 -47.04 3.5 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.754 0.821 . . . . 0.0 112.657 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.5 m -82.72 -24.26 33.68 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 75.8 mm-40 -74.0 -34.65 64.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.756 1.223 . . . . 0.0 111.075 -173.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t -55.88 123.28 51.93 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.428 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.56 -37.4 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.294 3.329 . . . . 0.0 113.694 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.31 20.48 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.1 0.56 . . . . 0.0 112.163 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 44.72 49.37 8.79 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 0.0 112.432 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.18 31.61 1.66 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.389 1.076 . . . . 0.0 111.157 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.48 146.25 30.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.763 0.825 . . . . 0.0 109.107 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.47 169.24 10.61 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.135 2.174 . . . . 0.0 109.897 172.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -75.22 125.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.72 -73.88 1.06 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.99 -70.04 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -115.08 -62.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.71 2.004 . . . . 0.0 107.232 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -167.24 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.529 1.132 . . . . 0.0 111.075 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 20.9 m-85 -73.32 151.8 41.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.427 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.02 159.75 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 127.677 2.391 . . . . 0.0 106.008 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.64 131.45 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.41 79.55 0.76 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 170.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.27 66.58 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -163.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.89 -34.34 77.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.795 1.238 . . . . 0.0 110.694 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -84.81 -40.83 16.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 110.433 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 t -61.27 149.67 37.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.128 0.876 . . . . 0.0 108.743 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 pt -90.84 -112.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 167.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.89 129.1 11.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 155.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -161.03 161.8 31.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.052 0.842 . . . . 0.0 109.848 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.25 -26.93 56.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.489 -0.757 . . . . 0.0 112.392 -173.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -47.8 -60.68 2.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.272 1.029 . . . . 0.0 113.207 -159.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.5 p -60.71 -41.55 95.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.651 0.659 . . . . 0.0 110.465 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.38 81.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.505 -0.747 . . . . 0.0 110.307 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -46.02 72.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.403 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.86 -37.35 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.405 1.002 . . . . 0.0 111.408 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -53.77 118.57 15.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.649 -167.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.44 -38.17 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.65 3.567 . . . . 0.0 114.813 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.06 24.34 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 112.15 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.59 62.09 5.09 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.385 0.539 . . . . 0.0 112.962 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.17 -23.74 0.21 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 126.722 2.009 . . . . 0.0 114.699 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -60.95 90.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.82 2.347 . . . . 0.0 108.038 162.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 m -159.19 144.54 6.69 Favored 'Isoleucine or valine' 0 C--O 1.252 1.209 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HA ' ' H ' ' A' ' 3' ' ' LYS . 35.3 tt0 -91.1 131.5 36.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 128.359 3.537 . . . . 0.0 114.23 -144.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 157.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.306 0 CA-C-O 117.354 -1.308 . . . . 0.0 108.801 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 61.45 -137.06 0.54 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -142.32 -163.36 1.59 Allowed 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 115.845 -2.342 . . . . 0.0 105.465 135.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.09 108.97 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 156.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.25 163.25 27.22 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.274 -0.891 . . . . 0.0 110.848 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.07 -12.31 4.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -52.43 -29.18 23.15 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.336 -0.852 . . . . 0.0 112.228 166.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 49.8 t -58.87 156.27 11.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.997 1.319 . . . . 0.0 111.653 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.59 167.67 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 164.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -65.39 64.48 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.012 1.325 . . . . 0.0 111.997 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -34.05 7.2 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.585 1.154 . . . . 0.0 112.716 -165.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.92 21.68 56.14 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.879 1.228 . . . . 0.0 114.742 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.79 -28.43 58.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.162 0.981 . . . . 0.0 111.46 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 p -79.31 -108.62 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 53.76 -101.65 0.12 Allowed 'General case' 0 C--N 1.34 0.174 0 CA-C-N 121.49 1.95 . . . . 0.0 111.799 170.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m -41.32 -36.29 0.78 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.409 1.884 . . . . 0.0 112.832 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -41.79 62.33 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 111.569 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.54 125.0 81.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.262 -166.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.53 -35.03 11.87 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.59 2.86 . . . . 0.0 114.096 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.4 m -107.08 5.19 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 48.69 37.43 9.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.032 1.333 . . . . 0.0 111.64 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.83 32.46 0.42 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.697 1.199 . . . . 0.0 111.958 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -132.1 151.14 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.885 1.274 . . . . 0.0 108.786 -172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 p -164.67 174.15 11.11 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.395 1.478 . . . . 0.0 109.195 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -77.38 125.24 29.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.77 -83.44 1.7 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -167.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -99.87 -50.33 4.05 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.25 1.02 . . . . 0.0 108.446 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.4 p -140.73 -57.7 0.52 Allowed 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.031 2.133 . . . . 0.0 106.609 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -104.45 -162.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.21 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -79.8 156.29 27.49 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.267 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -147.99 158.36 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 126.767 2.027 . . . . 0.0 108.28 -171.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.84 149.75 33.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 125.699 1.6 . . . . 0.0 108.957 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -82.77 114.17 20.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 157.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.621 1.1 . . . . 0.0 112.004 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 -38.92 85.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.7 1.2 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 m -79.85 -40.06 29.27 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.742 1.217 . . . . 0.0 109.745 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.9 112.04 1.9 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.582 0.628 . . . . 0.0 110.941 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.5 pt -79.76 47.28 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 121.244 -0.91 . . . . 0.0 111.316 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 14.73 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.609 2.763 . . . . 0.0 114.402 -173.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -5.27 40.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -171.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.99 -37.38 1.49 Allowed Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.035 -1.041 . . . . 0.0 114.23 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -46.17 -52.46 12.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -154.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -47.35 -37.7 11.62 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.147 1.779 . . . . 0.0 111.596 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -34.73 61.3 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.52 -0.738 . . . . 0.0 112.29 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -67.69 -44.89 76.69 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 117.87 0.304 . . . . 0.0 111.004 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.66 -30.37 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.868 -171.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.2 t -56.74 118.73 24.74 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.278 -170.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.88 -37.3 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.421 3.414 . . . . 0.0 114.253 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.73 22.65 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.995 0.918 . . . . 0.0 112.246 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.91 64.42 3.27 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 118.601 0.637 . . . . 0.0 113.039 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.39 -23.4 0.19 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -64.29 83.15 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.374 2.05 . . . . 0.0 108.28 163.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -162.27 151.72 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 -165.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.83 151.05 21.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 127.307 2.879 . . . . 0.0 113.614 -143.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.049 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 152.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -123.78 -157.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.604 2.362 . . . . 0.0 105.429 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' C ' HD12 ' A' ' 32' ' ' ILE . 13.1 ptpt -118.17 -179.33 3.74 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 143.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.449 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 48.8 mt -79.1 109.44 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 147.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.93 173.37 11.29 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 122.143 0.973 . . . . 0.0 111.286 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -47.96 -31.09 4.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.035 1.334 . . . . 0.0 113.299 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -65.11 13.19 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.613 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.7 t -74.17 -73.12 0.24 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.627 2.371 . . . . 0.0 112.793 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 8' ' ' CYS 0.274 1.3 m 75.77 137.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 127.197 2.199 . . . . 0.0 110.373 -159.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.25 57.03 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.941 2.096 . . . . 0.0 114.48 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -17.94 25.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.214 0.915 . . . . 0.0 112.903 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 30' ' ' PHE . . . 88.92 -57.96 4.02 Favored Glycine 0 C--N 1.337 0.636 0 O-C-N 120.92 -1.112 . . . . 0.0 114.005 167.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -30.38 -57.76 0.2 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.283 1.833 . . . . 0.0 114.756 -164.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.4 p -63.28 -20.92 65.9 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -169.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.91 -58.3 2.1 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.413 1.006 . . . . 0.0 112.444 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -29.17 67.22 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.287 1.035 . . . . 0.0 112.537 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.21 1.004 . . . . 0.0 111.632 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.31 123.66 83.25 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.519 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -42.4 -37.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.024 3.149 . . . . 0.0 113.938 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.14 14.45 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.24 44.11 6.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.525 1.13 . . . . 0.0 111.759 -177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.08 36.34 0.62 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.038 0.935 . . . . 0.0 110.598 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 mt -137.54 149.31 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 125.212 1.405 . . . . 0.0 107.698 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.9 t -164.23 176.73 8.92 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 124.77 1.228 . . . . 0.0 109.93 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.65 102.74 2.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.3 -65.64 1.77 Allowed Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -119.14 -77.2 0.57 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -108.61 -48.72 3.27 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.412 1.485 . . . . 0.0 110.193 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.82 -169.16 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 122.711 0.405 . . . . 0.0 109.98 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 20.1 m-85 -82.66 148.79 27.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.526 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.61 160.46 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 126.932 2.093 . . . . 0.0 107.734 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 3' ' ' LYS . 71.2 mt -108.73 140.19 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.837 1.255 . . . . 0.0 107.801 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -72.71 76.45 1.11 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -32.65 67.03 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -44.93 -47.69 11.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.297 1.839 . . . . 0.0 112.343 166.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -96.99 -31.99 12.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.606 2.362 . . . . 0.0 110.847 -165.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.8 t -57.01 136.78 56.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.403 1.001 . . . . 0.0 108.606 160.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.13 -102.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -158.63 135.79 9.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 155.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.06 177.94 8.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 109.663 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.86 -42.26 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.604 -0.553 . . . . 0.0 112.95 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.53 -60.13 3.76 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 117.633 0.716 . . . . 0.0 112.602 -147.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -53.07 -45.15 67.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.024 0.374 . . . . 0.0 111.124 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.08 90.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.886 -0.509 . . . . 0.0 110.343 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.26 -43.84 69.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.485 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.45 -40.27 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 119.351 0.978 . . . . 0.0 110.986 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -53.43 118.24 14.01 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.784 -0.627 . . . . 0.0 112.328 -163.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.83 -37.84 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.317 3.344 . . . . 0.0 114.456 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.4 m -118.73 16.17 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.94 50.22 39.22 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.713 0.688 . . . . 0.0 113.036 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.6 -19.73 0.26 Allowed Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.841 1.656 . . . . 0.0 115.061 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -58.36 86.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.036 2.491 . . . . 0.0 110.022 164.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 m -161.53 152.48 4.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -84.12 151.35 24.97 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 127.41 2.944 . . . . 0.0 114.008 -139.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 135.306 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -85.76 -157.46 0.33 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.1 174.96 5.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 144.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 mm -79.02 107.63 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 146.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.34 165.05 25.4 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 122.09 0.948 . . . . 0.0 111.445 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.57 -15.23 10.47 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.918 1.687 . . . . 0.0 113.596 -173.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 m -56.32 -23.49 37.38 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.399 -0.813 . . . . 0.0 112.515 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.7 t -54.25 154.16 4.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.096 1.358 . . . . 0.0 110.303 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.98 164.73 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 170.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.4 m -71.74 60.66 0.36 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.949 0.795 . . . . 0.0 111.649 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 -31.22 14.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.999 1.32 . . . . 0.0 111.818 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.25 -28.86 1.68 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.979 172.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -43.43 -48.78 7.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.72 1.208 . . . . 0.0 113.518 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -64.43 -12.57 44.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.78 -65.38 0.51 Allowed 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.106 -0.997 . . . . 0.0 112.89 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 m -69.27 -29.84 67.82 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -59.06 -39.89 83.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.215 1.006 . . . . 0.0 111.737 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -65.28 120.09 64.73 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.895 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.89 -37.0 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.562 2.841 . . . . 0.0 113.946 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.36 0.86 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.166 0.439 . . . . 0.0 112.011 -174.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.38 57.42 5.85 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.776 0.83 . . . . 0.0 111.037 -174.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.65 61.75 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.671 -0.643 . . . . 0.0 111.454 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.19 149.86 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.439 1.896 . . . . 0.0 112.132 -170.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 m -161.32 164.13 30.33 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 128.243 2.617 . . . . 0.0 108.488 154.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -75.15 119.23 19.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.87 -66.91 1.35 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -166.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -116.56 -71.96 0.71 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -113.5 -55.97 2.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.146 1.378 . . . . 0.0 108.745 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -100.94 -167.52 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.086 0.555 . . . . 0.0 110.649 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -84.68 146.96 27.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.412 0.625 . . . . 0.0 111.433 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.1 159.03 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 127.171 2.188 . . . . 0.0 106.153 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.42 149.65 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 C-N-CA 125.296 1.438 . . . . 0.0 109.431 -172.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -65.76 91.96 0.14 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 155.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.79 -29.04 67.95 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.676 -1.265 . . . . 0.0 112.404 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.09 -36.63 84.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.311 0.644 . . . . 0.0 111.368 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -79.77 -43.52 22.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.502 1.121 . . . . 0.0 109.379 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.7 t -54.63 132.31 45.07 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -78.33 -102.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.87 120.38 2.66 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 159.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.39 171.81 19.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.182 0.901 . . . . 0.0 110.796 -169.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.09 -40.51 8.59 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 119.544 -0.587 . . . . 0.0 113.122 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.61 -56.92 14.77 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.851 0.826 . . . . 0.0 112.995 -147.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 p -55.86 -44.64 78.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.02 -0.425 . . . . 0.0 110.926 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.07 94.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.793 -0.567 . . . . 0.0 110.108 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -62.76 -49.31 75.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.145 0.578 . . . . 0.0 111.413 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -68.25 -40.68 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 118.832 0.742 . . . . 0.0 111.833 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.36 117.95 19.26 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -162.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -59.92 -26.42 82.28 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.729 2.286 . . . . 0.0 112.38 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -116.09 21.74 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.967 0.907 . . . . 0.0 111.408 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 44.05 50.89 7.47 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.521 1.058 . . . . 0.0 113.346 171.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.8 -26.92 0.36 Allowed Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.265 1.426 . . . . 0.0 114.828 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -63.65 84.56 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.579 2.186 . . . . 0.0 109.443 168.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.1 m -165.77 157.81 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.78 155.33 18.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 127.624 3.077 . . . . 0.0 114.04 -124.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 . . . . . 0 C--O 1.257 1.465 0 C-N-CA 127.82 2.448 . . . . 0.0 106.44 157.486 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 66.6 -175.39 0.19 Allowed 'General case' 0 C--N 1.341 0.239 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -156.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -128.01 179.43 5.58 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 140.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 50.0 mt -79.7 107.69 12.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 156.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.83 15.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.145 0.974 . . . . 0.0 111.673 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -49.15 -23.4 1.26 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.604 2.362 . . . . 0.0 114.82 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -54.08 -24.38 17.24 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.556 -0.715 . . . . 0.0 112.521 171.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 47.7 t -57.72 121.63 10.88 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.291 1.437 . . . . 0.0 110.864 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.94 21.97 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.491 -0.756 . . . . 0.0 111.581 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 m 56.69 36.23 27.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.139 0.976 . . . . 0.0 110.552 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -75.33 152.59 38.14 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 111.21 -169.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.9 57.96 4.93 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.892 -1.13 . . . . 0.0 110.858 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . . . -143.72 -161.33 1.25 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.206 1.003 . . . . 0.0 108.889 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 17' ' ' GLU 0.57 3.7 p 39.25 -120.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 118.01 -0.995 . . . . 0.0 113.065 -160.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 49.69 -105.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 122.627 2.467 . . . . 0.0 110.904 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.1 m -58.06 -17.59 18.85 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 23.5 mt-10 -61.12 -29.3 69.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.383 0.992 . . . . 0.0 111.005 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.39 129.25 90.84 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.343 172.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.97 -34.34 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 124.135 3.224 . . . . 0.0 114.456 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 p -126.72 26.63 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.797 0.726 . . . . 0.0 112.686 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.31 38.44 21.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.88 0.872 . . . . 0.0 111.9 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.95 32.07 0.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.78 1.232 . . . . 0.0 111.811 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mt -144.21 152.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.278 1.431 . . . . 0.0 107.434 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -165.25 173.96 10.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.997 2.119 . . . . 0.0 108.925 164.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.82 123.68 19.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.75 -105.74 2.29 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -98.78 -49.05 4.71 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.581 1.152 . . . . 0.0 109.141 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -128.21 -53.05 1.29 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.334 1.854 . . . . 0.0 107.691 -172.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.41 -165.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.05 148.15 31.19 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.417 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 154.24 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 C-N-CA 126.072 1.749 . . . . 0.0 107.817 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.2 mt -104.53 136.65 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 107.674 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -74.6 77.16 2.0 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.58 62.25 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -41.24 -48.36 3.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.837 2.055 . . . . 0.0 112.232 165.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -99.63 -37.51 9.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.834 2.454 . . . . 0.0 111.236 -165.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.1 t -53.98 126.9 24.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.805 0.729 . . . . 0.0 111.114 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 pt -91.94 8.88 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.817 0.847 . . . . 0.0 112.754 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 54.64 75.32 0.3 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.903 2.481 . . . . 0.0 111.936 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.51 -13.9 13.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 114.04 -174.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.71 -17.76 10.36 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.335 0.969 . . . . 0.0 115.456 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -55.69 -47.85 76.08 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.719 1.759 . . . . 0.0 112.98 -171.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 22.7 p -58.08 -41.3 83.16 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.533 -0.729 . . . . 0.0 109.481 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.04 -43.38 81.91 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.555 -0.715 . . . . 0.0 110.186 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -62.9 -48.11 80.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.823 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 m -68.88 -39.6 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.88 0.763 . . . . 0.0 111.941 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.1 t -55.51 122.09 42.46 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.946 -167.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.18 -39.0 2.36 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.759 3.64 . . . . 0.0 115.137 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.97 28.22 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.248 0.619 . . . . 0.0 112.055 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.21 40.85 45.67 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 118.132 0.424 . . . . 0.0 113.653 171.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.26 1.44 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -58.93 78.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.324 2.683 . . . . 0.0 111.773 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 m -160.63 173.34 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 130.262 3.425 . . . . 0.0 105.173 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.72 158.24 20.82 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 124.045 0.84 . . . . 0.0 112.904 -96.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 128.133 2.573 . . . . 0.0 110.182 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.39 -161.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 166.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -120.44 -179.42 3.96 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 141.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 55.5 mt -83.52 111.13 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 152.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.25 25.06 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 122.191 0.996 . . . . 0.0 112.068 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.97 -28.25 2.65 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.733 2.013 . . . . 0.0 114.11 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -49.42 -24.94 2.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' VAL . 41.7 t -45.08 -73.57 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.268 2.227 . . . . 0.0 114.791 -174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER 66.5 143.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.473 1.109 . . . . 0.0 110.267 -156.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.73 56.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.125 1.77 . . . . 0.0 113.142 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 158.64 25.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.135 1.374 . . . . 0.0 108.713 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.16 28.9 13.27 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.057 -1.027 . . . . 0.0 112.969 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.65 -57.2 2.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.397 1.098 . . . . 0.0 112.998 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.334 28.5 p -73.1 -90.81 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.329 0.968 . . . . 0.0 112.711 -171.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 31.94 -98.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.815 1.643 . . . . 0.0 113.994 -169.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -46.79 -31.92 3.33 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.938 2.095 . . . . 0.0 113.497 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -50.32 -32.41 17.07 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.683 1.193 . . . . 0.0 112.895 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HA ' ' S1 ' ' A' ' 57' ' ' SF4 . 42.5 t -64.41 122.36 77.8 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.443 -0.786 . . . . 0.0 110.499 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -50.94 -35.07 48.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.011 2.474 . . . . 0.0 113.502 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.67 5.53 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 118.304 0.502 . . . . 0.0 111.033 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.06 40.94 26.8 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.007 1.723 . . . . 0.0 110.845 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.31 45.23 1.21 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.755 0.822 . . . . 0.0 110.011 -168.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.86 150.42 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.498 1.919 . . . . 0.0 106.434 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -171.48 174.56 4.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.139 2.176 . . . . 0.0 108.477 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.06 123.82 17.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 167.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.29 -98.47 2.41 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -99.27 -46.06 5.66 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.44 1.496 . . . . 0.0 108.822 -166.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 p -134.61 -56.51 0.84 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.183 1.793 . . . . 0.0 107.28 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 -162.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.339 1.056 . . . . 0.0 110.53 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -78.22 139.8 38.92 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.8 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.46 156.62 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 C-N-CA 126.278 1.831 . . . . 0.0 107.616 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -114.11 142.94 24.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -73.81 78.42 1.59 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.62 56.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 113.022 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -42.1 -49.71 4.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.986 2.114 . . . . 0.0 112.219 165.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -98.56 -31.26 12.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.578 2.351 . . . . 0.0 111.36 -165.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.0 t -49.95 116.86 2.0 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.211 0.914 . . . . 0.0 110.271 169.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.84 -17.84 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 122.735 0.414 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t0 76.62 118.81 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 C-N-CA 127.916 2.486 . . . . 0.0 108.499 -168.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.85 -47.96 0.09 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -168.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.98 -29.59 4.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.526 -1.152 . . . . 0.0 113.274 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -53.33 -51.13 63.39 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.539 1.67 . . . . 0.0 112.593 -164.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.29 -46.91 72.86 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.44 -0.162 . . . . 0.0 110.761 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.92 91.46 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.669 -0.644 . . . . 0.0 110.156 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -51.31 69.53 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.619 0.767 . . . . 0.0 111.806 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -70.13 -39.18 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 119.366 0.985 . . . . 0.0 111.797 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.0 t -55.02 116.65 11.87 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -162.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -46.09 -38.95 19.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.938 3.092 . . . . 0.0 113.835 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.47 9.26 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.716 1.206 . . . . 0.0 112.147 -173.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 48.79 50.85 25.25 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 118.792 0.723 . . . . 0.0 112.94 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.78 -25.35 0.29 Allowed Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 126.281 1.832 . . . . 0.0 114.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.26 81.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.061 2.507 . . . . 0.0 109.21 167.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -161.08 156.69 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 129.221 3.008 . . . . 0.0 104.006 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.5 174.4 7.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 127.445 2.966 . . . . 0.0 114.069 -121.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.82 158.083 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . 0.411 ' S1 ' ' HA ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.291 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -100.22 178.29 4.82 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 142.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -108.51 170.18 8.18 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 152.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 55.8 mt -79.91 106.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 150.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.09 174.94 10.1 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 122.689 1.233 . . . . 0.0 111.667 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.36 -13.69 9.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 128.563 2.745 . . . . 0.0 113.541 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.29 64.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 111.468 170.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 48.5 t -57.51 153.17 13.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.3 1.44 . . . . 0.0 112.272 -177.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.19 156.68 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 162.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m -61.25 66.59 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.815 1.646 . . . . 0.0 113.348 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 -30.33 9.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.342 1.057 . . . . 0.0 112.833 -168.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.15 9.68 60.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.191 1.377 . . . . 0.0 115.772 170.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.88 -61.84 1.83 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.552 1.676 . . . . 0.0 110.789 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.38 -34.09 32.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.275 1.03 . . . . 0.0 111.881 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.97 -45.67 7.89 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -88.02 -6.75 57.81 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.33 -41.27 13.76 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.119 1.768 . . . . 0.0 108.021 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.4 t -49.64 116.99 6.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.333 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.94 -33.28 14.19 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.767 2.978 . . . . 0.0 113.876 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.7 m -111.56 11.53 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.264 0.484 . . . . 0.0 112.065 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 47.89 34.11 3.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.2 40.29 0.62 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.881 1.272 . . . . 0.0 111.199 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.5 mt -133.2 146.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.109 1.364 . . . . 0.0 108.823 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -166.54 167.02 15.89 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.327 1.851 . . . . 0.0 109.649 167.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -74.34 119.18 18.18 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.24 -78.44 1.28 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -169.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -99.87 -54.91 2.78 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.941 0.896 . . . . 0.0 108.91 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -140.88 -56.24 0.5 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.867 2.067 . . . . 0.0 107.377 -167.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -102.64 -174.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.059 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -74.25 148.38 41.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.152 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.97 152.55 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 126.346 1.858 . . . . 0.0 106.988 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 77.4 mt -107.27 138.43 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.516 1.527 . . . . 0.0 107.788 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -74.07 76.2 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.55 60.05 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -167.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -43.97 -47.51 8.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.141 1.776 . . . . 0.0 112.243 167.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -100.27 -30.53 11.84 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.923 2.489 . . . . 0.0 111.393 -165.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -52.29 128.54 25.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.308 0.958 . . . . 0.0 109.793 167.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.0 pt -90.1 130.18 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 161.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.04 74.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.103 1.361 . . . . 0.0 112.236 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -15.17 16.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.507 1.523 . . . . 0.0 111.341 -176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.76 -23.63 0.82 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.233 1.873 . . . . 0.0 115.188 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.15 -39.16 71.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -156.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.4 p -47.44 -32.68 5.31 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.498 1.119 . . . . 0.0 112.578 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -44.47 32.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.379 0.536 . . . . 0.0 112.403 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -51.76 -39.47 58.61 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -167.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -79.71 -26.05 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 117.879 0.309 . . . . 0.0 111.749 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.86 119.11 69.27 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.949 -153.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.34 -37.98 7.81 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.175 3.25 . . . . 0.0 114.377 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.67 33.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.729 0.812 . . . . 0.0 111.633 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.48 49.29 11.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.31 0.957 . . . . 0.0 114.078 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.24 -28.34 0.39 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.814 1.645 . . . . 0.0 114.429 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.96 87.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.648 2.232 . . . . 0.0 109.712 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -165.95 158.82 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.909 0 C-N-CA 128.661 2.784 . . . . 0.0 104.296 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -90.67 166.03 13.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 127.266 2.854 . . . . 0.0 112.95 -118.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 C--O 1.249 1.055 0 C-N-CA 124.896 1.279 . . . . 0.0 110.994 -162.039 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 62.32 -152.13 0.36 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -168.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -131.18 -174.49 3.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 145.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 29.1 mm -79.14 110.07 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 153.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.48 162.45 27.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 122.166 0.984 . . . . 0.0 111.188 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -53.0 -21.36 4.35 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.7 2.0 . . . . 0.0 114.257 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -51.36 -25.65 6.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.737 -0.602 . . . . 0.0 112.565 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.3 t -56.08 109.81 0.65 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.508 1.123 . . . . 0.0 111.97 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -80.71 13.78 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 121.334 -0.854 . . . . 0.0 112.03 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.8 m 59.29 43.93 16.15 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.247 1.019 . . . . 0.0 110.772 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.51 -158.01 0.24 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.498 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.43 39.18 1.25 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 120.088 1.313 . . . . 0.0 111.109 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.46 -40.17 13.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 123.384 0.673 . . . . 0.0 110.987 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.9 p -85.43 -137.35 0.07 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.153 0.581 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.49 -77.72 0.03 OUTLIER 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.04 1.736 . . . . 0.0 113.356 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -56.63 -35.13 67.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.165 0.586 . . . . 0.0 109.952 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -53.38 -31.03 42.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 113.789 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -70.25 127.29 92.33 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.82 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.22 -36.35 5.99 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.689 2.926 . . . . 0.0 113.622 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.79 20.36 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.649 0.38 . . . . 0.0 111.41 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 44.27 39.74 3.2 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.025 1.73 . . . . 0.0 112.912 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.64 40.75 1.2 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.342 1.057 . . . . 0.0 111.296 -165.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.32 149.54 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.51 1.924 . . . . 0.0 106.085 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -173.07 172.9 3.8 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.658 1.983 . . . . 0.0 109.492 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 129.42 40.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.03 -111.06 3.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 124.728 1.156 . . . . 0.0 111.698 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -99.77 -48.72 4.61 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.965 0.906 . . . . 0.0 109.494 -170.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 p -115.65 -60.83 1.82 Allowed 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 127.509 2.324 . . . . 0.0 106.783 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.27 -156.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.725 1.61 . . . . 0.0 110.65 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -74.62 157.19 35.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.826 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 169.97 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 127.789 2.436 . . . . 0.0 108.89 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.7 mt -130.35 143.08 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.539 1.536 . . . . 0.0 107.388 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -75.55 79.13 2.56 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 164.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.11 63.23 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.224 -0.923 . . . . 0.0 113.262 -171.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.86 -35.91 75.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 110.57 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -84.26 -44.2 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.624 1.57 . . . . 0.0 111.091 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -57.57 139.06 54.45 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.572 1.078 . . . . 0.0 110.22 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.1 -116.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -140.18 30.46 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.691 1.997 . . . . 0.0 109.853 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.277 0.0 OUTLIER -72.81 177.54 4.77 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.945 -0.472 . . . . 0.0 111.555 -174.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.57 -32.87 4.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.623 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -54.22 -53.38 54.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.498 1.149 . . . . 0.0 113.516 -150.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.62 -45.2 85.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.566 0.222 . . . . 0.0 110.808 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.53 94.41 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.884 -0.51 . . . . 0.0 109.847 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -50.57 69.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 111.969 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.09 -38.34 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 119.487 1.04 . . . . 0.0 111.669 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -55.2 118.12 16.98 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -163.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -60.84 -23.78 77.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.718 2.278 . . . . 0.0 112.55 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.87 31.3 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.381 0.673 . . . . 0.0 111.073 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 41.62 63.13 1.74 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.646 1.117 . . . . 0.0 113.239 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.85 -30.9 0.24 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.994 1.718 . . . . 0.0 113.541 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.88 78.58 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.758 2.305 . . . . 0.0 108.684 165.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 m -160.79 153.36 4.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 128.67 2.788 . . . . 0.0 104.638 -167.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -91.67 149.65 21.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.493 2.995 . . . . 0.0 115.71 -132.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 102.275 -3.231 . . . . 0.0 102.275 131.808 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -92.61 -165.12 1.28 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.04 178.35 5.82 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 151.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 57.9 mt -84.17 108.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 150.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.79 171.11 15.26 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 122.091 0.948 . . . . 0.0 111.469 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -53.98 -20.6 6.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.196 1.798 . . . . 0.0 113.976 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m -57.77 -20.68 36.87 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.53 -0.731 . . . . 0.0 112.963 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.5 t -56.1 153.58 8.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.084 1.354 . . . . 0.0 111.32 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.7 156.26 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 161.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 m -67.41 63.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.122 0.874 . . . . 0.0 112.738 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.0 -16.79 21.45 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.184 1.393 . . . . 0.0 111.894 -169.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 -58.97 4.88 Favored Glycine 0 C--N 1.338 0.655 0 O-C-N 121.284 -0.885 . . . . 0.0 112.158 169.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -22.27 -65.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.91 2.084 . . . . 0.0 115.004 -167.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 p -56.7 -25.56 54.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.37 -50.35 1.49 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.028 0.931 . . . . 0.0 113.351 167.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.0 m -81.84 -23.74 36.23 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.12 -33.78 75.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.513 1.125 . . . . 0.0 110.959 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' HA ' ' S1 ' ' A' ' 57' ' ' SF4 . 42.6 t -63.54 115.73 20.56 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.416 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.01 -18.42 62.03 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.661 1.574 . . . . 0.0 111.478 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.4 14.16 8.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 CA-C-N 119.052 0.842 . . . . 0.0 111.582 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 43.68 48.02 6.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.851 1.26 . . . . 0.0 111.906 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.16 -5.98 51.18 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.897 0.879 . . . . 0.0 112.026 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.51 146.93 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.202 1.001 . . . . 0.0 110.308 -164.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.6 m -164.23 167.88 19.49 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.235 2.214 . . . . 0.0 109.012 163.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -69.97 122.29 19.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.48 -65.02 1.15 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -170.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -115.08 -70.35 0.8 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -118.82 -58.35 1.96 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.692 1.997 . . . . 0.0 107.759 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -94.67 -174.21 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.866 -176.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -78.16 151.1 33.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.066 0.46 . . . . 0.0 111.189 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.13 142.84 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 126.256 1.823 . . . . 0.0 107.568 -170.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -103.27 139.01 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 127.11 2.164 . . . . 0.0 109.662 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.268 64.3 m-20 -69.82 102.49 1.96 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 159.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.27 -32.77 73.53 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.041 -1.037 . . . . 0.0 112.332 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.55 -37.51 81.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.273 0.558 . . . . 0.0 110.929 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.0 m -80.19 -42.85 22.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.047 0.939 . . . . 0.0 110.6 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.93 127.58 32.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.919 0.781 . . . . 0.0 111.631 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.8 pt -100.64 28.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.863 1.265 . . . . 0.0 112.162 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 51.09 47.45 24.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.918 1.287 . . . . 0.0 111.707 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.256 0.5 OUTLIER -86.11 -164.7 1.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.23 -28.71 3.72 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.704 1.138 . . . . 0.0 114.069 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -54.85 -56.11 22.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.251 1.025 . . . . 0.0 112.885 -153.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.7 p -53.47 -45.6 69.62 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.239 -0.288 . . . . 0.0 110.916 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.62 97.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 110.278 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -61.34 -47.64 84.95 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.661 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.68 -42.13 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.042 0.837 . . . . 0.0 112.266 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -55.52 121.11 36.34 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.262 -159.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.3 -38.83 3.73 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.597 3.531 . . . . 0.0 115.029 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.97 17.55 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.359 0.663 . . . . 0.0 112.382 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.63 44.06 79.16 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 118.593 0.633 . . . . 0.0 112.907 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.65 -25.5 0.66 Allowed Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.46 87.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.936 2.424 . . . . 0.0 110.644 170.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.7 m -162.11 160.14 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.816 0 C-N-CA 128.937 2.895 . . . . 0.0 104.101 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -91.12 170.18 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 127.375 2.922 . . . . 0.0 115.149 -128.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 . . . . . 0 C--O 1.251 1.181 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.219 169.302 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . 0.405 ' S1 ' ' HA ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -89.31 -162.31 0.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 166.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 -177.18 4.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 149.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.27 110.1 20.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 162.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.08 162.04 28.89 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 122.083 0.945 . . . . 0.0 111.337 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -51.38 -26.23 7.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.721 1.609 . . . . 0.0 113.555 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -48.94 -25.45 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.6 t -48.63 -60.25 2.87 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 114.215 -174.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 66.12 162.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.725 -1.234 . . . . 0.0 110.856 -163.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 m -75.41 49.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 119.552 -1.968 . . . . 0.0 111.498 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.65 166.17 23.76 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 154.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.71 38.55 0.71 Allowed Glycine 0 CA--C 1.523 0.587 0 CA-C-N 120.557 1.526 . . . . 0.0 112.391 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.79 -63.02 1.51 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.471 0.635 . . . . 0.0 110.988 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 26.2 p -50.53 -24.58 3.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -169.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -33.85 -53.08 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.707 1.203 . . . . 0.0 114.197 166.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 p -76.09 -26.16 56.19 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.472 -0.768 . . . . 0.0 112.124 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' CG ' ' HA ' ' A' ' 14' ' ' CYS . 24.5 mm-40 -75.9 -29.65 58.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.817 2.047 . . . . 0.0 110.243 -169.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HA ' ' S1 ' ' A' ' 57' ' ' SF4 . 45.8 t -58.6 119.48 36.89 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.082 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.38 -31.83 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.166 2.577 . . . . 0.0 113.345 175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.26 8.17 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.413 0.551 . . . . 0.0 111.653 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 m120 44.98 44.13 7.8 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.831 1.652 . . . . 0.0 111.748 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 33' ' ' ASP . . . -115.14 47.77 1.25 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.976 0.91 . . . . 0.0 110.055 -169.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.43 150.91 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 126.754 2.022 . . . . 0.0 107.143 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -170.86 174.54 4.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.423 2.289 . . . . 0.0 109.049 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -73.33 132.08 42.65 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.52 -81.79 1.58 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -99.37 -56.13 2.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.921 1.288 . . . . 0.0 109.199 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.6 m -138.83 -51.09 0.55 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.968 2.107 . . . . 0.0 107.859 -177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.65 -161.33 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 122.953 0.501 . . . . 0.0 109.844 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.313 5.5 m-85 -79.35 163.63 24.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.418 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.4 163.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 127.774 2.429 . . . . 0.0 108.007 -170.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.35 143.37 38.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 125.248 1.419 . . . . 0.0 108.877 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 26.9 m-20 -75.37 83.71 2.48 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.36 -32.71 62.79 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -43.79 -48.42 8.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.921 1.688 . . . . 0.0 112.031 166.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -98.86 -30.86 12.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.842 2.057 . . . . 0.0 111.486 -165.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.8 t -55.68 127.64 30.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.586 1.084 . . . . 0.0 111.22 172.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.9 pt -104.63 33.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.594 1.558 . . . . 0.0 111.377 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 5.1 m-20 49.27 32.28 4.27 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.547 1.939 . . . . 0.0 113.491 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -76.43 -9.66 58.81 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -165.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.43 -23.52 6.3 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.788 -1.007 . . . . 0.0 114.23 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -53.69 -54.77 33.11 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.585 1.692 . . . . 0.0 111.338 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.43 -42.09 73.69 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.59 87.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.72 -0.613 . . . . 0.0 110.298 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -33.87 64.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 m -73.71 -38.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.813 1.188 . . . . 0.0 110.872 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.6 t -56.11 120.01 31.25 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.605 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -59.79 -29.83 90.55 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.692 2.261 . . . . 0.0 112.031 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.19 17.61 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.323 1.049 . . . . 0.0 111.675 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.03 49.93 5.27 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.818 1.199 . . . . 0.0 113.636 173.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.38 -30.28 0.41 Allowed Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 125.523 1.529 . . . . 0.0 114.76 -174.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.7 90.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.73 2.286 . . . . 0.0 109.942 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 54' ' ' GLN . 28.1 t -165.99 151.05 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 128.788 2.835 . . . . 0.0 103.688 -165.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.558 ' H ' HG12 ' A' ' 53' ' ' VAL . 26.5 tt0 -92.66 157.52 16.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 128.961 3.913 . . . . 0.0 115.609 -130.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 . . . . . 0 C--O 1.249 1.047 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 150.666 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . 0.45 ' S1 ' ' HA ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -93.31 -160.97 0.8 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 164.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -129.94 -176.73 4.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 148.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 64.6 mt -84.06 107.74 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 152.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.55 170.34 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 122.05 0.928 . . . . 0.0 111.289 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.34 -25.61 1.05 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.015 2.126 . . . . 0.0 114.527 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -55.94 -19.12 10.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 42.3 t -56.93 156.85 6.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.241 1.416 . . . . 0.0 111.253 174.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.53 156.91 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 164.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -67.65 65.03 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.909 0.884 . . . . 0.0 111.832 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.261 0.1 OUTLIER -93.54 -162.2 0.92 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.609 1.563 . . . . 0.0 108.816 -177.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.62 42.45 0.71 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 120.932 1.696 . . . . 0.0 110.708 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.96 -37.46 12.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.436 0.695 . . . . 0.0 111.431 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.332 21.5 p -85.53 -100.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.55 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.68 -119.4 0.62 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 121.406 1.912 . . . . 0.0 112.058 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m -68.69 11.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -40.15 96.91 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 158.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.2 t -58.42 120.22 42.59 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.705 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -44.72 -36.98 11.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.774 2.983 . . . . 0.0 113.901 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 p -107.43 5.53 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 117.97 0.35 . . . . 0.0 111.54 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.11 48.36 12.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.436 1.095 . . . . 0.0 111.573 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.02 -11.96 61.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.085 0.954 . . . . 0.0 111.813 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -99.98 144.3 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.469 1.507 . . . . 0.0 110.484 -170.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -166.67 170.9 12.11 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.824 2.45 . . . . 0.0 108.765 162.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -66.74 130.73 44.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.37 -84.7 1.82 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -173.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -99.32 -52.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.59 1.156 . . . . 0.0 108.272 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 m -140.84 -57.58 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.267 2.227 . . . . 0.0 106.37 -171.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -99.91 -158.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.453 0.701 . . . . 0.0 109.828 178.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -93.18 149.68 21.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 111.814 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.57 137.28 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 126.678 1.991 . . . . 0.0 108.662 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -96.72 136.15 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 127.094 2.157 . . . . 0.0 109.733 172.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.252 29.1 m-20 -66.89 102.4 0.96 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 156.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.0 -33.53 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.743 -1.223 . . . . 0.0 112.352 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.79 -38.65 82.47 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.499 0.666 . . . . 0.0 110.609 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -79.23 -43.05 24.57 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.498 1.119 . . . . 0.0 110.1 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.2 t -55.88 115.97 2.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.526 0.603 . . . . 0.0 111.527 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.2 pt -80.03 -0.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 t0 68.92 79.3 0.21 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 110.332 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.22 -31.43 4.39 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -164.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.78 -35.82 4.77 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.636 1.107 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -53.54 163.89 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 161.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . 0.352 5.2 p 60.3 -55.29 0.08 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.535 1.534 . . . . 0.0 112.963 -153.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.5 94.4 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 120.022 1.283 . . . . 0.0 109.806 -174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.83 -28.34 69.49 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.739 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -88.26 -38.87 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.808 1.185 . . . . 0.0 111.176 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -53.6 118.48 14.96 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -166.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.1 -38.22 10.42 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 124.273 3.315 . . . . 0.0 114.159 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.36 18.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.272 1.029 . . . . 0.0 112.377 -176.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.84 42.49 37.84 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.588 0.631 . . . . 0.0 113.792 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 -22.96 0.38 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 125.696 1.599 . . . . 0.0 115.183 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.78 84.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.55 2.167 . . . . 0.0 109.621 166.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -159.68 157.2 3.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 128.808 2.843 . . . . 0.0 104.765 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -91.62 155.85 18.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 127.681 3.113 . . . . 0.0 115.12 -133.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 C--O 1.256 1.411 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 144.749 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -76.84 -177.86 4.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 153.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -118.97 168.69 10.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 102.999 -2.963 . . . . 0.0 102.999 145.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 53.1 mt -80.43 105.34 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 148.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.54 163.83 26.53 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 119.366 -0.933 . . . . 0.0 111.01 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.27 -23.13 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.624 2.77 . . . . 0.0 114.85 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -25.77 4.34 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 168.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.8 t -57.62 158.64 5.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 111.764 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.54 160.84 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 164.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -66.12 63.64 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.99 1.316 . . . . 0.0 112.948 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.73 -32.65 8.32 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.531 1.133 . . . . 0.0 112.44 -165.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.49 15.34 57.05 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.014 1.292 . . . . 0.0 114.585 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.59 -33.14 68.77 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.383 1.092 . . . . 0.0 111.376 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.255 29.0 p -74.17 -90.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 44.05 -110.54 0.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 121.149 1.795 . . . . 0.0 112.236 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m -65.7 -5.96 10.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -38.21 64.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.977 0.808 . . . . 0.0 109.063 164.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 t -58.07 123.11 63.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.903 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -45.02 -38.45 13.66 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.752 2.968 . . . . 0.0 113.799 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 p -101.4 1.83 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.592 0.357 . . . . 0.0 111.344 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 54.22 33.47 18.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.791 1.236 . . . . 0.0 110.925 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.27 38.67 0.49 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.158 1.383 . . . . 0.0 112.053 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.2 mt -133.16 150.48 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 124.292 1.037 . . . . 0.0 109.584 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.4 m -166.5 172.58 10.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.576 2.351 . . . . 0.0 108.136 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -66.32 127.76 33.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.82 -81.73 1.44 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.84 -53.68 3.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.415 1.086 . . . . 0.0 108.436 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 p -141.39 -54.58 0.47 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.192 2.197 . . . . 0.0 107.319 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.25 -173.91 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 122.919 0.488 . . . . 0.0 110.792 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.24 142.9 32.71 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 111.022 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.09 155.25 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 126.413 1.885 . . . . 0.0 108.662 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.48 140.78 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.57 1.548 . . . . 0.0 108.604 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.0 91.25 4.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.82 -36.77 72.72 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.921 -1.112 . . . . 0.0 113.864 -168.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.94 -35.86 67.13 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.122 0.969 . . . . 0.0 110.391 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.0 m -84.41 -47.63 10.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.864 1.666 . . . . 0.0 110.489 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.1 t -57.31 123.16 14.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.989 -0.444 . . . . 0.0 112.119 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.2 pt -90.44 23.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.029 0.932 . . . . 0.0 112.498 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.32 39.52 28.39 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.013 1.725 . . . . 0.0 111.539 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.42 -10.07 59.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -170.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.03 -33.23 1.28 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.916 1.246 . . . . 0.0 115.056 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -48.93 -46.73 43.58 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -157.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.1 p -46.9 -31.67 3.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.991 1.317 . . . . 0.0 112.679 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.15 -43.23 31.19 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.504 0.593 . . . . 0.0 112.368 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -49.92 -38.96 38.51 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.71 -24.94 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.44 119.24 71.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.531 -153.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -43.92 -40.16 11.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.043 3.162 . . . . 0.0 114.41 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.49 16.29 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 112.521 -173.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.52 53.62 19.92 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 118.711 0.687 . . . . 0.0 112.959 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.86 -23.01 0.24 Allowed Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.576 1.951 . . . . 0.0 115.065 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.33 90.15 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.128 1.885 . . . . 0.0 107.603 164.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 m -162.79 152.71 3.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -171.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -90.44 175.11 7.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.986 3.304 . . . . 0.0 112.076 -128.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 115.585 -2.15 . . . . 0.0 110.337 -157.843 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -113.61 -178.27 3.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 103.803 -2.665 . . . . 0.0 103.803 152.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -112.19 168.59 9.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 144.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 8' ' ' CYS . 36.0 mt -80.58 109.46 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 152.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.38 165.73 24.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.468 1.128 . . . . 0.0 111.259 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.57 -20.98 15.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.571 1.548 . . . . 0.0 113.903 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p -55.9 -21.41 20.16 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.584 -0.697 . . . . 0.0 112.829 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 42.0 t -46.58 -72.78 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.538 1.935 . . . . 0.0 115.107 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 68.05 155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.813 1.245 . . . . 0.0 111.864 -163.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 m -66.7 57.39 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.889 1.276 . . . . 0.0 113.431 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . 0.252 0.1 OUTLIER -84.41 -38.38 20.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.472 1.033 . . . . 0.0 113.033 -168.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.71 -155.85 18.3 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.74 1.162 . . . . 0.0 113.207 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.79 -70.58 0.11 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.414 1.886 . . . . 0.0 113.725 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.22 -29.03 63.41 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -161.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.32 -49.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.081 0.953 . . . . 0.0 113.128 166.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.9 m -85.68 -15.74 41.33 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.117 0.567 . . . . 0.0 112.398 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -76.71 -37.11 56.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.471 1.109 . . . . 0.0 110.302 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.09 119.89 38.48 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.498 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.28 -34.44 31.63 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.155 2.57 . . . . 0.0 113.601 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.85 5.72 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.717 0.407 . . . . 0.0 111.238 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.92 31.15 10.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.019 1.327 . . . . 0.0 111.579 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 38.44 0.42 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mt -142.2 146.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.417 1.487 . . . . 0.0 107.342 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -168.08 163.83 13.49 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.454 1.902 . . . . 0.0 110.032 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -68.57 117.19 9.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.69 -76.8 1.21 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -164.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -110.57 -71.2 0.77 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -104.56 -61.01 1.51 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.362 1.065 . . . . 0.0 108.945 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.76 -160.52 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.064 0.946 . . . . 0.0 110.024 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.88 144.26 41.27 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.736 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.76 151.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.414 1.885 . . . . 0.0 106.094 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 mt -105.27 140.3 23.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.74 74.44 1.11 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 162.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.98 -33.19 64.59 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -170.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -42.83 -46.48 5.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.805 2.042 . . . . 0.0 112.216 166.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -104.1 -27.29 12.18 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.116 2.566 . . . . 0.0 112.034 -163.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.6 t -45.2 119.08 1.91 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.622 1.101 . . . . 0.0 110.54 167.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 pt -80.28 34.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.368 -0.833 . . . . 0.0 112.01 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t0 29.38 63.35 0.14 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.152 2.581 . . . . 0.0 113.251 -174.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . 0.28 0.5 OUTLIER -98.36 -141.76 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.291 1.036 . . . . 0.0 108.596 173.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.66 10.94 0.44 Allowed Glycine 0 CA--C 1.529 0.934 0 CA-C-N 121.843 2.11 . . . . 0.0 114.685 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.64 -47.61 76.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.048 1.924 . . . . 0.0 110.876 -172.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.1 p -57.33 -43.93 83.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.028 0.531 . . . . 0.0 110.692 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.35 94.41 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.465 -0.772 . . . . 0.0 109.505 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -51.71 68.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.71 0.804 . . . . 0.0 112.083 173.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.66 -39.22 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.527 1.058 . . . . 0.0 112.446 -174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.2 t -55.7 121.62 40.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -161.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.24 -31.93 82.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.735 2.29 . . . . 0.0 111.961 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.68 11.05 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.893 0.877 . . . . 0.0 111.851 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.69 63.95 3.19 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.18 0.895 . . . . 0.0 112.714 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.56 -28.07 0.19 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 126.382 1.873 . . . . 0.0 114.005 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.53 78.98 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.962 2.441 . . . . 0.0 108.437 164.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.8 m -158.65 153.65 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 128.562 2.745 . . . . 0.0 104.361 -168.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.16 174.18 7.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 128.555 3.66 . . . . 0.0 112.551 -113.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.254 1.308 0 CA-C-O 115.686 -2.102 . . . . 0.0 109.256 -164.307 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.291 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -68.08 -160.13 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.475 1.11 . . . . 0.0 108.299 150.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -122.0 178.31 4.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 146.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.76 107.55 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 151.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.64 168.0 20.85 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.371 1.081 . . . . 0.0 111.268 171.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.57 -9.28 5.62 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.305 1.842 . . . . 0.0 113.888 -173.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -23.58 61.12 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.863 -1.148 . . . . 0.0 111.861 166.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.3 t -63.17 158.83 18.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.006 0.923 . . . . 0.0 110.822 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -136.87 -175.44 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.9 p -73.28 64.08 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.75 175.2 5.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.853 1.661 . . . . 0.0 108.093 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.81 38.36 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 CA-C-N 120.143 1.338 . . . . 0.0 110.868 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -15.18 30.68 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.52 0.728 . . . . 0.0 112.29 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.305 29.9 p -101.41 -95.22 0.28 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 118.589 -0.72 . . . . 0.0 111.219 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 39.7 -99.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.111 1.764 . . . . 0.0 113.689 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -49.49 -29.62 6.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.507 1.523 . . . . 0.0 112.864 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -52.02 -33.39 38.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.316 1.046 . . . . 0.0 112.877 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.0 t -64.26 119.89 60.01 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.483 -0.76 . . . . 0.0 109.781 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.04 -32.29 23.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.236 2.624 . . . . 0.0 113.147 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.7 19.85 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 122.706 0.403 . . . . 0.0 110.947 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.45 22.8 0.77 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.339 1.855 . . . . 0.0 114.231 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.5 44.19 1.02 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.878 1.271 . . . . 0.0 111.322 -166.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.05 147.34 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.818 1.247 . . . . 0.0 107.934 -174.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 m -170.7 169.31 7.12 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.171 2.188 . . . . 0.0 109.49 167.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -67.5 125.66 26.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.69 -84.22 1.68 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -168.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -102.3 -48.04 4.31 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.942 1.297 . . . . 0.0 108.463 -170.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 p -140.21 -59.71 0.53 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.615 1.966 . . . . 0.0 106.854 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -155.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.12 0.968 . . . . 0.0 109.642 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -82.38 157.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.98 0.419 . . . . 0.0 110.672 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.23 160.91 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 C-N-CA 126.099 1.759 . . . . 0.0 106.887 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -119.48 146.74 23.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 125.259 1.424 . . . . 0.0 108.486 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.14 76.29 1.26 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 165.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.68 -35.34 60.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -167.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.4 -37.79 73.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.175 1.39 . . . . 0.0 110.384 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 m -79.9 -49.49 11.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.513 1.525 . . . . 0.0 110.815 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.3 t -61.33 111.8 1.91 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.697 1.237 . . . . 0.0 113.434 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.0 pt -83.45 142.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 156.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 60.68 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.54 2.336 . . . . 0.0 112.412 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 -27.79 48.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.789 0.836 . . . . 0.0 112.806 -166.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.8 -34.03 5.32 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.38 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -54.61 -55.77 25.97 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.674 1.737 . . . . 0.0 112.051 -162.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 p -52.56 -43.04 64.97 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.719 0.295 . . . . 0.0 111.226 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.43 77.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.522 -0.736 . . . . 0.0 110.719 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -70.49 -47.32 61.1 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 119.394 -0.336 . . . . 0.0 110.407 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -68.82 -38.41 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.62 0.646 . . . . 0.0 112.167 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.3 t -55.94 120.06 30.83 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.318 -0.373 . . . . 0.0 111.958 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -59.59 -26.6 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.905 2.404 . . . . 0.0 112.37 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -121.04 24.49 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.705 0.802 . . . . 0.0 111.682 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 42.79 62.72 2.17 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.113 0.864 . . . . 0.0 113.07 172.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.69 -28.03 0.24 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 126.027 1.731 . . . . 0.0 113.998 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.6 80.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.634 2.223 . . . . 0.0 108.009 164.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -157.67 149.01 9.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -92.7 153.88 18.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 128.974 3.921 . . . . 0.0 115.714 -133.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 144.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_